APOA1

Summary Top Help

Gene Description:

apolipoprotein A-I

Synonyms:

Sep-1, Brp-14, Lvtw-1, Sep-2, Sep2, Apoa-1, apoA-I, APOA1, Ltw-1, Apoa1, Alp-1

Orthologs:

Human APOA1 (protein-coding), Mouse Apoa1 (protein-coding), Rat Apoa1 (protein-coding)

Sources

Gene Overview from Genome Browser Top Help

(Human) GRCh37 - chr11:116706467..116708666 (2.20 kb) View in Genome Browser

(Mouse) NCBIM37 - chr9:46036663..46038549 (1.89 kb) View in Genome Browser

HaemAtlas Expression from HaemAtlas Top Help

HaemAtlas Expression Table for APOA1:

Beta Cell Expression from Beta Cell Gene Atlas Top Help

Cell Types Showing Expression: Available

Users should be aware that the scale represents a rank within an experiment rather than a normalized expression signal.

Human					Mouse			Rat
ductal cells	exocrine pancreas	pancreatic islets	primary beta cells	Pancreatic Islets MPSS	beta cell line	pancreatic islets	whole pancreas	alpha cell	beta cell line	pancreatic islets	primary beta cells	whole pancreas

Expression Legend

Tissue Expression from GNF Gene Atlas Top Help

Tissues Showing Expression: Available

Users should be aware that the scale represents a rank within an experiment rather than a normalized expression signal.

Expression Legend

Interactions Top Help

Interactions Table for APOA1:

Cross-Reference to Pathways and GO Terms Top Help

View all

KEGG Network: 4

Biocarta: 1

Reactome: 14

NCI-Nature Pathway Interaction Database: 1

Gene Ontology: 63

Beta-amyloid binding	GO:0001540
Regulation of protein phosphorylation	GO:0001932
Endothelial cell proliferation	GO:0001935
Platelet degranulation	GO:0002576
Negative regulation of cytokine secretion involved in immune response	GO:0002740
Lipid transporter activity	GO:0005319
Protein binding	GO:0005515
Phospholipid binding	GO:0005543
Extracellular region	GO:0005576
Extracellular space	GO:0005615
Endoplasmic reticulum lumen	GO:0005788
Plasma membrane	GO:0005886
Lipid metabolic process	GO:0006629
Phospholipid metabolic process	GO:0006644
Phosphatidylcholine biosynthetic process	GO:0006656
Cholesterol biosynthetic process	GO:0006695
G-protein coupled receptor signaling pathway	GO:0007186
Blood coagulation	GO:0007596
High-density lipoprotein particle binding	GO:0008035
Steroid metabolic process	GO:0008202
Cholesterol metabolic process	GO:0008203
Glucocorticoid metabolic process	GO:0008211
Positive regulation of cholesterol esterification	GO:0010873
Negative regulation of very-low-density lipoprotein particle remodeling	GO:0010903
Cholesterol binding	GO:0015485
Cholesterol transporter activity	GO:0017127
Enzyme binding	GO:0019899
Lipid storage	GO:0019915
Endocytic vesicle	GO:0030139
Secretory granule	GO:0030141
Platelet activation	GO:0030168
Regulation of intestinal cholesterol absorption	GO:0030300
Cholesterol transport	GO:0030301
Adrenal gland development	GO:0030325
Cytoplasmic vesicle	GO:0031410
Cdc42 protein signal transduction	GO:0032488
Cholesterol efflux	GO:0033344
Phospholipid efflux	GO:0033700
Apolipoprotein receptor binding	GO:0034190
Apolipoprotein A-I receptor binding	GO:0034191
Very-low-density lipoprotein particle	GO:0034361
High-density lipoprotein particle	GO:0034364
Spherical high-density lipoprotein particle	GO:0034366
High-density lipoprotein particle remodeling	GO:0034375
High-density lipoprotein particle assembly	GO:0034380
High-density lipoprotein particle clearance	GO:0034384
Lipoprotein metabolic process	GO:0042157
Lipoprotein biosynthetic process	GO:0042158
Cholesterol homeostasis	GO:0042632
Identical protein binding	GO:0042802
Blood vessel endothelial cell migration	GO:0043534
Reverse cholesterol transport	GO:0043691
Cellular lipid metabolic process	GO:0044255
Small molecule metabolic process	GO:0044281
Negative regulation of interleukin-1 beta secretion	GO:0050713
Protein stabilization	GO:0050821
Positive regulation of hydrolase activity	GO:0051345
Negative regulation of hydrolase activity	GO:0051346
Positive regulation of transferase activity	GO:0051347
Transmembrane transport	GO:0055085
Phosphatidylcholine-sterol O-acyltransferase activator activity	GO:0060228
Cholesterol import	GO:0070508
High-density lipoprotein particle receptor binding	GO:0070653

KEGG Network: 4
African trypanosomiasis	Human - 5143	Mouse - 5143	Rat - 5143
Fat digestion and absorption	Human - 4975	Mouse - 4975	Rat - 4975
PPAR signaling pathway	Human - 3320	Mouse - 3320	Rat - 3320
Vitamin digestion and absorption	Human - 4977	Mouse - 4977	Rat - 4977

Biocarta: 1
Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha)	Human

Reactome: 14
ABC-family proteins mediated transport	REACT_15480
Chylomicron-mediated lipid transport	REACT_6841
Fatty acid, triacylglycerol, and ketone body metabolism	REACT_22279
Formation of Platelet plug	REACT_20
HDL-mediated lipid transport	REACT_13621
Hemostasis	REACT_604
Lipid digestion, mobilization, and transport	REACT_602
Lipoprotein metabolism	REACT_6823
Metabolism of lipids and lipoproteins	REACT_22258
Platelet Activation	REACT_798
Platelet degranulation	REACT_318
Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	REACT_19241
Response to elevated platelet cytosolic Ca2+	REACT_1280
Transmembrane transport of small molecules	REACT_15518

NCI-Nature Pathway Interaction Database: 1

FOXA2 and FOXA3 transcription factor networks

Gene Ontology: 63
Beta-amyloid binding	GO:0001540
Regulation of protein phosphorylation	GO:0001932
Endothelial cell proliferation	GO:0001935
Platelet degranulation	GO:0002576
Negative regulation of cytokine secretion involved in immune response	GO:0002740
Lipid transporter activity	GO:0005319
Protein binding	GO:0005515
Phospholipid binding	GO:0005543
Extracellular region	GO:0005576
Extracellular space	GO:0005615
Endoplasmic reticulum lumen	GO:0005788
Plasma membrane	GO:0005886
Lipid metabolic process	GO:0006629
Phospholipid metabolic process	GO:0006644
Phosphatidylcholine biosynthetic process	GO:0006656
Cholesterol biosynthetic process	GO:0006695
G-protein coupled receptor signaling pathway	GO:0007186
Blood coagulation	GO:0007596
High-density lipoprotein particle binding	GO:0008035
Steroid metabolic process	GO:0008202
Cholesterol metabolic process	GO:0008203
Glucocorticoid metabolic process	GO:0008211
Positive regulation of cholesterol esterification	GO:0010873
Negative regulation of very-low-density lipoprotein particle remodeling	GO:0010903
Cholesterol binding	GO:0015485
Cholesterol transporter activity	GO:0017127
Enzyme binding	GO:0019899
Lipid storage	GO:0019915
Endocytic vesicle	GO:0030139
Secretory granule	GO:0030141
Platelet activation	GO:0030168
Regulation of intestinal cholesterol absorption	GO:0030300
Cholesterol transport	GO:0030301
Adrenal gland development	GO:0030325
Cytoplasmic vesicle	GO:0031410
Cdc42 protein signal transduction	GO:0032488
Cholesterol efflux	GO:0033344
Phospholipid efflux	GO:0033700
Apolipoprotein receptor binding	GO:0034190
Apolipoprotein A-I receptor binding	GO:0034191
Very-low-density lipoprotein particle	GO:0034361
High-density lipoprotein particle	GO:0034364
Spherical high-density lipoprotein particle	GO:0034366
High-density lipoprotein particle remodeling	GO:0034375
High-density lipoprotein particle assembly	GO:0034380
High-density lipoprotein particle clearance	GO:0034384
Lipoprotein metabolic process	GO:0042157
Lipoprotein biosynthetic process	GO:0042158
Cholesterol homeostasis	GO:0042632
Identical protein binding	GO:0042802
Blood vessel endothelial cell migration	GO:0043534
Reverse cholesterol transport	GO:0043691
Cellular lipid metabolic process	GO:0044255
Small molecule metabolic process	GO:0044281
Negative regulation of interleukin-1 beta secretion	GO:0050713
Protein stabilization	GO:0050821
Positive regulation of hydrolase activity	GO:0051345
Negative regulation of hydrolase activity	GO:0051346
Positive regulation of transferase activity	GO:0051347
Transmembrane transport	GO:0055085
Phosphatidylcholine-sterol O-acyltransferase activator activity	GO:0060228
Cholesterol import	GO:0070508
High-density lipoprotein particle receptor binding	GO:0070653

Publications from PubMed Top Help

Type 1 Diabetes Publications: 9

Identification of de novo synthesized and relatively older proteins -- Accelerated oxidative damage to de novo synthesized ApoA-1 in type 1 diabetes.
Jaleel A, Henderson GC, Madden BJ, Klaus KA, Morse DM, Gopala S, Nair KS
Diabetes. 2010
PubMed ID: 20622162
Elevation of apolipoprotein A-I and apolipoprotein H levels in the vitreous fluid and overexpression in the retina of diabetic patients.
Simó R, Higuera M, García-Ramírez M, Canals F, García-Arumí J, Hernández C
Arch Ophthalmol. 2008
PubMed ID: 18695102
Identification of transcripts with enriched expression in the developing and adult pancreas.
Hoffman BG, Zavaglia B, Witzsche J, Ruiz de Algara T, Beach M, Hoodless PA, Jones S, Marra MA, Helgason CD
Genome Biol. 2008
PubMed ID: 18554416
Increased methionine sulfoxide content of apoA-I in type 1 diabetes.
Brock JW, Jenkins AJ, Lyons TJ, Klein RL, Yim E, Lopes-Virella M, Carter RE, (DCCT/EDIC) Research Group, Thorpe SR, Baynes JW
J Lipid Res. 2008
PubMed ID: 18202432
The roles of ATF3 in glucose homeostasis. A transgenic mouse model with liver dysfunction and defects in endocrine pancreas.
Allen-Jennings AE, Hartman MG, Kociba GJ, Hai T
J Biol Chem. 2001
PubMed ID: 11371557
Inactivation of the winged helix transcription factor HNF3alpha affects glucose homeostasis and islet glucagon gene expression in vivo.
Kaestner KH, Katz J, Liu Y, Drucker DJ, Schütz G
Genes Dev. 1999
PubMed ID: 10049364
Predominance of large low density lipoprotein particles and lower fractional esterification rate of cholesterol in high density lipoprotein in children with insulin-dependent diabetes mellitus.
Ohta T, Nishiyama S, Nakamura T, Saku K, Maung KK, Matsuda I
Eur J Pediatr. 1998
PubMed ID: 9578960
Genetic control of diabetogenesis in NOD/Lt mice. Development and analysis of congenic stocks.
Prochazka M, Serreze DV, Worthen SM, Leiter EH
Diabetes. 1989
PubMed ID: 2576007
Three recessive loci required for insulin-dependent diabetes in nonobese diabetic mice.
Prochazka M, Leiter EH, Serreze DV, Coleman DL
Science. 1987
PubMed ID: 2885918

Publications: 858

The interaction between ubiquitin C-terminal hydrolase 37 and glucose-regulated protein 78 in hepatocellular carcinoma.
Fang Y, Mu J, Ma Y, Ma D, Fu D, Shen X
Mol Cell Biochem. 2012
PubMed ID: 21800051
Apolipoprotein A-I stimulates cholesteryl ester transfer protein and apolipoprotein E secretion from lipid-loaded macrophages; the role of NF-κB and PKA signaling pathways.
Niculescu LS, Robciuc MR, Sanda GM, Sima AV
Biochem Biophys Res Commun. 2011
PubMed ID: 22056562
Crystal structure of C-terminal truncated apolipoprotein A-I reveals the assembly of high density lipoprotein (HDL) by dimerization.
Mei X, Atkinson D
J Biol Chem. 2011
PubMed ID: 21914797
Membrane microdomains modulate oligomeric ABCA1 function: impact on apoAI-mediated lipid removal and phosphatidylcholine biosynthesis.
Iatan I, Bailey D, Ruel I, Hafiane A, Campbell S, Krimbou L, Genest J
J Lipid Res. 2011
PubMed ID: 21846716
Disruption of the murine procollagen C-proteinase enhancer 2 gene causes accumulation of pro-apoA-I and increased HDL levels.
Francone OL, Ishida BY, de la Llera-Moya M, Royer L, Happe C, Zhu J, Chalkey RJ, Schaefer P, Cox C, Burlingame A, Kane JP, Rothblat GH
J Lipid Res. 2011
PubMed ID: 21771977
Impact of self-association on function of apolipoprotein A-I.
Jayaraman S, Abe-Dohmae S, Yokoyama S, Cavigiolio G
J Biol Chem. 2011
PubMed ID: 21835924
Proteome of skeletal muscle lipid droplet reveals association with mitochondria and apolipoprotein a-I.
Zhang H, Wang Y, Li J, Yu J, Pu J, Li L, Zhang H, Zhang S, Peng G, Yang F, Liu P
J Proteome Res. 2011
PubMed ID: 21870882
ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice.
Murphy AJ, Akhtari M, Tolani S, Pagler T, Bijl N, Kuo CL, Wang M, Sanson M, Abramowicz S, Welch C, Bochem AE, Kuivenhoven JA, Yvan-Charvet L, Tall AR
J Clin Invest. 2011
PubMed ID: 21968112
Amyloidogenicity and clinical phenotype associated with five novel mutations in apolipoprotein A-I.
Rowczenio D, Dogan A, Theis JD, Vrana JA, Lachmann HJ, Wechalekar AD, Gilbertson JA, Hunt T, Gibbs SD, Sattianayagam PT, Pinney JH, Hawkins PN, Gillmore JD
Am J Pathol. 2011
PubMed ID: 21820994
The Apolipoprotein B/Apolipoprotein A 1 ratio in relation to metabolic syndrome and its components in a sample of the Tunisian population.
Belfki H, Ben Ali S, Bougatef S, Ben Ahmed D, Haddad N, Jmal A, Abdennebi M, Ben Romdhane H
Exp Mol Pathol. 2011
PubMed ID: 21801720
Interfacial interactions of apolipoprotein AI and high density lipoprotein: overlooked phenomena in blood-material contact.
Cornelius RM, Macri J, Brash JL
J Biomed Mater Res A. 2011
PubMed ID: 21800421
A directed protein interaction network for investigating intracellular signal transduction.
Vinayagam A, Stelzl U, Foulle R, Plassmann S, Zenkner M, Timm J, Assmus HE, Andrade-Navarro MA, Wanker EE
Sci Signal. 2011
PubMed ID: 21900206
Farnesoid X receptor represses hepatic human APOA gene expression.
Chennamsetty I, Claudel T, Kostner KM, Baghdasaryan A, Kratky D, Levak-Frank S, Frank S, Gonzalez FJ, Trauner M, Kostner GM
J Clin Invest. 2011
PubMed ID: 21804189
Identification of haptoglobin and apolipoprotein A-I as biomarkers for high altitude pulmonary edema.
Ahmad Y, Shukla D, Garg I, Sharma NK, Saxena S, Malhotra VK, Bhargava K
Funct Integr Genomics. 2011
PubMed ID: 21755356
Human apolipoprotein A-I induces cyclooxygenase-2 expression and prostaglandin I-2 release in endothelial cells through ATP-binding cassette transporter A1.
Liu D, Ji L, Tong X, Pan B, Han JY, Huang Y, Chen YE, Pennathur S, Zhang Y, Zheng L
Am J Physiol Cell Physiol. 2011
PubMed ID: 21734188
Apolipoprotein A1 and C-terminal fragment of α-1 antichymotrypsin are candidate plasma biomarkers associated with acute renal allograft rejection.
Ziegler ME, Chen T, LeBlanc JF, Wei X, Gjertson DW, Li KC, Khalighi MA, Lassman CR, Veale JL, Gritsch HA, Reed EF
Transplantation. 2011
PubMed ID: 21730889
Association of a DNA polymorphism of the apolipoprotein AI-CIII-AIV gene cluster with myocardial infarction in a Tunisian population.
Sediri Y, Kallel A, Feki M, Mourali S, Elasmi M, Abdessalem S, Mechmeche R, Jemaa R, Kaabachi N
Eur J Intern Med. 2011
PubMed ID: 21767760
Complement component C4A and apolipoprotein A-I in plasmas as biomarkers of the severe, early-onset preeclampsia.
Zhang H, Zhang Y, Yang F, Li L, Liu S, Xu Z, Wang J, Sun S
Mol Biosyst. 2011
PubMed ID: 21677994
Identification of apolipoprotein A1 in the human embryonic secretome.
Mains LM, Christenson L, Yang B, Sparks AE, Mathur S, Van Voorhis BJ
Fertil Steril. 2011
PubMed ID: 21676393
ApoA-I deficiency in mice is associated with redistribution of apoA-II and aggravated AApoAII amyloidosis.
Wang Y, Sawashita J, Qian J, Zhang B, Fu X, Tian G, Chen L, Mori M, Higuchi K
J Lipid Res. 2011
PubMed ID: 21622630
The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins.
Di Bartolo BA, Nicholls SJ, Bao S, Rye KA, Heather AK, Barter PJ, Bursill C
Atherosclerosis. 2011
PubMed ID: 21571275
Mutation in APOA1 predicts increased risk of ischaemic heart disease and total mortality without low HDL cholesterol levels.
Haase CL, Frikke-Schmidt R, Nordestgaard BG, Kateifides AK, Kardassis D, Nielsen LB, Andersen CB, Køber L, Johnsen AH, Grande P, Zannis VI, Tybjaerg-Hansen A
J Intern Med. 2011
PubMed ID: 21443680
Plasma myeloperoxidase activity and apolipoprotein A-1 expression in chronic hepatitis B patients.
Mohamadkhani A, Jazii FR, Sayehmiri K, Jafari-Nejad S, Montaser-Kouhsari L, Poustchi H, Montazeri G
Arch Iran Med. 2011
PubMed ID: 21726101
Alteration of negatively charged residues in the 89 to 99 domain of apoA-I affects lipid homeostasis and maturation of HDL.
Kateifides AK, Gorshkova IN, Duka A, Chroni A, Kardassis D, Zannis VI
J Lipid Res. 2011
PubMed ID: 21504968
Inhibition of rupture of established atherosclerotic plaques by treatment with apolipoprotein A-I.
Reimers GJ, Jackson CL, Rickards J, Chan PY, Cohn JS, Rye KA, Barter PJ, Rodgers KJ
Cardiovasc Res. 2011
PubMed ID: 21354994
A conditional knockout resource for the genome-wide study of mouse gene function.
Skarnes WC, Rosen B, West AP, Koutsourakis M, Bushell W, Iyer V, Mujica AO, Thomas M, Harrow J, Cox T, Jackson D, Severin J, Biggs P, Fu J, Nefedov M, de Jong PJ, Stewart AF, Bradley A
Nature. 2011
PubMed ID: 21677750
Effect of the amyloidogenic L75P apolipoprotein A-I variant on HDL subpopulations.
Gomaraschi M, Obici L, Simonelli S, Gregorini G, Negrinelli A, Merlini G, Franceschini G, Calabresi L
Clin Chim Acta. 2011
PubMed ID: 21458433
Characterization of antioxidant/anti-inflammatory properties and apoA-I-containing subpopulations of HDL from family subjects with monogenic low HDL disorders.
Daniil G, Phedonos AA, Holleboom AG, Motazacker MM, Argyri L, Kuivenhoven JA, Chroni A
Clin Chim Acta. 2011
PubMed ID: 21420943
Steatosis induced by the accumulation of apolipoprotein A-I and elevated ROS levels in H-ras12V transgenic mice contributes to hepatic lesions.
Wang AG, Moon HB, Chae JI, Kim JM, Kim YE, Yu DY, Lee DS
Biochem Biophys Res Commun. 2011
PubMed ID: 21600874
Female patients with atrial fibrillation have increased oxidized and glycated lipoprotein properties and lower apolipoprotein A-I expression in HDL.
Kim SM, Lee JH, Kim JR, Shin DG, Lee SH, Cho KH
Int J Mol Med. 2011
PubMed ID: 21399863
Validation of human ApoB and ApoAI immunoturbidity assays for non-human primate dyslipidemia and atherosclerosis research.
Chen Z, Strack AM, Stefanni AC, Chen Y, Wu W, Pan Y, Urosevic-Price O, Wang L, McLaughlin T, Geoghagen N, Lassman ME, Roddy TP, Wong KK, Hubbard BK, Flattery AM
J Cardiovasc Transl Res. 2011
PubMed ID: 21394531
Analysis of apolipoprotein A-I as a substrate for matrix metalloproteinase-14.
Park JH, Park SM, Park KH, Cho KH, Lee ST
Biochem Biophys Res Commun. 2011
PubMed ID: 21549099
Pressure perturbation calorimetry of lipoproteins reveals an endothermic transition without detectable volume changes. Implications for adsorption of apolipoprotein to a phospholipid surface.
Jayaraman S, Jasuja R, Zakharov MN, Gursky O
Biochemistry. 2011
PubMed ID: 21452855
Comparison of lipid profiles with APOA1 MspI polymorphism in obese children with hyperlipidemia.
Toptas B, Görmüş U, Ergen A, Gürkan H, Keleşoglu F, Darendeliler F, Bas F, Dalan AB, Izbirak G, Isbir T
In Vivo. 2011
PubMed ID: 21576418
High-density lipoprotein cholesterol and apolipoprotein A1 levels strongly influence the reactivity of small peripheral arteries.
Ferré R, Aragonès G, Plana N, Merino J, Heras M, Buixadera C, Masana L
Atherosclerosis. 2011
PubMed ID: 21367423
Lipid-free apolipoprotein A-I and discoidal reconstituted high-density lipoproteins differentially inhibit glucose-induced oxidative stress in human macrophages.
Tabet F, Lambert G, Cuesta Torres LF, Hou L, Sotirchos I, Touyz RM, Jenkins AJ, Barter PJ, Rye KA
Arterioscler Thromb Vasc Biol. 2011
PubMed ID: 21330603
Proteomic analysis reveals that apolipoprotein A1 levels are decreased in patients with Budd-Chiari syndrome.
Talens S, Hoekstra J, Dirkx SP, Darwish Murad S, Trebicka J, Elias E, Primignani M, García-Pagán JC, Valla DC, Janssen HL, Leebeek FW, Rijken DC, EN-Vie Study Group
J Hepatol. 2011
PubMed ID: 21145806
Apolipoprotein B/A1 ratio is associated with free androgen index and visceral adiposity and may be an indicator of metabolic syndrome in male children and adolescents.
Lee YH, Choi SH, Lee KW, Kim DJ
Clin Endocrinol (Oxf). 2011
PubMed ID: 21138461
HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells.
Feig JE, Rong JX, Shamir R, Sanson M, Vengrenyuk Y, Liu J, Rayner K, Moore K, Garabedian M, Fisher EA
Proc Natl Acad Sci U S A. 2011
PubMed ID: 21482781
Tristetraprolin-dependent post-transcriptional regulation of inflammatory cytokine mRNA expression by apolipoprotein A-I: role of ATP-binding membrane cassette transporter A1 and signal transducer and activator of transcription 3.
Yin K, Deng X, Mo ZC, Zhao GJ, Jiang J, Cui LB, Tan CZ, Wen GB, Fu Y, Tang CK
J Biol Chem. 2011
PubMed ID: 21339300
The low resolution structure of ApoA1 in spherical high density lipoprotein revealed by small angle neutron scattering.
Wu Z, Gogonea V, Lee X, May RP, Pipich V, Wagner MA, Undurti A, Tallant TC, Baleanu-Gogonea C, Charlton F, Ioffe A, DiDonato JA, Rye KA, Hazen SL
J Biol Chem. 2011
PubMed ID: 21292766
Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma.
Huang R, Silva RA, Jerome WG, Kontush A, Chapman MJ, Curtiss LK, Hodges TJ, Davidson WS
Nat Struct Mol Biol. 2011
PubMed ID: 21399642
Effects of the known pathogenic mutations on the aggregation pathway of the amyloidogenic peptide of apolipoprotein A-I.
Raimondi S, Guglielmi F, Giorgetti S, Di Gaetano S, Arciello A, Monti DM, Relini A, Nichino D, Doglia SM, Natalello A, Pucci P, Mangione P, Obici L, Merlini G, Stoppini M, Robustelli P, Tartaglia GG, Vendruscolo M, Dobson CM, Piccoli R, Bellotti V
J Mol Biol. 2011
PubMed ID: 21296086
Apolipoprotein A-I possesses an anti-obesity effect associated with increase of energy expenditure and up-regulation of UCP1 in brown fat.
Ruan X, Li Z, Zhang Y, Yang L, Pan Y, Wang Z, Feng GS, Chen Y
J Cell Mol Med. 2011
PubMed ID: 20193037
"Sticky" and "promiscuous", the yin and yang of apolipoprotein A-I termini in discoidal high-density lipoproteins: a combined computational-experimental approach.
Jones MK, Gu F, Catte A, Li L, Segrest JP
Biochemistry. 2011
PubMed ID: 21329368
Enhanced binding of apolipoprotein A-I variants associated with hypertriglyceridemia to triglyceride-rich particles.
Gorshkova IN, Atkinson D
Biochemistry. 2011
PubMed ID: 21288012
Carboxyl terminus of apolipoprotein A-I (ApoA-I) is necessary for the transport of lipid-free ApoA-I but not prelipidated ApoA-I particles through aortic endothelial cells.
Ohnsorg PM, Rohrer L, Perisa D, Kateifides A, Chroni A, Kardassis D, Zannis VI, von Eckardstein A
J Biol Chem. 2011
PubMed ID: 21209084
Protein-protein interaction heterogeneity of plasma apolipoprotein A1 in nephrotic syndrome.
Santucci L, Candiano G, Petretto A, Pavone B, Bruschi M, Gusmano R, Federici G, Urbani A, Ghiggeri GM
Mol Biosyst. 2011
PubMed ID: 21416664
APOA-1 is a novel marker of erythroid cell maturation from hematopoietic stem cells in mice and humans.
Inoue T, Sugiyama D, Kurita R, Oikawa T, Kulkeaw K, Kawano H, Miura Y, Okada M, Suehiro Y, Takahashi A, Marumoto T, Inoue H, Komatsu N, Tani K
Stem Cell Rev. 2011
PubMed ID: 20376577
Homocysteine is a determinant of ApoA-I and both are associated with ankle brachial index, in an ambulatory elderly population.
Guéant-Rodriguez RM, Spada R, Moreno-Garcia M, Anello G, Bosco P, Lagrost L, Romano A, Elia M, Guéant JL
Atherosclerosis. 2011
PubMed ID: 21156318
Membrane insertion topology of the central apolipoprotein A-I region. Fluorescence studies using single tryptophan mutants.
Prieto ED, Garda HA
Biochemistry. 2011
PubMed ID: 21141907
Do lipids and apolipoproteins predict coronary heart disease under statin and fibrate therapy in the primary prevention setting in community-dwelling elderly subjects? The 3C Study.
Straczek C, Tafflet M, Barberger-Gateau P, Bertrand M, Dupuy AM, Ducimetière P, Empana JP
Atherosclerosis. 2011
PubMed ID: 21129746
Gene-nutrient interactions and gender may modulate the association between ApoA1 and ApoB gene polymorphisms and metabolic syndrome risk.
Phillips CM, Goumidi L, Bertrais S, Field MR, McManus R, Hercberg S, Lairon D, Planells R, Roche HM
Atherosclerosis. 2011
PubMed ID: 21122859
The β-subunit of ATP synthase is involved in cellular uptake and resecretion of apoA-I but does not control apoA-I-induced lipid efflux in adipocytes.
Howard AD, Verghese PB, Arrese EL, Soulages JL
Mol Cell Biochem. 2011
PubMed ID: 21069432
Structure of apolipoprotein A-I N terminus on nascent high density lipoproteins.
Lagerstedt JO, Cavigiolio G, Budamagunta MS, Pagani I, Voss JC, Oda MN
J Biol Chem. 2011
PubMed ID: 21047795
Caveolin-1-mediated apolipoprotein A-I membrane binding sites are not required for cholesterol efflux.
Le Lay S, Rodriguez M, Jessup W, Rentero C, Li Q, Cartland S, Grewal T, Gaus K
PLoS One. 2011
PubMed ID: 21858084
Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels.
Yin RX, Li YY, Lai CQ
Lipids Health Dis. 2011
PubMed ID: 21854571
Human apolipoprotein A-I-derived amyloid: its association with atherosclerosis.
Ramella NA, Rimoldi OJ, Prieto ED, Schinella GR, Sanchez SA, Jaureguiberry MS, Vela ME, Ferreira ST, Tricerri MA
PLoS One. 2011
PubMed ID: 21811627
Apolipoprotein A-I, A-II, and H mRNA and protein accumulation sites in the developing lung in late gestation.
Côté M, Provost PR, Tremblay Y
BMC Res Notes. 2011
PubMed ID: 21756353
Plasma proteome changes in cardiovascular disease patients: novel isoforms of apolipoprotein A1.
Májek P, Reicheltová Z, Suttnar J, Malý M, Oravec M, Pečánková K, Dyr JE
J Transl Med. 2011
PubMed ID: 21631938
Metabolic syndrome in South Asian immigrants: more than low HDL requiring aggressive management.
Dodani S, Henkhaus R, Wick J, Vacek J, Gupta K, Dong L, Butler MG
Lipids Health Dis. 2011
PubMed ID: 21410987
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease.
Schunkert H, König IR, Kathiresan S, Reilly MP, Assimes TL, Holm H, Preuss M, Stewart AF, Barbalic M, Gieger C, Absher D, Aherrahrou Z, Allayee H, Altshuler D, Anand SS, Andersen K, Anderson JL, Ardissino D, Ball SG, Balmforth AJ, Barnes TA, Becker DM, Becker LC, Berger K, Bis JC, Boekholdt SM, Boerwinkle E, Braund PS, Brown MJ, Burnett MS, Buysschaert I, Cardiogenics, Carlquist JF, Chen L, Cichon S, Codd V, Davies RW, Dedoussis G, Dehghan A, Demissie S, Devaney JM, Diemert P, Do R, Doering A, Eifert S, Mokhtari NE, Ellis SG, Elosua R, Engert JC, Epstein SE, de Faire U, Fischer M, Folsom AR, Freyer J, Gigante B, Girelli D, Gretarsdottir S, Gudnason V, Gulcher JR, Halperin E, Hammond N, Hazen SL, Hofman A, Horne BD, Illig T, Iribarren C, Jones GT, Jukema JW, Kaiser MA, Kaplan LM, Kastelein JJ, Khaw KT, Knowles JW, Kolovou G, Kong A, Laaksonen R, Lambrechts D, Leander K, Lettre G, Li M, Lieb W, Loley C, Lotery AJ, Mannucci PM, Maouche S, Martinelli N, McKeown PP, Meisinger C, Meitinger T, Melander O, Merlini PA, Mooser V, Morgan T, Mühleisen TW, Muhlestein JB, Münzel T, Musunuru K, Nahrstaedt J, Nelson CP, Nöthen MM, Olivieri O, Patel RS, Patterson CC, Peters A, Peyvandi F, Qu L, Quyyumi AA, Rader DJ, Rallidis LS, Rice C, Rosendaal FR, Rubin D, Salomaa V, Sampietro ML, Sandhu MS, Schadt E, Schäfer A, Schillert A, Schreiber S, Schrezenmeir J, Schwartz SM, Siscovick DS, Sivananthan M, Sivapalaratnam S, Smith A, Smith TB, Snoep JD, Soranzo N, Spertus JA, Stark K, Stirrups K, Stoll M, Tang WH, Tennstedt S, Thorgeirsson G, Thorleifsson G, Tomaszewski M, Uitterlinden AG, van Rij AM, Voight BF, Wareham NJ, Wells GA, Wichmann HE, Wild PS, Willenborg C, Witteman JC, Wright BJ, Ye S, Zeller T, Ziegler A, Cambien F, Goodall AH, Cupples LA, Quertermous T, März W, Hengstenberg C, Blankenberg S, Ouwehand WH, Hall AS, Deloukas P, Thompson JR, Stefansson K, Roberts R, Thorsteinsdottir U, O'Donnell CJ, McPherson R, Erdmann J, CARDIoGRAM Consortium, Samani NJ
Nat Genet. 2011
PubMed ID: 21378990
[Effects of the +83C/T polymorphism in apolipoprotein AI gene on the changes of serum biochemical traits of gluocse and lipid metabolism induced by high-carbohydrate diets].
Song YY, Gong RR, Li RH, Li YJ, Zhang Z, Fang DZ
Sichuan Da Xue Xue Bao Yi Xue Ban. 2011
PubMed ID: 21355296
Initial characterization of the human central proteome.
Burkard TR, Planyavsky M, Kaupe I, Breitwieser FP, Bürckstümmer T, Bennett KL, Superti-Furga G, Colinge J
BMC Syst Biol. 2011
PubMed ID: 21269460
A high-resolution anatomical atlas of the transcriptome in the mouse embryo.
Diez-Roux G, Banfi S, Sultan M, Geffers L, Anand S, Rozado D, Magen A, Canidio E, Pagani M, Peluso I, Lin-Marq N, Koch M, Bilio M, Cantiello I, Verde R, De Masi C, Bianchi SA, Cicchini J, Perroud E, Mehmeti S, Dagand E, Schrinner S, Nürnberger A, Schmidt K, Metz K, Zwingmann C, Brieske N, Springer C, Hernandez AM, Herzog S, Grabbe F, Sieverding C, Fischer B, Schrader K, Brockmeyer M, Dettmer S, Helbig C, Alunni V, Battaini MA, Mura C, Henrichsen CN, Garcia-Lopez R, Echevarria D, Puelles E, Garcia-Calero E, Kruse S, Uhr M, Kauck C, Feng G, Milyaev N, Ong CK, Kumar L, Lam M, Semple CA, Gyenesei A, Mundlos S, Radelof U, Lehrach H, Sarmientos P, Reymond A, Davidson DR, Dollé P, Antonarakis SE, Yaspo ML, Martinez S, Baldock RA, Eichele G, Ballabio A
PLoS Biol. 2011
PubMed ID: 21267068
Effect of estrogen receptor β A1730G polymorphism on ABCA1 gene expression response to postmenopausal hormone replacement therapy.
Darabi M, Ani M, Panjehpour M, Rabbani M, Movahedian A, Zarean E
Genet Test Mol Biomarkers. 2011
PubMed ID: 21117950
5A, an apolipoprotein A-I mimetic peptide, attenuates the induction of house dust mite-induced asthma.
Yao X, Dai C, Fredriksson K, Dagur PK, McCoy JP, Qu X, Yu ZX, Keeran KJ, Zywicke GJ, Amar MJ, Remaley AT, Levine SJ
J Immunol. 2011
PubMed ID: 21115733
Influence of N-terminal helix bundle stability on the lipid-binding properties of human apolipoprotein A-I.
Tanaka M, Dhanasekaran P, Nguyen D, Nickel M, Takechi Y, Lund-Katz S, Phillips MC, Saito H
Biochim Biophys Acta. 2011
PubMed ID: 21040803
Novel N-terminal mutation of human apolipoprotein A-I reduces self-association and impairs LCAT activation.
Weers PM, Patel AB, Wan LC, Guigard E, Kay CM, Hafiane A, McPherson R, Marcel YL, Kiss RS
J Lipid Res. 2011
PubMed ID: 20884842
Mutations in APOA-I and ABCA1 in Norwegians with low levels of HDL cholesterol.
Berge KE, Leren TP
Clin Chim Acta. 2010
PubMed ID: 20800056
Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart disease.
Peloso GM, Demissie S, Collins D, Mirel DB, Gabriel SB, Cupples LA, Robins SJ, Schaefer EJ, Brousseau ME
J Lipid Res. 2010
PubMed ID: 20855565
Genetically elevated apolipoprotein a-I, high-density lipoprotein cholesterol levels, and risk of ischemic heart disease.
Haase CL, Tybjærg-Hansen A, Grande P, Frikke-Schmidt R
J Clin Endocrinol Metab. 2010
PubMed ID: 20826588
Inhibition of collar-induced carotid atherosclerosis by recombinant apoA-I cysteine mutants in apoE-deficient mice.
Zhang X, Zhu X, Chen B
J Lipid Res. 2010
PubMed ID: 20817832
The ApoB/ApoA1 ratio is associated with metabolic syndrome and its components in a Chinese population.
Zhong L, Li Q, Jiang Y, Cheng D, Liu Z, Wang B, Luo R, Cheng Q, Qing H
Inflammation. 2010
PubMed ID: 20213498
Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease.
Lewis TL, Cao D, Lu H, Mans RA, Su YR, Jungbauer L, Linton MF, Fazio S, LaDu MJ, Li L
J Biol Chem. 2010
PubMed ID: 20847045
Apolipoprotein A-I deficiency increases cerebral amyloid angiopathy and cognitive deficits in APP/PS1DeltaE9 mice.
Lefterov I, Fitz NF, Cronican AA, Fogg A, Lefterov P, Kodali R, Wetzel R, Koldamova R
J Biol Chem. 2010
PubMed ID: 20739292
The "atheroprotective" mediators apolipoprotein A-I and Foxp3 are over-abundant in unstable carotid plaques.
Patel S, Chung SH, White G, Bao S, Celermajer DS
Int J Cardiol. 2010
PubMed ID: 19481824
Apolipoprotein A-I modulates regulatory T cells in autoimmune LDLr-/-, ApoA-I-/- mice.
Wilhelm AJ, Zabalawi M, Owen JS, Shah D, Grayson JM, Major AS, Bhat S, Gibbs DP, Thomas MJ, Sorci-Thomas MG
J Biol Chem. 2010
PubMed ID: 20833724
High-density lipoprotein suppresses the type I interferon response, a family of potent antiviral immunoregulators, in macrophages challenged with lipopolysaccharide.
Suzuki M, Pritchard DK, Becker L, Hoofnagle AN, Tanimura N, Bammler TK, Beyer RP, Bumgarner R, Vaisar T, de Beer MC, de Beer FC, Miyake K, Oram JF, Heinecke JW
Circulation. 2010
PubMed ID: 20974999
Structural and dynamic features of apolipoprotein A-I cysteine mutants, Milano and Paris, in synthetic HDL.
Rocco AG, Sensi C, Gianazza E, Calabresi L, Franceschini G, Sirtori CR, Eberini I
J Mol Graph Model. 2010
PubMed ID: 20869895
Genetic variants influencing circulating lipid levels and risk of coronary artery disease.
Waterworth DM, Ricketts SL, Song K, Chen L, Zhao JH, Ripatti S, Aulchenko YS, Zhang W, Yuan X, Lim N, Luan J, Ashford S, Wheeler E, Young EH, Hadley D, Thompson JR, Braund PS, Johnson T, Struchalin M, Surakka I, Luben R, Khaw KT, Rodwell SA, Loos RJ, Boekholdt SM, Inouye M, Deloukas P, Elliott P, Schlessinger D, Sanna S, Scuteri A, Jackson A, Mohlke KL, Tuomilehto J, Roberts R, Stewart A, Kesäniemi YA, Mahley RW, Grundy SM, Wellcome Trust Case Control Consortium, McArdle W, Cardon L, Waeber G, Vollenweider P, Chambers JC, Boehnke M, Abecasis GR, Salomaa V, Järvelin MR, Ruokonen A, Barroso I, Epstein SE, Hakonarson HH, Rader DJ, Reilly MP, Witteman JC, Hall AS, Samani NJ, Strachan DP, Barter P, van Duijn CM, Kooner JS, Peltonen L, Wareham NJ, McPherson R, Mooser V, Sandhu MS
Arterioscler Thromb Vasc Biol. 2010
PubMed ID: 20864672
Effect of apolipoprotein C3 and apolipoprotein A1 polymorphisms on postprandial response to a fat overload in metabolic syndrome patients.
Clemente-Postigo M, Queipo-Ortuño M, Valdivielso P, Tinahones FJ, Cardona F
Clin Biochem. 2010
PubMed ID: 20727869
Apolipoprotein B-to-A1 ratio as a predictor of acute ischemic nonembolic stroke in elderly subjects.
Kostapanos MS, Christogiannis LG, Bika E, Bairaktari ET, Goudevenos JA, Elisaf MS, Milionis HJ
J Stroke Cerebrovasc Dis. 2010
PubMed ID: 20538481
Tetranectin and apolipoprotein A-I in cerebrospinal fluid as potential biomarkers for Parkinson's disease.
Wang ES, Sun Y, Guo JG, Gao X, Hu JW, Zhou L, Hu J, Jiang CC
Acta Neurol Scand. 2010
PubMed ID: 20085559
Membrane curvature induction and tubulation are common features of synucleins and apolipoproteins.
Varkey J, Isas JM, Mizuno N, Jensen MB, Bhatia VK, Jao CC, Petrlova J, Voss JC, Stamou DG, Steven AC, Langen R
J Biol Chem. 2010
PubMed ID: 20693280
Liver-specific expression of an exogenous gene controlled by human apolipoprotein A-I promoter.
Hu Y, Ren X, Wang H, Ma Y, Wang L, Shen Y, Oka K, Zhang Z, Zhang Y
Int J Pharm. 2010
PubMed ID: 20656001
A genetic association study of maternal and fetal candidate genes that predispose to preterm prelabor rupture of membranes (PROM).
Romero R, Friel LA, Velez Edwards DR, Kusanovic JP, Hassan SS, Mazaki-Tovi S, Vaisbuch E, Kim CJ, Erez O, Chaiworapongsa T, Pearce BD, Bartlett J, Salisbury BA, Anant MK, Vovis GF, Lee MS, Gomez R, Behnke E, Oyarzun E, Tromp G, Williams SM, Menon R
Am J Obstet Gynecol. 2010
PubMed ID: 20673868
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B, Yusuf S, Gerstein HC, Engert JC, Anand S, DREAM investigators
Diabetes Care. 2010
PubMed ID: 20628086
Common variants of HMGCR, CETP, APOAI, ABCB1, CYP3A4, and CYP7A1 genes as predictors of lipid-lowering response to atorvastatin therapy.
Poduri A, Khullar M, Bahl A, Sehrawat BS, Sharma Y, Talwar KK
DNA Cell Biol. 2010
PubMed ID: 20578904
Evaluating the discriminative power of multi-trait genetic risk scores for type 2 diabetes in a northern Swedish population.
Fontaine-Bisson B, Renström F, Rolandsson O, MAGIC, Payne F, Hallmans G, Barroso I, Franks PW
Diabetologia. 2010
PubMed ID: 20571754
Apolipoprotein A1 -75 G/A and +83 C/T polymorphisms: susceptibility and prognostic implications in breast cancer.
Hamrita B, Nasr HB, Gabbouj S, Bouaouina N, Chouchane L, Chahed K
Mol Biol Rep. 2010
PubMed ID: 20842444
Pinin modulates expression of an intestinal homeobox gene, Cdx2, and plays an essential role for small intestinal morphogenesis.
Joo JH, Taxter TJ, Munguba GC, Kim YH, Dhaduvai K, Dunn NW, Degan WJ, Oh SP, Sugrue SP
Dev Biol. 2010
PubMed ID: 20637749
Mechanism of Trypanosoma brucei gambiense (group 1) resistance to human trypanosome lytic factor.
Kieft R, Capewell P, Turner CM, Veitch NJ, MacLeod A, Hajduk S
Proc Natl Acad Sci U S A. 2010
PubMed ID: 20805508
[Influence of genetic combinations on HDL-C levels in a Southern Brazilian population.]
Andrade FM, Fiegenbaum M, Almeida SD, Hutz MH
Arq Bras Cardiol. 2010
PubMed ID: 20835684
Complete Apo AI deficiency in an Iraqi Mandaean family: case studies and review of the literature.
Al-Sarraf A, Al-Ghofaili K, Sullivan DR, Wasan KM, Hegele R, Frohlich J
J Clin Lipidol. 2010
PubMed ID: 21122686
Metabolic syndrome and carotid intima-media thickness in young adults: roles of apolipoprotein B, apolipoprotein A-I, C-reactive protein, and secretory phospholipase A2: the cardiovascular risk in young Finns study.
Mattsson N, Magnussen CG, Rönnemaa T, Mallat Z, Benessiano J, Jula A, Taittonen L, Kähönen M, Juonala M, Viikari JS, Raitakari OT
Arterioscler Thromb Vasc Biol. 2010
PubMed ID: 20539018
Cysteinemia, rather than homocysteinemia, is associated with plasma apolipoprotein A-I levels in hyperhomocysteinemia: lipid metabolism in cystathionine beta-synthase deficiency.
Nuño-Ayala M, Guillén N, Navarro MA, Lou-Bonafonte JM, Arnal C, Gascón S, Barranquero C, Godino J, Royo-Cañas M, Sarría AJ, Guzmán MA, Hernandez E, Bregante MA, García-Gimeno MA, Osada J
Atherosclerosis. 2010
PubMed ID: 20537649
Genetic deletion of apolipoprotein A-I increases airway hyperresponsiveness, inflammation, and collagen deposition in the lung.
Wang W, Xu H, Shi Y, Nandedkar S, Zhang H, Gao H, Feroah T, Weihrauch D, Schulte ML, Jones DW, Jarzembowski J, Sorci-Thomas M, Pritchard KA
J Lipid Res. 2010
PubMed ID: 20498409
Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis.
Kim TH, Lee YH, Kim KH, Lee SH, Cha JY, Shin EK, Jung S, Jang AS, Park SW, Uh ST, Kim YH, Park JS, Sin HG, Youm W, Koh ES, Cho SY, Paik YK, Rhim TY, Park CS
Am J Respir Crit Care Med. 2010
PubMed ID: 20463180
Simultaneous Mutation Detection in 90 Retinal Disease Genes in Multiple Patients Using a Custom-designed 300-kb Retinal Resequencing Chip.
Booij JC, Bakker A, Kulumbetova J, Moutaoukil Y, Smeets B, Verheij J, Kroes HY, Klaver CC, van Schooneveld M, Bergen AA, Florijn RJ
Ophthalmology. 2010
PubMed ID: 20801516
Apolipoprotein A1 gene polymorphism (G-75A and C+83T) in patients with myocardial infarction: a pilot study in a north Indian population.
Dawar R, Gurtoo A, Singh R
Am J Clin Pathol. 2010
PubMed ID: 20660328
No interaction between alcohol consumption and HDL-related genes on HDL cholesterol levels.
Marques-Vidal P, Bochud M, Paccaud F, Waterworth D, Bergmann S, Preisig M, Waeber G, Vollenweider P
Atherosclerosis. 2010
PubMed ID: 20430392
Soluble fibre (Plantago ovata husk) reduces plasma low-density lipoprotein (LDL) cholesterol, triglycerides, insulin, oxidised LDL and systolic blood pressure in hypercholesterolaemic patients: A randomised trial.
Solà R, Bruckert E, Valls RM, Narejos S, Luque X, Castro-Cabezas M, Doménech G, Torres F, Heras M, Farrés X, Vaquer JV, Martínez JM, Almaraz MC, Anguera A
Atherosclerosis. 2010
PubMed ID: 20413122
Apolipoprotein B/A-I ratio related to visceral but not to subcutaneous adipose tissue in elderly Swedes.
Barbier CE, Lind L, Ahlström H, Larsson A, Johansson L
Atherosclerosis. 2010
PubMed ID: 20382384
Effects of a lipid environment on the fibrillogenic pathway of the N-terminal polypeptide of human apolipoprotein A-I, responsible for in vivo amyloid fibril formation.
Monti DM, Guglielmi F, Monti M, Cozzolino F, Torrassa S, Relini A, Pucci P, Arciello A, Piccoli R
Eur Biophys J. 2010
PubMed ID: 20182709
Clinical and genetic features in a family with CADASIL and high lipoprotein (a) values.
Gong M, Rueschendorf F, Marx P, Schulz H, Kraft HG, Huebner N, Koennecke HC
J Neurol. 2010
PubMed ID: 20143106
The APOA1/C3/A4/A5 cluster and markers of allostatic load in the Boston Puerto Rican Health Study.
Mattei J, Demissie S, Tucker KL, Ordovas JM
Nutr Metab Cardiovasc Dis. 2010
PubMed ID: 20674306
Effect of TNFalpha on activities of different promoters of human apolipoprotein A-I gene.
Orlov SV, Mogilenko DA, Shavva VS, Dizhe EB, Ignatovich IA, Perevozchikov AP
Biochem Biophys Res Commun. 2010
PubMed ID: 20599735
Physiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol?
Ruaño G, Thompson PD, Kane JP, Pullinger CR, Windemuth A, Seip RL, Kocherla M, Holford TR, Wu AH
Pharmacogenomics. 2010
PubMed ID: 20602615
Lower HDL-C and apolipoprotein A-I are related to higher glomerular filtration rate in subjects without kidney disease.
Krikken JA, Gansevoort RT, Dullaart RP, PREVEND Study Group
J Lipid Res. 2010
PubMed ID: 20211930
Oxidation of apolipoprotein A-I by myeloperoxidase impairs the initial interactions with ABCA1 required for signaling and cholesterol export.
Shao B, Tang C, Heinecke JW, Oram JF
J Lipid Res. 2010
PubMed ID: 20064972
HDL/apolipoprotein A-I binds to macrophage-derived progranulin and suppresses its conversion into proinflammatory granulins.
Okura H, Yamashita S, Ohama T, Saga A, Yamamoto-Kakuta A, Hamada Y, Sougawa N, Ohyama R, Sawa Y, Matsuyama A
J Atheroscler Thromb. 2010
PubMed ID: 20215705
Conformation of dimeric apolipoprotein A-I milano on recombinant lipoprotein particles.
Bhat S, Sorci-Thomas MG, Calabresi L, Samuel MP, Thomas MJ
Biochemistry. 2010
PubMed ID: 20524691
The paradox of high apolipoprotein A-I levels independently predicting incident type-2 diabetes among Turks.
Onat A, Hergenç G, Bulur S, Uğur M, Küçükdurmaz Z, Can G
Int J Cardiol. 2010
PubMed ID: 19171400
Reduced plasma APOA1 level is associated with gastric tumor growth in MKN45 mouse xenograft model.
Chong PK, Lee H, Zhou J, Liu SC, Loh MC, So JB, Lim KH, Yeoh KG, Lim YP
J Proteomics. 2010
PubMed ID: 20399916
Exchange of apolipoprotein A-I between lipid-associated and lipid-free states: a potential target for oxidative generation of dysfunctional high density lipoproteins.
Cavigiolio G, Geier EG, Shao B, Heinecke JW, Oda MN
J Biol Chem. 2010
PubMed ID: 20385548
Modifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway.
Shao B, Pennathur S, Pagani I, Oda MN, Witztum JL, Oram JF, Heinecke JW
J Biol Chem. 2010
PubMed ID: 20378541
APOA1/A5 variants and haplotypes as a risk factor for obesity and better lipid profiles in a Brazilian Elderly Cohort.
Chen ES, Furuya TK, Mazzotti DR, Ota VK, Cendoroglo MS, Ramos LR, Araujo LQ, Burbano RR, de Arruda Cardoso Smith M
Lipids. 2010
PubMed ID: 20480398
Senescence-related truncation and multimerization of apolipoprotein A-I in high-density lipoprotein with an elevated level of advanced glycated end products and cholesteryl ester transfer activity.
Park KH, Shin DG, Kim JR, Cho KH
J Gerontol A Biol Sci Med Sci. 2010
PubMed ID: 20421239
Interaction of common sequence variants and selected risk factors in determination of HDL cholesterol levels.
Katerina H, Michaela S, Michal V, Helena S, Jana Z, Jaroslav H, Richard C
Clin Biochem. 2010
PubMed ID: 20394740
Overexpression of steroidogenic acute regulatory protein increases macrophage cholesterol efflux to apolipoprotein AI.
Taylor JM, Borthwick F, Bartholomew C, Graham A
Cardiovasc Res. 2010
PubMed ID: 20083572
Analysis of lipid pathway genes indicates association of sequence variation near SREBF1/TOM1L2/ATPAF2 with dementia risk.
Reynolds CA, Hong MG, Eriksson UK, Blennow K, Wiklund F, Johansson B, Malmberg B, Berg S, Alexeyenko A, Grönberg H, Gatz M, Pedersen NL, Prince JA
Hum Mol Genet. 2010
PubMed ID: 20167577
Identification of fetal and maternal single nucleotide polymorphisms in candidate genes that predispose to spontaneous preterm labor with intact membranes.
Romero R, Velez Edwards DR, Kusanovic JP, Hassan SS, Mazaki-Tovi S, Vaisbuch E, Kim CJ, Chaiworapongsa T, Pearce BD, Friel LA, Bartlett J, Anant MK, Salisbury BA, Vovis GF, Lee MS, Gomez R, Behnke E, Oyarzun E, Tromp G, Williams SM, Menon R
Am J Obstet Gynecol. 2010
PubMed ID: 20452482
Hedgehog signaling controls mesenchymal growth in the developing mammalian digestive tract.
Mao J, Kim BM, Rajurkar M, Shivdasani RA, McMahon AP
Development. 2010
PubMed ID: 20430747
Large-scale candidate gene analysis of spontaneous clearance of hepatitis C virus.
Mosbruger TL, Duggal P, Goedert JJ, Kirk GD, Hoots WK, Tobler LH, Busch M, Peters MG, Rosen HR, Thomas DL, Thio CL
J Infect Dis. 2010
PubMed ID: 20331378
Cholesterol efflux to apoA-I in ABCA1-expressing cells is regulated by Ca2+-dependent calcineurin signaling.
Karwatsky J, Ma L, Dong F, Zha X
J Lipid Res. 2010
PubMed ID: 19965585
Systematic analysis of human protein complexes identifies chromosome segregation proteins.
Hutchins JR, Toyoda Y, Hegemann B, Poser I, Hériché JK, Sykora MM, Augsburg M, Hudecz O, Buschhorn BA, Bulkescher J, Conrad C, Comartin D, Schleiffer A, Sarov M, Pozniakovsky A, Slabicki MM, Schloissnig S, Steinmacher I, Leuschner M, Ssykor A, Lawo S, Pelletier L, Stark H, Nasmyth K, Ellenberg J, Durbin R, Buchholz F, Mechtler K, Hyman AA, Peters JM
Science. 2010
PubMed ID: 20360068
Relationships between serum lipid, lipoprotein, triglyceride-rich lipoprotein, and high-density lipoprotein particle concentrations in post-renal transplant patients.
Kimak E, Hałabiś M, Baranowicz-Gaszczyk I
J Zhejiang Univ Sci B. 2010
PubMed ID: 20349521
Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction.
Vuilleumier N, Rossier MF, Pagano S, Python M, Charbonney E, Nkoulou R, James R, Reber G, Mach F, Roux-Lombard P
Eur Heart J. 2010
PubMed ID: 20176799
APOA1 and APOA4 gene polymorphisms influence the effects of dietary fat on LDL particle size and oxidation in healthy young adults.
Gomez P, Perez-Martinez P, Marin C, Camargo A, Yubero-Serrano EM, Garcia-Rios A, Rodriguez F, Delgado-Lista J, Perez-Jimenez F, Lopez-Miranda J
J Nutr. 2010
PubMed ID: 20164363
Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I.
Nobécourt E, Tabet F, Lambert G, Puranik R, Bao S, Yan L, Davies MJ, Brown BE, Jenkins AJ, Dusting GJ, Bonnet DJ, Curtiss LK, Barter PJ, Rye KA
Arterioscler Thromb Vasc Biol. 2010
PubMed ID: 20110571
Plasma concentrations of apolipoproteins A-I, B, and M in patients with critical limb ischemia.
Ahnström J, Gottsäter A, Lindblad B, Dahlbäck B
Clin Biochem. 2010
PubMed ID: 20080084
Proteomic analysis of endometrium from fertile and infertile patients suggests a role for apolipoprotein A-I in embryo implantation failure and endometriosis.
Brosens JJ, Hodgetts A, Feroze-Zaidi F, Sherwin JR, Fusi L, Salker MS, Higham J, Rose GL, Kajihara T, Young SL, Lessey BA, Henriet P, Langford PR, Fazleabas AT
Mol Hum Reprod. 2010
PubMed ID: 20008415
Disruption of the C-terminal helix by single amino acid deletion is directly responsible for impaired cholesterol efflux ability of apolipoprotein A-I Nichinan.
Kono M, Tanaka T, Tanaka M, Vedhachalam C, Chetty PS, Nguyen D, Dhanasekaran P, Lund-Katz S, Phillips MC, Saito H
J Lipid Res. 2010
PubMed ID: 19805625
Can we predict top-level sports performance in power vs endurance events? A genetic approach.
Buxens A, Ruiz JR, Arteta D, Artieda M, Santiago C, González-Freire M, Martínez A, Tejedor D, Lao JI, Gómez-Gallego F, Lucia A
Scand J Med Sci Sports. 2010
PubMed ID: 20459474
Single nucleotide polymorphisms in genes that are associated with a modified response to statin therapy: the Rotterdam Study.
de Keyser CE, Eijgelsheim M, Hofman A, Sijbrands EJ, Maitland-van der Zee AH, van Duijn CM, Uitterlinden AG, Witteman JC, Ch Stricker BH
Pharmacogenomics J. 2010
PubMed ID: 20195290
Arterial intima-media thickness, endothelial function, and apolipoproteins in adolescents frequently exposed to tobacco smoke.
Kallio K, Jokinen E, Saarinen M, Hämäläinen M, Volanen I, Kaitosaari T, Rönnemaa T, Viikari J, Raitakari OT, Simell O
Circ Cardiovasc Qual Outcomes. 2010
PubMed ID: 20197510
Plasma concentrations of apolipoproteins A-I, B and M in patients with abdominal aortic aneurysms.
Ahnström J, Gottsäter A, Lindblad B, Dahlbäck B
Clin Biochem. 2010
PubMed ID: 19932694
Surface plasmon resonance analysis of the mechanism of binding of apoA-I to high density lipoprotein particles.
Lund-Katz S, Nguyen D, Dhanasekaran P, Kono M, Nickel M, Saito H, Phillips MC
J Lipid Res. 2010
PubMed ID: 19786567
Fructated apolipoprotein A-I showed severe structural modification and loss of beneficial functions in lipid-free and lipid-bound state with acceleration of atherosclerosis and senescence.
Park KH, Jang W, Kim KY, Kim JR, Cho KH
Biochem Biophys Res Commun. 2010
PubMed ID: 20059975
Structures of discoidal high density lipoproteins: a combined computational-experimental approach.
Gu F, Jones MK, Chen J, Patterson JC, Catte A, Jerome WG, Li L, Segrest JP
J Biol Chem. 2010
PubMed ID: 19948731
Methionine oxidation induces amyloid fibril formation by full-length apolipoprotein A-I.
Wong YQ, Binger KJ, Howlett GJ, Griffin MD
Proc Natl Acad Sci U S A. 2010
PubMed ID: 20133843
Sex hormone-binding globulin and lipid profile in pubertal children.
Garcés C, Oya I, Lasunción MA, López-Simón L, Cano B, de Oya M
Metabolism. 2010
PubMed ID: 19765778
[Correlation of metabolic syndrome clinical signs and genetic determinants at children with obese].
Shcherbakova MIu, Sinitsin PA, Poriadina GI, Larionova VI, Khmyrova AP, Petriaĭkina EE, Pronina LA
Eksp Klin Gastroenterol. 2010
PubMed ID: 21033077
Common inherited variation in mitochondrial genes is not enriched for associations with type 2 diabetes or related glycemic traits.
Segrè AV, DIAGRAM Consortium, MAGIC investigators, Groop L, Mootha VK, Daly MJ, Altshuler D
PLoS Genet. 2010
PubMed ID: 20714348
Effect of apoA-I on cholesterol release and apoE secretion in human mature adipocytes.
Bencharif K, Hoareau L, Murumalla RK, Tarnus E, Tallet F, Clerc RG, Gardes C, Cesari M, Roche R
Lipids Health Dis. 2010
PubMed ID: 20642861
ApoA-1 mimetic peptide reverses uremia-induced upregulation of pro-atherogenic pathways in the aorta.
Vaziri ND, Bai Y, Yuan J, Said HL, Sigala W, Ni Z
Am J Nephrol. 2010
PubMed ID: 20639628
Maternal genes and facial clefts in offspring: a comprehensive search for genetic associations in two population-based cleft studies from Scandinavia.
Jugessur A, Shi M, Gjessing HK, Lie RT, Wilcox AJ, Weinberg CR, Christensen K, Boyles AL, Daack-Hirsch S, Nguyen TT, Christiansen L, Lidral AC, Murray JC
PLoS One. 2010
PubMed ID: 20634891
Human apoA-I increases macrophage foam cell derived PLTP activity without affecting the PLTP mass.
Robciuc MR, Metso J, Sima A, Ehnholm C, Jauhiainen M
Lipids Health Dis. 2010
PubMed ID: 20534134
Genome-wide association study of Lp-PLA(2) activity and mass in the Framingham Heart Study.
Suchindran S, Rivedal D, Guyton JR, Milledge T, Gao X, Benjamin A, Rowell J, Ginsburg GS, McCarthy JJ
PLoS Genet. 2010
PubMed ID: 20442857
Enhanced hepatic apoA-I secretion and peripheral efflux of cholesterol and phospholipid in CD36 null mice.
Yue P, Chen Z, Nassir F, Bernal-Mizrachi C, Finck B, Azhar S, Abumrad NA
PLoS One. 2010
PubMed ID: 20360851
Comparison of serum apolipoprotein A-I between Chinese multiple sclerosis and other related autoimmune disease.
Zhang B, Pu S, Li B, Ying J, Song XW, Gao C
Lipids Health Dis. 2010
PubMed ID: 20350318
Macrophage scavenger receptor A mediates adhesion to apolipoproteins A-I and E.
Neyen C, Plüddemann A, Roversi P, Thomas B, Cai L, van der Westhuyzen DR, Sim RB, Gordon S
Biochemistry. 2009
PubMed ID: 19911804
Integrative predictive model of coronary artery calcification in atherosclerosis.
McGeachie M, Ramoni RL, Mychaleckyj JC, Furie KL, Dreyfuss JM, Liu Y, Herrington D, Guo X, Lima JA, Post W, Rotter JI, Rich S, Sale M, Ramoni MF
Circulation. 2009
PubMed ID: 19948975
An initial characterization of the serum phosphoproteome.
Zhou W, Ross MM, Tessitore A, Ornstein D, Vanmeter A, Liotta LA, Petricoin EF
J Proteome Res. 2009
PubMed ID: 19824718
HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesis.
Zerrad-Saadi A, Therond P, Chantepie S, Couturier M, Rye KA, Chapman MJ, Kontush A
Arterioscler Thromb Vasc Biol. 2009
PubMed ID: 19762782
Apolipoproteins A-I, A-II and E are independently distributed among intracellular and newly secreted HDL of human hepatoma cells.
Gillard BK, Lin HY, Massey JB, Pownall HJ
Biochim Biophys Acta. 2009
PubMed ID: 19635584
Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.
Talmud PJ, Drenos F, Shah S, Shah T, Palmen J, Verzilli C, Gaunt TR, Pallas J, Lovering R, Li K, Casas JP, Sofat R, Kumari M, Rodriguez S, Johnson T, Newhouse SJ, Dominiczak A, Samani NJ, Caulfield M, Sever P, Stanton A, Shields DC, Padmanabhan S, Melander O, Hastie C, Delles C, Ebrahim S, Marmot MG, Smith GD, Lawlor DA, Munroe PB, Day IN, Kivimaki M, Whittaker J, Humphries SE, Hingorani AD, ASCOT investigators, NORDIL investigators, BRIGHT Consortium
Am J Hum Genet. 2009
PubMed ID: 19913121
Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease.
Roher AE, Maarouf CL, Sue LI, Hu Y, Wilson J, Beach TG
Biomarkers. 2009
PubMed ID: 19863188
Levels of lipids and apolipoproteins in three cultures.
Solhpour A, Parkhideh S, Sarrafzadegan N, Asgary S, Williams K, Jungner I, Aastveit A, Walldius G, Sniderman A
Atherosclerosis. 2009
PubMed ID: 19766218
Structural features and dynamics properties of human apolipoprotein A-I in a model of synthetic HDL.
Rocco AG, Gianazza E, Calabresi L, Sensi C, Franceschini G, Sirtori CR, Eberini I
J Mol Graph Model. 2009
PubMed ID: 19740687
Regulatory effects of fenofibrate and atorvastatin on lipoprotein A-I and lipoprotein A-I:A-II kinetics in the metabolic syndrome.
Chan DC, Watts GF, Ooi EM, Rye KA, Ji J, Johnson AG, Barrett PH
Diabetes Care. 2009
PubMed ID: 19651918
Characterization of apolipoprotein A-I as a potential biomarker for cholangiocarcinoma.
Wang X, Dai S, Zhang Z, Liu L, Wang J, Xiao X, He D, Liu B
Eur J Cancer Care (Engl). 2009
PubMed ID: 19486127
Marked high density lipoprotein deficiency due to apolipoprotein A-I Tomioka (codon 138 deletion).
Wada M, Iso T, Asztalos BF, Takama N, Nakajima T, Seta Y, Kaneko K, Taniguchi Y, Kobayashi H, Nakajima K, Schaefer EJ, Kurabayashi M
Atherosclerosis. 2009
PubMed ID: 19473658
Reduction of serum lipids by soy protein and soluble fiber is not associated with the ABCG5/G8, apolipoprotein E, and apolipoprotein A1 polymorphisms in a group of hyperlipidemic Mexican subjects.
Torres N, Guevara-Cruz M, Granados J, Vargas-Alarcón G, González-Palacios B, Ramos-Barragan VE, Quiroz-Olguín G, Flores-Islas IM, Tovar AR
Nutr Res. 2009
PubMed ID: 19917453
Increased apoB/apoA-I ratio is predictive of peripheral arterial disease in initially healthy 58-year-old men during 8.9 years of follow-up.
Johansson L, Schmidt C
Angiology. 2009
PubMed ID: 19022789
Nevirapine increases high-density lipoprotein cholesterol concentration by stimulation of apolipoprotein A-I production.
Franssen R, Sankatsing RR, Hassink E, Hutten B, Ackermans MT, Brinkman K, Oesterholt R, Arenas-Pinto A, Storfer SP, Kastelein JJ, Sauerwein HP, Reiss P, Stroes ES
Arterioscler Thromb Vasc Biol. 2009
PubMed ID: 19667106
A combination of proatherogenic single-nucleotide polymorphisms is associated with increased risk of coronary artery disease and myocardial infarction in Asian Indians.
Poduri A, Khullar M, Bahl A, Sharma YP, Talwar KK
DNA Cell Biol. 2009
PubMed ID: 19558216
An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide.
Wool GD, Vaisar T, Reardon CA, Getz GS
J Lipid Res. 2009
PubMed ID: 19433476
Up-regulation of reverse cholesterol transport key players and rescue from global inflammation by ApoA-I(Milano).
Cimmino G, Ibanez B, Vilahur G, Speidl WS, Fuster V, Badimon L, Badimon JJ
J Cell Mol Med. 2009
PubMed ID: 19120689
Apolipoprotein modulation of streptococcal serum opacity factor activity against human plasma high-density lipoproteins.
Rosales C, Gillard BK, Courtney HS, Blanco-Vaca F, Pownall HJ
Biochemistry. 2009
PubMed ID: 19618959
Genetic variants on apolipoprotein gene cluster influence triglycerides with a risk of coronary artery disease among Indians.
Ashokkumar M, Subhashini NG, Saibabu R, Ramesh A, Cherian KM, Emmanuel C
Mol Biol Rep. 2009
PubMed ID: 19701693
Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese.
Liu ZK, Hu M, Baum L, Thomas GN, Tomlinson B
Atherosclerosis. 2009
PubMed ID: 19732897
Identification of apolipoproteinA1 reduction in the polycystic kidney by proteomics analysis of the Mxi1-deficient mouse.
Yoo KH, Kim YN, Lee MJ, Seong JK, Park JH
Proteomics. 2009
PubMed ID: 19637234
Association of genetic variants with chronic kidney disease in individuals with different lipid profiles.
Yoshida T, Kato K, Yokoi K, Oguri M, Watanabe S, Metoki N, Yoshida H, Satoh K, Aoyagi Y, Nishigaki Y, Nozawa Y, Yamada Y
Int J Mol Med. 2009
PubMed ID: 19578796
A protein interaction network for the large conductance Ca(2+)-activated K(+) channel in the mouse cochlea.
Kathiresan T, Harvey M, Orchard S, Sakai Y, Sokolowski B
Mol Cell Proteomics. 2009
PubMed ID: 19423573
Effects of variations in the APOA1/C3/A4/A5 gene cluster on different parameters of postprandial lipid metabolism in healthy young men.
Delgado-Lista J, Perez-Jimenez F, Ruano J, Perez-Martinez P, Fuentes F, Criado-Garcia J, Parnell LD, Garcia-Rios A, Ordovas JM, Lopez-Miranda J
J Lipid Res. 2009
PubMed ID: 19592705
Hemoglobin and its scavenger protein haptoglobin associate with apoA-1-containing particles and influence the inflammatory properties and function of high density lipoprotein.
Watanabe J, Grijalva V, Hama S, Barbour K, Berger FG, Navab M, Fogelman AM, Reddy ST
J Biol Chem. 2009
PubMed ID: 19433579
Stimulation of cell surface F1-ATPase activity by apolipoprotein A-I inhibits endothelial cell apoptosis and promotes proliferation.
Radojkovic C, Genoux A, Pons V, Combes G, de Jonge H, Champagne E, Rolland C, Perret B, Collet X, Tercé F, Martinez LO
Arterioscler Thromb Vasc Biol. 2009
PubMed ID: 19372457
Structural and functional consequences of the Milano mutation (R173C) in human apolipoprotein A-I.
Alexander ET, Tanaka M, Kono M, Saito H, Rader DJ, Phillips MC
J Lipid Res. 2009
PubMed ID: 19318685
Cholesteryl ester transfer protein I405V polymorphism influences apolipoprotein A-I response to a change in dietary fatty acid composition.
Darabi M, Abolfathi AA, Noori M, Kazemi A, Ostadrahimi A, Rahimipour A, Darabi M, Ghatrehsamani K
Horm Metab Res. 2009
PubMed ID: 19242900
Regulation of apoAI processing by procollagen C-proteinase enhancer-2 and bone morphogenetic protein-1.
Zhu J, Gardner J, Pullinger CR, Kane JP, Thompson JF, Francone OL
J Lipid Res. 2009
PubMed ID: 19237735
High apoB/apoA-I ratio is associated with increased progression rate of carotid artery intima-media thickness in clinically healthy 58-year-old men: experiences from very long-term follow-up in the AIR study.
Schmidt C, Wikstrand J
Atherosclerosis. 2009
PubMed ID: 19124125
ATP-binding cassette transporter A1 expression and apolipoprotein A-I binding are impaired in intima-type arterial smooth muscle cells.
Choi HY, Rahmani M, Wong BW, Allahverdian S, McManus BM, Pickering JG, Chan T, Francis GA
Circulation. 2009
PubMed ID: 19528336
Integrated associations of genotypes with multiple blood biomarkers linked to coronary heart disease risk.
Drenos F, Talmud PJ, Casas JP, Smeeth L, Palmen J, Humphries SE, Hingorani AD
Hum Mol Genet. 2009
PubMed ID: 19336475
The association between serum apolipoprotein A-I and apolipoprotein B and the severity of angiographical coronary artery disease.
Khadem-Ansari MH, Rasmi Y, Rahimi-Pour A, Jafarzadeh M
Singapore Med J. 2009
PubMed ID: 19551315
Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity.
Wilhelm AJ, Zabalawi M, Grayson JM, Weant AE, Major AS, Owen J, Bharadwaj M, Walzem R, Chan L, Oka K, Thomas MJ, Sorci-Thomas MG
Arterioscler Thromb Vasc Biol. 2009
PubMed ID: 19286630
Membrane permeabilization by trypanosome lytic factor, a cytolytic human high density lipoprotein.
Harrington JM, Howell S, Hajduk SL
J Biol Chem. 2009
PubMed ID: 19324878
Lineage-specific biology revealed by a finished genome assembly of the mouse.
Church DM, Goodstadt L, Hillier LW, Zody MC, Goldstein S, She X, Bult CJ, Agarwala R, Cherry JL, DiCuccio M, Hlavina W, Kapustin Y, Meric P, Maglott D, Birtle Z, Marques AC, Graves T, Zhou S, Teague B, Potamousis K, Churas C, Place M, Herschleb J, Runnheim R, Forrest D, Amos-Landgraf J, Schwartz DC, Cheng Z, Lindblad-Toh K, Eichler EE, Ponting CP, Mouse Genome Sequencing Consortium
PLoS Biol. 2009
PubMed ID: 19468303
Apolipoprotein A1 gene polymorphisms as risk factors for hypertension and obesity.
Chen ES, Mazzotti DR, Furuya TK, Cendoroglo MS, Ramos LR, Araujo LQ, Burbano RR, de Arruda Cardoso Smith M
Clin Exp Med. 2009
PubMed ID: 19408098
Hereditary apolipoprotein AI-associated amyloidosis in surgical pathology specimens: identification of three novel mutations in the APOA1 gene.
Eriksson M, Schönland S, Yumlu S, Hegenbart U, von Hutten H, Gioeva Z, Lohse P, Büttner J, Schmidt H, Röcken C
J Mol Diagn. 2009
PubMed ID: 19324996
Low serum concentration of apolipoprotein A-I is an indicator of poor prognosis in cirrhotic patients with severe sepsis.
Tsai MH, Peng YS, Chen YC, Lien JM, Tian YC, Fang JT, Weng HH, Chen PC, Yang CW, Wu CS
J Hepatol. 2009
PubMed ID: 19304335
Genetic determinants of plasma HDL-cholesterol levels in prepubertal children.
López-Simón L, de Oya M, Lasunción MA, Riestra P, Benavente M, de Oya I, Cano B, Schoppen S, Garcés C
Clin Chim Acta. 2009
PubMed ID: 19285487
Formation of two intramolecular disulfide bonds is necessary for ApoA-I-dependent cholesterol efflux mediated by ABCA1.
Hozoji M, Kimura Y, Kioka N, Ueda K
J Biol Chem. 2009
PubMed ID: 19258317
Apo-B/AI ratio identifies cardiovascular risk in childhood: the Australian Aboriginal Birth Cohort study.
Sellers EA, Singh GR, Sayers SM
Diab Vasc Dis Res. 2009
PubMed ID: 20368199
Identification of differently expressed genes in chemical carcinogen-induced rat bladder cancers.
Chen G, Chan FL, Zhang X, Chan PS
J Huazhong Univ Sci Technolog Med Sci. 2009
PubMed ID: 19399409
Determination of genetic predisposition to patent ductus arteriosus in preterm infants.
Dagle JM, Lepp NT, Cooper ME, Schaa KL, Kelsey KJ, Orr KL, Caprau D, Zimmerman CR, Steffen KM, Johnson KJ, Marazita ML, Murray JC
Pediatrics. 2009
PubMed ID: 19336370
Interaction between the N- and C-terminal domains modulates the stability and lipid binding of apolipoprotein A-I.
Koyama M, Tanaka M, Dhanasekaran P, Lund-Katz S, Phillips MC, Saito H
Biochemistry. 2009
PubMed ID: 19239199
Influence of cholesteryl ester transfer protein, peroxisome proliferator-activated receptor alpha, apolipoprotein E, and apolipoprotein A-I polymorphisms on high-density lipoprotein cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I:A-I
Do HQ, Nazih H, Luc G, Arveiler D, Ferrières J, Evans A, Amouyel P, Cambien F, Ducimetière P, Bard JM
Metabolism. 2009
PubMed ID: 19217440
Apolipoprotein AI and Apolipoprotein B gene polymorphisms and lipid profile in Tamilian population.
Padmaja N, Ravindra Kumar M, Adithan C
Ann Hum Biol. 2009
PubMed ID: 19191080
Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
Ray KK, Cannon CP, Cairns R, Morrow DA, Ridker PM, Braunwald E
Arterioscler Thromb Vasc Biol. 2009
PubMed ID: 19122170
Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men.
Chan DC, Barrett PH, Ooi EM, Ji J, Chan DT, Watts GF
J Clin Endocrinol Metab. 2009
PubMed ID: 19116237
Apolipoprotein A-I, A-II, C-II, and H expression in the developing lung and sex difference in surfactant lipids.
Provost PR, Boucher E, Tremblay Y
J Endocrinol. 2009
PubMed ID: 19106236
Wild-type apo A-I and apo A-I(Milano) gene transfer reduce native and transplant arteriosclerosis to a similar extent.
Feng Y, Van Craeyveld E, Jacobs F, Lievens J, Snoeys J, De Geest B
J Mol Med. 2009
PubMed ID: 19066833
A novel peptide from human apolipoprotein(a) inhibits angiogenesis and tumor growth by targeting c-Src phosphorylation in VEGF-induced human umbilical endothelial cells.
Yi ZF, Cho SG, Zhao H, Wu YY, Luo J, Li D, Yi T, Xu X, Wu Z, Liu M
Int J Cancer. 2009
PubMed ID: 19035465
Mechanisms and significance of lipoprotein(a) in hepatocellular carcinoma.
Jiang JT, Wu CP, Xu N, Zhang XG
Hepatobiliary Pancreat Dis Int. 2009
PubMed ID: 19208510
Common sequence variant in lipoprotein lipase gene conferring triglyceride response to fibrate treatment.
Chien KL, Lin YL, Wen HC, Lin HP, Yen CT, Lin SW, Kao JT
Pharmacogenomics. 2009
PubMed ID: 19207029
Retroendocytosis pathway of ABCA1/apoA-I contributes to HDL formation.
Azuma Y, Takada M, Shin HW, Kioka N, Nakayama K, Ueda K
Genes Cells. 2009
PubMed ID: 19170766
The environmental and genetic evidence for the association of hyperlipidemia and hypertension.
Ruixing Y, Jinzhen W, Weixiong L, Yuming C, Dezhai Y, Shangling P
J Hypertens. 2009
PubMed ID: 19155782
Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network study.
Liu Y, Ordovas JM, Gao G, Province M, Straka RJ, Tsai MY, Lai CQ, Zhang K, Borecki I, Hixson JE, Allison DB, Arnett DK
Pharmacogenet Genomics. 2009
PubMed ID: 19057464
Apolipoprotein A1 is overexpressed in the retina of diabetic patients.
Simó R, García-Ramírez M, Higuera M, Hernández C
Am J Ophthalmol. 2009
PubMed ID: 18848320
ABCA1 mutants reveal an interdependency between lipid export function, apoA-I binding activity, and Janus kinase 2 activation.
Vaughan AM, Tang C, Oram JF
J Lipid Res. 2009
PubMed ID: 18776170
Critical role of scavenger receptor-BI-expressing bone marrow-derived endothelial progenitor cells in the attenuation of allograft vasculopathy after human apo A-I transfer.
Feng Y, van Eck M, Van Craeyveld E, Jacobs F, Carlier V, Van Linthout S, Erdel M, Tjwa M, De Geest B
Blood. 2009
PubMed ID: 18824596
Fulfilling the promise of personalized medicine? Systematic review and field synopsis of pharmacogenetic studies.
Holmes MV, Shah T, Vickery C, Smeeth L, Hingorani AD, Casas JP
PLoS One. 2009
PubMed ID: 19956635
Candidate genetic analysis of plasma high-density lipoprotein-cholesterol and severity of coronary atherosclerosis.
Chen SN, Cilingiroglu M, Todd J, Lombardi R, Willerson JT, Gotto AM, Ballantyne CM, Marian AJ
BMC Med Genet. 2009
PubMed ID: 19878569
Association of polymorphisms in apolipoprotein A1 and apolipoprotein B genes with lipid profile in tamilian population.
Padmaja N, Kumar MR, Adithan C
Indian Heart J. 2009
PubMed ID: 19729689
Foxl2 functions in sex determination and histogenesis throughout mouse ovary development.
Garcia-Ortiz JE, Pelosi E, Omari S, Nedorezov T, Piao Y, Karmazin J, Uda M, Cao A, Cole SW, Forabosco A, Schlessinger D, Ottolenghi C
BMC Dev Biol. 2009
PubMed ID: 19538736
New horny layer marker proteins for evaluating skin condition in atopic dermatitis.
Yamane Y, Moriyama K, Yasuda C, Miyata S, Aihara M, Ikezawa Z, Miyazaki K
Int Arch Allergy Immunol. 2009
PubMed ID: 19339807
Apolipoprotein A-I and cholesterol in synovial fluid of patients with rheumatoid arthritis, psoriatic arthritis and osteoarthritis.
Oliviero F, Sfriso P, Baldo G, Dayer JM, Giunco S, Scanu A, Bernardi D, Ramonda R, Plebani M, Punzi L
Clin Exp Rheumatol. 2009
PubMed ID: 19327233
Association of apolipoproteins with symptoms of asthma and atopy among schoolchildren.
Nagel G, Weiland SK, Rapp K, Link B, Zoellner I, Koenig W
Int Arch Allergy Immunol. 2009
PubMed ID: 19218819
Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts.
Aulchenko YS, Ripatti S, Lindqvist I, Boomsma D, Heid IM, Pramstaller PP, Penninx BW, Janssens AC, Wilson JF, Spector T, Martin NG, Pedersen NL, Kyvik KO, Kaprio J, Hofman A, Freimer NB, Jarvelin MR, Gyllensten U, Campbell H, Rudan I, Johansson A, Marroni F, Hayward C, Vitart V, Jonasson I, Pattaro C, Wright A, Hastie N, Pichler I, Hicks AA, Falchi M, Willemsen G, Hottenga JJ, de Geus EJ, Montgomery GW, Whitfield J, Magnusson P, Saharinen J, Perola M, Silander K, Isaacs A, Sijbrands EJ, Uitterlinden AG, Witteman JC, Oostra BA, Elliott P, Ruokonen A, Sabatti C, Gieger C, Meitinger T, Kronenberg F, Döring A, Wichmann HE, Smit JH, McCarthy MI, van Duijn CM, Peltonen L, ENGAGE Consortium
Nat Genet. 2009
PubMed ID: 19060911
Common variants at 30 loci contribute to polygenic dyslipidemia.
Kathiresan S, Willer CJ, Peloso GM, Demissie S, Musunuru K, Schadt EE, Kaplan L, Bennett D, Li Y, Tanaka T, Voight BF, Bonnycastle LL, Jackson AU, Crawford G, Surti A, Guiducci C, Burtt NP, Parish S, Clarke R, Zelenika D, Kubalanza KA, Morken MA, Scott LJ, Stringham HM, Galan P, Swift AJ, Kuusisto J, Bergman RN, Sundvall J, Laakso M, Ferrucci L, Scheet P, Sanna S, Uda M, Yang Q, Lunetta KL, Dupuis J, de Bakker PI, O'Donnell CJ, Chambers JC, Kooner JS, Hercberg S, Meneton P, Lakatta EG, Scuteri A, Schlessinger D, Tuomilehto J, Collins FS, Groop L, Altshuler D, Collins R, Lathrop GM, Melander O, Salomaa V, Peltonen L, Orho-Melander M, Ordovas JM, Boehnke M, Abecasis GR, Mohlke KL, Cupples LA
Nat Genet. 2009
PubMed ID: 19060906
Evaluation of lipid-binding properties of the N-terminal helical segments in human apolipoprotein A-I using fragment peptides.
Tanaka M, Tanaka T, Ohta S, Kawakami T, Konno H, Akaji K, Aimoto S, Saito H
J Pept Sci. 2009
PubMed ID: 19048603
Serum retinol-binding protein concentration and its association with components of the uremic metabolic syndrome in nondiabetic patients with chronic kidney disease stage 5.
Axelsson J, O'Byrne SM, Blaner WS, Carrero JJ, Bruchfeld A, Heimbürger O, Bárány P, Lindholm B, Stenvinkel P
Am J Nephrol. 2009
PubMed ID: 19023195
Potent and selective PPAR-alpha agonist LY518674 upregulates both ApoA-I production and catabolism in human subjects with the metabolic syndrome.
Millar JS, Duffy D, Gadi R, Bloedon LT, Dunbar RL, Wolfe ML, Movva R, Shah A, Fuki IV, McCoy M, Harris CJ, Wang MD, Howey DC, Rader DJ
Arterioscler Thromb Vasc Biol. 2009
PubMed ID: 18988892
Endothelial lipase promotes apolipoprotein AI-mediated cholesterol efflux in THP-1 macrophages.
Qiu G, Hill JS
Arterioscler Thromb Vasc Biol. 2009
PubMed ID: 18988890
A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection.
Pollin TI, Damcott CM, Shen H, Ott SH, Shelton J, Horenstein RB, Post W, McLenithan JC, Bielak LF, Peyser PA, Mitchell BD, Miller M, O'Connell JR, Shuldiner AR
Science. 2008
PubMed ID: 19074352
Pharmacogenetic predictors of statin-mediated low-density lipoprotein cholesterol reduction and dose response.
Voora D, Shah SH, Reed CR, Zhai J, Crosslin DR, Messer C, Salisbury BA, Ginsburg GS
Circ Cardiovasc Genet. 2008
PubMed ID: 20031551
Phosphatidylinositol acts through mitogen-activated protein kinase to stimulate hepatic apolipoprotein A-I secretion.
Hopewell S, Pandey NR, Misquith A, Twomey E, Sparks DL
Metabolism. 2008
PubMed ID: 19013290
Serological proteomics of gastritis: degradation of apolipoprotein A-I and alpha1-antitrypsin is a common response to inflammation irrespective of Helicobacter pylori infection.
He QY, Yang H, Wong BC, Chiu JF
Dig Dis Sci. 2008
PubMed ID: 18594986
Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues.
Huang JT, Wang L, Prabakaran S, Wengenroth M, Lockstone HE, Koethe D, Gerth CW, Gross S, Schreiber D, Lilley K, Wayland M, Oxley D, Leweke FM, Bahn S
Mol Psychiatry. 2008
PubMed ID: 17938634
ApoA-I induced CD31 in bone marrow-derived vascular progenitor cells increases adhesion: implications for vascular repair.
Mythreye K, Satterwhite LL, Davidson WS, Goldschmidt-Clermont PJ
Biochim Biophys Acta. 2008
PubMed ID: 18775511
Apolipoprotein A-I tryptophan substitution leads to resistance to myeloperoxidase-mediated loss of function.
Peng DQ, Brubaker G, Wu Z, Zheng L, Willard B, Kinter M, Hazen SL, Smith JD
Arterioscler Thromb Vasc Biol. 2008
PubMed ID: 18688016
Enhancing apolipoprotein A-I-dependent cholesterol efflux elevates cholesterol export from macrophages in vivo.
Mukhamedova N, Escher G, D'Souza W, Tchoua U, Grant A, Krozowski Z, Bukrinsky M, Sviridov D
J Lipid Res. 2008
PubMed ID: 18622028
Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I.
Van Lenten BJ, Wagner AC, Jung CL, Ruchala P, Waring AJ, Lehrer RI, Watson AD, Hama S, Navab M, Anantharamaiah GM, Fogelman AM
J Lipid Res. 2008
PubMed ID: 18621920
Initial interaction of apoA-I with ABCA1 impacts in vivo metabolic fate of nascent HDL.
Mulya A, Lee JY, Gebre AK, Boudyguina EY, Chung SK, Smith TL, Colvin PL, Jiang XC, Parks JS
J Lipid Res. 2008
PubMed ID: 18583707
Conformational flexibility of the N-terminal domain of apolipoprotein a-I bound to spherical lipid particles.
Kono M, Okumura Y, Tanaka M, Nguyen D, Dhanasekaran P, Lund-Katz S, Phillips MC, Saito H
Biochemistry. 2008
PubMed ID: 18831538
The apolipoprotein CIII enhancer regulates both extensive histone modification and intergenic transcription of human apolipoprotein AI/CIII/AIV genes but not apolipoprotein AV.
Li YJ, Wei YS, Fu XH, Hao DL, Xue Z, Gong H, Zhang ZQ, Liu DP, Liang CC
J Biol Chem. 2008
PubMed ID: 18678879
Lp(a) and Risk of Recurrent Cardiac Events in Obese Postinfarction Patients.
Corsetti JP, Ryan D, Rainwater DL, Moss AJ, Zareba W, Block RC, Sparks CE
Obesity (Silver Spring). 2008
PubMed ID: 18927546
Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and Apolipoprotein B among 6382 white women in genome-wide analysis with replication.
Chasman DI, Paré G, Zee RY, Parker AN, Cook NR, Buring JE, Kwiatkowski DJ, Rose LM, Smith JD, Williams PT, Rieder MJ, Rotter JI, Nickerson DA, Krauss RM, Miletich JP, Ridker PM
Circ Cardiovasc Genet. 2008
PubMed ID: 19802338
Pentanucleotide repeat polymorphism, lipoprotein(a) levels, and risk of ischemic heart disease.
Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG
J Clin Endocrinol Metab. 2008
PubMed ID: 18682504
ApoA-I facilitates ABCA1 recycle/accumulation to cell surface by inhibiting its intracellular degradation and increases HDL generation.
Lu R, Arakawa R, Ito-Osumi C, Iwamoto N, Yokoyama S
Arterioscler Thromb Vasc Biol. 2008
PubMed ID: 18617649
Homocysteine modulates the effect of simvastatin on expression of ApoA-I and NF-kappaB/iNOS.
Mikael LG, Rozen R
Cardiovasc Res. 2008
PubMed ID: 18540024
Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin.
Jaichander P, Selvarajan K, Garelnabi M, Parthasarathy S
J Lipid Res. 2008
PubMed ID: 18519978
ABCA1 promotes the de novo biogenesis of apolipoprotein CIII-containing HDL particles in vivo and modulates the severity of apolipoprotein CIII-induced hypertriglyceridemia.
Kypreos KE
Biochemistry. 2008
PubMed ID: 18767813
A novel function of karyopherin beta3 associated with apolipoprotein A-I secretion.
Chung KM, Cha SS, Jang SK
Mol Cells. 2008
PubMed ID: 18562802
An APOA1 promoter polymorphism is associated with cognitive performance in patients with multiple sclerosis.
Koutsis G, Panas M, Giogkaraki E, Karadima G, Sfagos C, Vassilopoulos D
Mult Scler. 2008
PubMed ID: 18805838
ApoB/ApoA-I ratio in young patients with ischemic cerebral stroke or peripheral arterial disease.
Sabino AP, De Oliveira Sousa M, Moreira Lima L, Dias Ribeiro D, Sant'Ana Dusse LM, Das Graças Carvalho M, Fernandes AP
Transl Res. 2008
PubMed ID: 18774540
Protein interaction data set highlighted with human Ras-MAPK/PI3K signaling pathways.
Wang J, Yuan Y, Zhou Y, Guo L, Zhang L, Kuai X, Deng B, Pan Z, Li D, He F
J Proteome Res. 2008
PubMed ID: 18624398
Morphogenetic competence of HNF4 alpha-deficient mouse hepatic cells.
Hayhurst GP, Strick-Marchand H, Mulet C, Richard AF, Morosan S, Kremsdorf D, Weiss MC
J Hepatol. 2008
PubMed ID: 18617288
Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins.
Lamon-Fava S, Diffenderfer MR, Barrett PH, Buchsbaum A, Nyaku M, Horvath KV, Asztalos BF, Otokozawa S, Ai M, Matthan NR, Lichtenstein AH, Dolnikowski GG, Schaefer EJ
Arterioscler Thromb Vasc Biol. 2008
PubMed ID: 18566298
Apolipoprotein A-I attenuates renal ischemia/reperfusion injury in rats.
Shi N, Wu MP
J Biomed Sci. 2008
PubMed ID: 18535924
Three-dimensional models of HDL apoA-I: implications for its assembly and function.
Thomas MJ, Bhat S, Sorci-Thomas MG
J Lipid Res. 2008
PubMed ID: 18515783
Genome-wide search for QTLs for apolipoprotein A-I level in elderly Swedish DZ twins: evidence of female-specific locus on 15q11-13.
Magnusson PK, Boman M, de Faire U, Perola M, Peltonen L, Pedersen NL
Eur J Hum Genet. 2008
PubMed ID: 18322452
Structure of apolipoprotein A-I in spherical high density lipoproteins of different sizes.
Silva RA, Huang R, Morris J, Fang J, Gracheva EO, Ren G, Kontush A, Jerome WG, Rye KA, Davidson WS
Proc Natl Acad Sci U S A. 2008
PubMed ID: 18719128
Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I.
Shao B, Cavigiolio G, Brot N, Oda MN, Heinecke JW
Proc Natl Acad Sci U S A. 2008
PubMed ID: 18719109
Dominant and redundant functions of TFIID involved in the regulation of hepatic genes.
Tatarakis A, Margaritis T, Martinez-Jimenez CP, Kouskouti A, Mohan WS, Haroniti A, Kafetzopoulos D, Tora L, Talianidis I
Mol Cell. 2008
PubMed ID: 18722179
Association of lipoprotein lipase D9N polymorphism with myocardial infarction in type 2 diabetes The genetics, outcomes, and lipids in type 2 diabetes (GOLD) study.
Izar MC, Helfenstein T, Ihara SS, Relvas WG, Santos AO, Fischer SC, Pinto LE, Lopes IE, Pomaro DR, Fonseca MI, Bodanese LC, Moriguchi EH, Saraiva JF, Introcaso L, Souza AD, Scartezini M, Torres KP, Zagury L, Jardim PC, Costa EA, Tacito LH, Forti A, Magalhaes ME, Chacra AR, Bertolami MC, Loures-Vale AA, Barros MA, Xavier HT, Lyra R, Argamanijan D, Guimaraes A, Novazzi JP, Kasinski N, Afiune A, Martinez TL, Santos RD, Nicolau JC, Cesar LA, Povoa RM, Carvalho AC, Han SW, Fonseca FA, on behalf of the GOLD Investigators
Atherosclerosis. 2008
PubMed ID: 18823627
Effect of lipid-bound apoA-I cysteine mutants on lipopolysaccharide-induced endotoxemia in mice.
Wang Y, Zhu X, Wu G, Shen L, Chen B
J Lipid Res. 2008
PubMed ID: 18458046
Multiple genetic variants along candidate pathways influence plasma high-density lipoprotein cholesterol concentrations.
Lu Y, Dollé ME, Imholz S, Slot RV, Verschuren WM, Wijmenga C, Feskens EJ, Boer JM
J Lipid Res. 2008
PubMed ID: 18660489
Increase levels of apo-A1 and apo B are associated in knee osteoarthritis: lack of association with VEGF-460 T/C and +405 C/G polymorphisms.
Sánchez-Enríquez S, Torres-Carrillo NM, Vázquez-Del Mercado M, Salgado-Goytia L, Rangel-Villalobos H, Muñoz-Valle JF
Rheumatol Int. 2008
PubMed ID: 18597093
Coexpression of CLA-1 and human PDZK1 in murine liver modulates HDL cholesterol metabolism.
Komori H, Arai H, Kashima T, Huby T, Kita T, Ueda Y
Arterioscler Thromb Vasc Biol. 2008
PubMed ID: 18403724
Low diurnal variability of apolipoprotein A1, apolipoprotein B and apolipoprotein B/apolipoprotein A1 ratio during normal sleep and after an acute shift of sleep.
Larsson A, Carlsson L, Axelsson J
Clin Biochem. 2008
PubMed ID: 18387362
Cathepsin S genotypes are associated with Apo-A1 and HDL-cholesterol in lean and obese French populations.
Spielmann N, Mutch D, Rousseau F, Tores F, Hager J, Bertrais S, Basdevant A, Tounian P, Dubern B, Galan P, Clément K
Clin Genet. 2008
PubMed ID: 18565099
ATP-binding cassette A1-mediated lipidation of apolipoprotein A-I occurs at the plasma membrane and not in the endocytic compartments.
Denis M, Landry YD, Zha X
J Biol Chem. 2008
PubMed ID: 18385134
Associations of the apolipoprotein A-I gene polymorphism and serum lipid levels in the Guangxi Hei Yi Zhuang and Han populations.
Li Y, Yin R, Zhou Y, Deng Y, Yang D, Pan S, Lin W
Int J Mol Med. 2008
PubMed ID: 18506369
Synergistic effect between apolipoprotein E and apolipoprotein A1 gene polymorphisms in the risk for coronary artery disease.
Rai TS, Khullar M, Sehrawat BS, Ahuja M, Sharma PK, Vijayvergiya R, Grover A
Mol Cell Biochem. 2008
PubMed ID: 18398670
Risk stratification of apolipoprotein B, apolipoprotein A1, and apolipoprotein B/AI ratio on the prevalence of the metabolic syndrome: the ATTICA study.
Pitsavos C, Panagiotakos DB, Skoumas J, Papadimitriou L, Stefanadis C
Angiology. 2008
PubMed ID: 18388068
Cholesterol is a determinant of the structures of discoidal high density lipoproteins formed by the solubilization of phospholipid membranes by apolipoprotein A-I.
Massey JB, Pownall HJ
Biochim Biophys Acta. 2008
PubMed ID: 18406360
The central type Y amphipathic alpha-helices of apolipoprotein AI are involved in the mobilization of intracellular cholesterol depots.
Gonzalez MC, Toledo JD, Tricerri MA, Garda HA
Arch Biochem Biophys. 2008
PubMed ID: 18316036
Association between lipoprotein(a) levels, apo(a) isoforms and family history of premature CAD in young Asian Indians.
Gambhir JK, Kaur H, Prabhu KM, Morrisett JD, Gambhir DS
Clin Biochem. 2008
PubMed ID: 18280807
Characterization and properties of pre beta-HDL particles formed by ABCA1-mediated cellular lipid efflux to apoA-I.
Duong PT, Weibel GL, Lund-Katz S, Rothblat GH, Phillips MC
J Lipid Res. 2008
PubMed ID: 18252847
Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells.
Norata GD, Marchesi P, Pirillo A, Uboldi P, Chiesa G, Maina V, Garlanda C, Mantovani A, Catapano AL
Arterioscler Thromb Vasc Biol. 2008
PubMed ID: 18218986
A novel mutation of the apolipoprotein A-I gene in a family with familial combined hyperlipidemia.
Pisciotta L, Fasano T, Calabresi L, Bellocchio A, Fresa R, Borrini C, Calandra S, Bertolini S
Atherosclerosis. 2008
PubMed ID: 17950741
Quantitative analysis of ABCA1-dependent compartmentalization and trafficking of apolipoprotein A-I: implications for determining cellular kinetics of nascent high density lipoprotein biogenesis.
Hassan HH, Bailey D, Lee DY, Iatan I, Hafiane A, Ruel I, Krimbou L, Genest J
J Biol Chem. 2008
PubMed ID: 18218626
APOA1/C3/A5 haplotype and risk of hypertriglyceridemia in Taiwanese.
Chien KL, Fang WH, Wen HC, Lin HP, Lin YL, Lin SW, Wu JH, Kao JT
Clin Chim Acta. 2008
PubMed ID: 18206649
Carotid atherosclerosis in familial combined hyperlipidemia associated with the APOB/APOA-I ratio.
Junyent M, Zambón D, Gilabert R, Cofán M, Núñez I, Ros E
Atherosclerosis. 2008
PubMed ID: 17698072
Role of apolipoproteins E and A-I: Epistatic villains of triglyceride mediation in coronary heart disease.
Singh P, Singh M, Kaur T
Int J Cardiol. 2008
PubMed ID: 18378026
ProApolipoprotein A1: a serum marker of brain metastases in lung cancer patients.
Marchi N, Mazzone P, Fazio V, Mekhail T, Masaryk T, Janigro D
Cancer. 2008
PubMed ID: 18257091
Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity.
de Souza JA, Vindis C, Hansel B, Nègre-Salvayre A, Therond P, Serrano CV, Chantepie S, Salvayre R, Bruckert E, Chapman MJ, Kontush A
Atherosclerosis. 2008
PubMed ID: 17868679
Influence of tertiary structure domain properties on the functionality of apolipoprotein A-I.
Tanaka M, Koyama M, Dhanasekaran P, Nguyen D, Nickel M, Lund-Katz S, Saito H, Phillips MC
Biochemistry. 2008
PubMed ID: 18205410
[Effects of apolipoprotein A1 and B gene polymorphism on avascular necrosis of the femoral head in Chinese population]
Wang XY, Niu XH, Chen WH, Lin N, Song JN, Chen B, Jin H
Zhongguo Gu Shang. 2008
PubMed ID: 19105467
Discrete roles of apoA-I and apoE in the biogenesis of HDL species: lessons learned from gene transfer studies in different mouse models.
Zannis VI, Koukos G, Drosatos K, Vezeridis A, Zanni EE, Kypreos KE, Chroni A
Ann Med. 2008
PubMed ID: 18246469
Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides.
Kooner JS, Chambers JC, Aguilar-Salinas CA, Hinds DA, Hyde CL, Warnes GR, Gómez Pérez FJ, Frazer KA, Elliott P, Scott J, Milos PM, Cox DR, Thompson JF
Nat Genet. 2008
PubMed ID: 18193046
Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans.
Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, Rieder MJ, Cooper GM, Roos C, Voight BF, Havulinna AS, Wahlstrand B, Hedner T, Corella D, Tai ES, Ordovas JM, Berglund G, Vartiainen E, Jousilahti P, Hedblad B, Taskinen MR, Newton-Cheh C, Salomaa V, Peltonen L, Groop L, Altshuler DM, Orho-Melander M
Nat Genet. 2008
PubMed ID: 18193044
Newly identified loci that influence lipid concentrations and risk of coronary artery disease.
Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, Heath SC, Timpson NJ, Najjar SS, Stringham HM, Strait J, Duren WL, Maschio A, Busonero F, Mulas A, Albai G, Swift AJ, Morken MA, Narisu N, Bennett D, Parish S, Shen H, Galan P, Meneton P, Hercberg S, Zelenika D, Chen WM, Li Y, Scott LJ, Scheet PA, Sundvall J, Watanabe RM, Nagaraja R, Ebrahim S, Lawlor DA, Ben-Shlomo Y, Davey-Smith G, Shuldiner AR, Collins R, Bergman RN, Uda M, Tuomilehto J, Cao A, Collins FS, Lakatta E, Lathrop GM, Boehnke M, Schlessinger D, Mohlke KL, Abecasis GR
Nat Genet. 2008
PubMed ID: 18193043
CARM1 promotes adipocyte differentiation by coactivating PPARgamma.
Yadav N, Cheng D, Richard S, Morel M, Iyer VR, Aldaz CM, Bedford MT
EMBO Rep. 2008
PubMed ID: 18188184
Human ApoA-I transfer attenuates transplant arteriosclerosis via enhanced incorporation of bone marrow-derived endothelial progenitor cells.
Feng Y, Jacobs F, Van Craeyveld E, Brunaud C, Snoeys J, Tjwa M, Van Linthout S, De Geest B
Arterioscler Thromb Vasc Biol. 2008
PubMed ID: 18063807
Biogenesis of HDL by SAA is dependent on ABCA1 in the liver in vivo.
Hu W, Abe-Dohmae S, Tsujita M, Iwamoto N, Ogikubo O, Otsuka T, Kumon Y, Yokoyama S
J Lipid Res. 2008
PubMed ID: 18033752
A new APOA1 mutation with severe HDL-cholesterol deficiency and premature coronary artery disease.
Esperón P, Raggio V, Stoll M, Vital M, Alallón W
Clin Chim Acta. 2008
PubMed ID: 17991432
Genetic association study of APOA1/C3/A4/A5 gene cluster and haplotypes on triglyceride and HDL cholesterol in a community-based population.
Chien KL, Chen MF, Hsu HC, Su TC, Chang WT, Lee CM, Lee YT
Clin Chim Acta. 2008
PubMed ID: 17964293
Apolipoprotein A-I but not high-density lipoproteins are internalised by RAW macrophages: roles of ATP-binding cassette transporter A1 and scavenger receptor BI.
Lorenzi I, von Eckardstein A, Cavelier C, Radosavljevic S, Rohrer L
J Mol Med. 2008
PubMed ID: 17906976
Hepatic CTP:phosphocholine cytidylyltransferase-alpha is a critical predictor of plasma high density lipoprotein and very low density lipoprotein.
Jacobs RL, Lingrell S, Zhao Y, Francis GA, Vance DE
J Biol Chem. 2008
PubMed ID: 18042552
The apolipoprotein AII rs5082 variant is associated with reduced risk of coronary artery disease in an Australian male population.
Xiao J, Zhang F, Wiltshire S, Hung J, Jennens M, Beilby JP, Thompson PL, McQuillan BM, McCaskie PA, Carter KW, Palmer LJ, Powell BL
Atherosclerosis. 2008
PubMed ID: 18179799
Genetic studies on the APOA1-C3-A5 gene cluster in Asian Indians with premature coronary artery disease.
Shanker J, Perumal G, Rao VS, Khadrinarasimhiah NB, John S, Hebbagodi S, Mukherjee M, Kakkar VV
Lipids Health Dis. 2008
PubMed ID: 18801202
Genetic background in apolipoprotein A-I and cystathionine beta-synthase deficiency.
Carnicer R, Guzman MA, Acin S, Surra JC, Navarro MA, Arbones-Mainar JM, Arnal C, Morales R, Osada J
Front Biosci. 2008
PubMed ID: 18508577
Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia.
Wallace C, Newhouse SJ, Braund P, Zhang F, Tobin M, Falchi M, Ahmadi K, Dobson RJ, Marçano AC, Hajat C, Burton P, Deloukas P, Brown M, Connell JM, Dominiczak A, Lathrop GM, Webster J, Farrall M, Spector T, Samani NJ, Caulfield MJ, Munroe PB
Am J Hum Genet. 2008
PubMed ID: 18179892
An apolipoprotein A-I gene promoter polymorphism associated with cognitive decline, but not with Alzheimer's disease.
Helbecque N, Codron V, Cottel D, Amouyel P
Dement Geriatr Cogn Disord. 2008
PubMed ID: 18073484
Macrophage PLTP is atheroprotective in LDLr-deficient mice with systemic PLTP deficiency.
Valenta DT, Bulgrien JJ, Bonnet DJ, Curtiss LK
J Lipid Res. 2008
PubMed ID: 17928634
Effect of the combination of the variants -75G/A APOA1 and Trp64Arg ADRB3 on the risk of type 2 diabetes (DM2).
Morcillo S, Cardona F, Rojo-Martínez G, Almaraz MC, Esteva I, Ruiz-De-Adana MS, Olveira G, García-Fuentes E, Gómez-Zumaquero JM, Soriguer F
Clin Endocrinol (Oxf). 2008
PubMed ID: 17727676
Mapping, genetic isolation, and characterization of genetic loci that determine resistance to atherosclerosis in C3H mice.
Wang SS, Shi W, Wang X, Velky L, Greenlee S, Wang MT, Drake TA, Lusis AJ
Arterioscler Thromb Vasc Biol. 2007
PubMed ID: 17916774
Atherogenic, enlarged, and dysfunctional HDL in human PLTP/apoA-I double transgenic mice.
Moerland M, Samyn H, van Gent T, Jauhiainen M, Metso J, van Haperen R, Grosveld F, van Tol A, de Crom R
J Lipid Res. 2007
PubMed ID: 17761633
Normal vascular function despite low levels of high-density lipoprotein cholesterol in carriers of the apolipoprotein A-I(Milano) mutant.
Gomaraschi M, Baldassarre D, Amato M, Eligini S, Conca P, Sirtori CR, Franceschini G, Calabresi L
Circulation. 2007
PubMed ID: 17967773
Prediction of genetic risk for dyslipidemia.
Yamada Y, Matsuo H, Warita S, Watanabe S, Kato K, Oguri M, Yokoi K, Metoki N, Yoshida H, Satoh K, Ichihara S, Aoyagi Y, Yasunaga A, Park H, Tanaka M, Nozawa Y
Genomics. 2007
PubMed ID: 17919884
Maternal and fetal variation in genes of cholesterol metabolism is associated with preterm delivery.
Steffen KM, Cooper ME, Shi M, Caprau D, Simhan HN, Dagle JM, Marazita ML, Murray JC
J Perinatol. 2007
PubMed ID: 17855807
ApoA-I cleaved by transthyretin has reduced ability to promote cholesterol efflux and increased amyloidogenicity.
Liz MA, Gomes CM, Saraiva MJ, Sousa MM
J Lipid Res. 2007
PubMed ID: 17693625
Adiponectin deficiency suppresses ABCA1 expression and ApoA-I synthesis in the liver.
Oku H, Matsuura F, Koseki M, Sandoval JC, Yuasa-Kawase M, Tsubakio-Yamamoto K, Masuda D, Maeda N, Ohama T, Ishigami M, Nishida M, Hirano K, Kihara S, Hori M, Shimomura I, Yamashita S
FEBS Lett. 2007
PubMed ID: 17936760
GRP94 is essential for mesoderm induction and muscle development because it regulates insulin-like growth factor secretion.
Wanderling S, Simen BB, Ostrovsky O, Ahmed NT, Vogen SM, Gidalevitz T, Argon Y
Mol Biol Cell. 2007
PubMed ID: 17634284
Hemoglobin is a co-factor of human trypanosome lytic factor.
Widener J, Nielsen MJ, Shiflett A, Moestrup SK, Hajduk S
PLoS Pathog. 2007
PubMed ID: 17845074
LCAT can rescue the abnormal phenotype produced by the natural ApoA-I mutations (Leu141Arg)Pisa and (Leu159Arg)FIN.
Koukos G, Chroni A, Duka A, Kardassis D, Zannis VI
Biochemistry. 2007
PubMed ID: 17711302
A novel haplotype in ApoAI-CIII-AIV gene region is detrimental to Northwest Indians with coronary heart disease.
Singh P, Singh M, Kaur TP, Grewal SS
Int J Cardiol. 2007
PubMed ID: 17825930
Effect of complexes of apolipoprotein A-I with tetrahydrocortisol and pregnenolone on protein biosynthesis in rat hepatocytes culture.
Panin LE, Knyazev RA, Sumenkova DV, Polyakov LM
Bull Exp Biol Med. 2007
PubMed ID: 18457017
Association of apolipoprotein A1-C3 gene cluster polymorphisms with gallstone disease.
Dixit M, Choudhuri G, Saxena R, Mittal B
Can J Gastroenterol. 2007
PubMed ID: 17853951
Apolipoprotein AI and apolipoprotein E mRNA expression in peripheral white blood cells from patients with orthotopic liver transplantation.
Martínez-López E, Nuño-González P, Ruiz-Madrigal B, Rodríguez-Sancho LC, Hernández-Nazará ZH, Segura-Ortega JE, Panduro A
Liver Int. 2007
PubMed ID: 17696931
Wild-type ApoA-I and the Milano variant have similar abilities to stimulate cellular lipid mobilization and efflux.
Weibel GL, Alexander ET, Joshi MR, Rader DJ, Lund-Katz S, Phillips MC, Rothblat GH
Arterioscler Thromb Vasc Biol. 2007
PubMed ID: 17615385
Mechanism of ATP-binding cassette transporter A1-mediated cellular lipid efflux to apolipoprotein A-I and formation of high density lipoprotein particles.
Vedhachalam C, Duong PT, Nickel M, Nguyen D, Dhanasekaran P, Saito H, Rothblat GH, Lund-Katz S, Phillips MC
J Biol Chem. 2007
PubMed ID: 17604270
The role of different regions of ATP-binding cassette transporter A1 in cholesterol efflux.
Mukhamedova N, Fu Y, Bukrinsky M, Remaley AT, Sviridov D
Biochemistry. 2007
PubMed ID: 17655203
Increased protein nitration burden in the atherosclerotic lesions and plasma of apolipoprotein A-I deficient mice.
Parastatidis I, Thomson L, Fries DM, Moore RE, Tohyama J, Fu X, Hazen SL, Heijnen HF, Dennehy MK, Liebler DC, Rader DJ, Ischiropoulos H
Circ Res. 2007
PubMed ID: 17615369
The structure of apolipoprotein A-I in high density lipoproteins.
Davidson WS, Thompson TB
J Biol Chem. 2007
PubMed ID: 17526499
Phases of canonical Wnt signaling during the development of mouse intestinal epithelium.
Kim BM, Mao J, Taketo MM, Shivdasani RA
Gastroenterology. 2007
PubMed ID: 17681174
Minimal lipidation of pre-beta HDL by ABCA1 results in reduced ability to interact with ABCA1.
Mulya A, Lee JY, Gebre AK, Thomas MJ, Colvin PL, Parks JS
Arterioscler Thromb Vasc Biol. 2007
PubMed ID: 17510466
Bone morphogenetic protein-1 (BMP-1) cleaves human proapolipoprotein A1 and regulates its activation for lipid binding.
Chau P, Fielding PE, Fielding CJ
Biochemistry. 2007
PubMed ID: 17580958
Conformational adaptation of apolipoprotein A-I to discretely sized phospholipid complexes.
Bhat S, Sorci-Thomas MG, Tuladhar R, Samuel MP, Thomas MJ
Biochemistry. 2007
PubMed ID: 17563120
A complete NMR spectral assignment of the lipid-free mouse apolipoprotein A-I (apoAI) C-terminal truncation mutant, apoAI(1-216).
Yang Y, Hoyt D, Wang J
Biomol NMR Assign. 2007
PubMed ID: 19636841
A complete backbone spectral assignment of human apolipoprotein AI on a 38 kDa prebetaHDL (Lp1-AI) particle.
Ren X, Yang Y, Neville T, Hoyt D, Sparks D, Wang J
Biomol NMR Assign. 2007
PubMed ID: 19636829
Hereditary amyloidosis with progressive peripheral neuropathy associated with apolipoprotein AI Gly26Arg: outcome of hepatorenal transplantation.
Testro AG, Brennan SO, Macdonell RA, Hawkins PN, Angus PW
Liver Transpl. 2007
PubMed ID: 17600344
ABCA1-induced cell surface binding sites for ApoA-I.
Vedhachalam C, Ghering AB, Davidson WS, Lund-Katz S, Rothblat GH, Phillips MC
Arterioscler Thromb Vasc Biol. 2007
PubMed ID: 17478755
Speciation of human plasma high-density lipoprotein (HDL): HDL stability and apolipoprotein A-I partitioning.
Pownall HJ, Hosken BD, Gillard BK, Higgins CL, Lin HY, Massey JB
Biochemistry. 2007
PubMed ID: 17530866
The ApoAI-CIII-AIV gene cluster and its relation to lipid levels in type 2 diabetes mellitus and coronary heart disease: determination of a novel susceptible haplotype.
Singh P, Singh M, Gaur S, Kaur T
Diab Vasc Dis Res. 2007
PubMed ID: 17654446
Large disk intermediate precedes formation of apolipoprotein A-I-dimyristoylphosphatidylcholine small disks.
Zhu K, Brubaker G, Smith JD
Biochemistry. 2007
PubMed ID: 17474718
The carboxy-terminal region of apoA-I is required for the ABCA1-dependent formation of alpha-HDL but not prebeta-HDL particles in vivo.
Chroni A, Koukos G, Duka A, Zannis VI
Biochemistry. 2007
PubMed ID: 17447731
ApoB C7623T polymorphism predicts risk for steroid-induced osteonecrosis of the femoral head after renal transplantation.
Hirata T, Fujioka M, Takahashi KA, Arai Y, Asano T, Ishida M, Kuribayashi M, Akioka K, Okamoto M, Yoshimura N, Satomi Y, Nishino H, Fukushima W, Hirota Y, Nakajima S, Kato S, Kubo T
J Orthop Sci. 2007
PubMed ID: 17530370
Association of low serum levels of apolipoprotein A-I with adverse outcomes in patients with nonischemic heart failure.
Iwaoka M, Obata JE, Abe M, Nakamura T, Kitta Y, Kodama Y, Kawabata K, Takano H, Fujioka D, Saito Y, Kobayashi T, Hasebe H, Kugiyama K
J Card Fail. 2007
PubMed ID: 17517342
Apolipoprotein A-I/C-III/A-IV SstI and apolipoprotein B XbaI polymorphisms do not affect early functional and structural changes in atherosclerosis: the Cardiovascular Risk in Young Finns study.
Nieminen T, Kähönen M, Islam S, Raitakari OT, Hutri-Kähönen N, Marniemi J, Juonala M, Rontu R, Viikari J, Lehtimäki T
Circ J. 2007
PubMed ID: 17457002
Genetic etiology of isolated low HDL syndrome: incidence and heterogeneity of efflux defects.
Kiss RS, Kavaslar N, Okuhira K, Freeman MW, Walter S, Milne RW, McPherson R, Marcel YL
Arterioscler Thromb Vasc Biol. 2007
PubMed ID: 17303779
The relation between apolipoprotein A-I and dementia: the Honolulu-Asia aging study.
Saczynski JS, White L, Peila RL, Rodriguez BL, Launer LJ
Am J Epidemiol. 2007
PubMed ID: 17298957
Functional LCAT deficiency in human apolipoprotein A-I transgenic, SR-BI knockout mice.
Lee JY, Badeau RM, Mulya A, Boudyguina E, Gebre AK, Smith TL, Parks JS
J Lipid Res. 2007
PubMed ID: 17272829
Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes.
Qi L, Liu S, Rifai N, Hunter D, Hu FB
Atherosclerosis. 2007
PubMed ID: 16781717
Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT.
Kypreos KE, Zannis VI
Biochem J. 2007
PubMed ID: 17206937
Stage-specific association of apolipoprotein A-I and E in developing mouse retina.
Kurumada S, Onishi A, Imai H, Ishii K, Kobayashi T, Sato SB
Invest Ophthalmol Vis Sci. 2007
PubMed ID: 17389516
Expression of glycolytic enzymes is increased in pancreatic cancerous tissues as evidenced by proteomic profiling by two-dimensional electrophoresis and liquid chromatography-mass spectrometry/mass spectrometry.
Mikuriya K, Kuramitsu Y, Ryozawa S, Fujimoto M, Mori S, Oka M, Hamano K, Okita K, Sakaida I, Nakamura K
Int J Oncol. 2007
PubMed ID: 17332923
Electron paramagnetic resonance spectroscopy of site-directed spin labels reveals the structural heterogeneity in the N-terminal domain of apoA-I in solution.
Lagerstedt JO, Budamagunta MS, Oda MN, Voss JC
J Biol Chem. 2007
PubMed ID: 17204472
Activity-dependent neuroprotective protein (ADNP) differentially interacts with chromatin to regulate genes essential for embryogenesis.
Mandel S, Rechavi G, Gozes I
Dev Biol. 2007
PubMed ID: 17222401
Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.
Ehmann M, Felix K, Hartmann D, Schnölzer M, Nees M, Vorderwülbecke S, Bogumil R, Büchler MW, Friess H
Pancreas. 2007
PubMed ID: 17312459
The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase.
Nobecourt E, Davies MJ, Brown BE, Curtiss LK, Bonnet DJ, Charlton F, Januszewski AS, Jenkins AJ, Barter PJ, Rye KA
Diabetologia. 2007
PubMed ID: 17216278
Apolipoprotein AI-CIII-AIV gene cluster polymorphisms in relation to cholesterol gallstone.
Yao YG, Qiu X, Ma MK, Pu DS, Xiao LJ
J Dig Dis. 2007
PubMed ID: 17261136
Do mutations causing low HDL-C promote increased carotid intima-media thickness?
Miller M, Rhyne J, Hong SH, Friel G, Dolinar C, Riley W
Clin Chim Acta. 2007
PubMed ID: 17113061
Vasodilation in resistance arteries is related to the apolipoprotein B/A1 ratio in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study.
Lind L
Atherosclerosis. 2007
PubMed ID: 16545386
ApolipoproteinA1-75 G/A (M1-) polymorphism and lipoprotein(a); anti- vs. pro-Atherogenic properties.
Albahrani AI, Usher JJ, Alkindi M, Marks E, Ranganath L, Al-yahyaee S
Lipids Health Dis. 2007
PubMed ID: 17683612
The AcB/BcA recombinant congenic strains of mice: strategies for phenotype dissection, mapping and cloning of quantitative trait genes.
Fortin A, Diez E, Henderson JE, Mogil JS, Gros P, Skamene E
Novartis Found Symp. 2007
PubMed ID: 17534071
Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extent.
Lebherz C, Sanmiguel J, Wilson JM, Rader DJ
Cardiovasc Diabetol. 2007
PubMed ID: 17475009
Polymorphisms in the APOA1/C3/A4/A5 gene cluster and cholesterol responsiveness to dietary change.
Hubacek JA, Bohuslavova R, Skodova Z, Pitha J, Bobkova D, Poledne R
Clin Chem Lab Med. 2007
PubMed ID: 17378725
Decreased levels of apolipoprotein A-I in plasma of schizophrenic patients.
La YJ, Wan CL, Zhu H, Yang YF, Chen YS, Pan YX, Feng GY, He L
J Neural Transm. 2007
PubMed ID: 17165100
Proteomic analysis of human very low-density lipoprotein by two-dimensional gel electrophoresis and MALDI-TOF/TOF.
Mancone C, Amicone L, Fimia GM, Bravo E, Piacentini M, Tripodi M, Alonzi T
Proteomics. 2007
PubMed ID: 17154273
Ratio determination of plasma wild-type and L159R apoA-I using mass spectrometry: tools for studying apoA-IFin.
Owen JS, Bharadwaj MS, Thomas MJ, Bhat S, Samuel MP, Sorci-Thomas MG
J Lipid Res. 2007
PubMed ID: 17071967
Inflammation and skin cholesterol in LDLr-/-, apoA-I-/- mice: link between cholesterol homeostasis and self-tolerance?
Zabalawi M, Bharadwaj M, Horton H, Cline M, Willingham M, Thomas MJ, Sorci-Thomas MG
J Lipid Res. 2007
PubMed ID: 17071966
Altered hepatic lipid status and apolipoprotein A-I metabolism in mice lacking phospholipid transfer protein.
Siggins S, Bykov I, Hermansson M, Somerharju P, Lindros K, Miettinen TA, Jauhiainen M, Olkkonen VM, Ehnholm C
Atherosclerosis. 2007
PubMed ID: 16554055
Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study.
Hallman DM, Srinivasan SR, Chen W, Boerwinkle E, Berenson GS
Metabolism. 2006
PubMed ID: 17142127
Correction of apolipoprotein A-I-mediated lipid efflux and high density lipoprotein particle formation in human Niemann-Pick type C disease fibroblasts.
Boadu E, Choi HY, Lee DW, Waddington EI, Chan T, Asztalos B, Vance JE, Chan A, Castro G, Francis GA
J Biol Chem. 2006
PubMed ID: 17020879
Overexpression of human ApoAI transgene provides long-term atheroprotection in LDL receptor-deficient mice.
Valenta DT, Bulgrien JJ, Banka CL, Curtiss LK
Atherosclerosis. 2006
PubMed ID: 16423356
Amyloid contained in the knee joint meniscus is formed from apolipoprotein A-I.
Solomon A, Murphy CL, Kestler D, Coriu D, Weiss DT, Makovitzky J, Westermark P
Arthritis Rheum. 2006
PubMed ID: 17075859
Human immunodeficiency virus impairs reverse cholesterol transport from macrophages.
Mujawar Z, Rose H, Morrow MP, Pushkarsky T, Dubrovsky L, Mukhamedova N, Fu Y, Dart A, Orenstein JM, Bobryshev YV, Bukrinsky M, Sviridov D
PLoS Biol. 2006
PubMed ID: 17076584
Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance.
Liao D, Tan H, Hui R, Li Z, Jiang X, Gaubatz J, Yang F, Durante W, Chan L, Schafer AI, Pownall HJ, Yang X, Wang H
Circ Res. 2006
PubMed ID: 16931800
Interaction of fibrin(ogen) with apolipoprotein(a): further characterization and identification of a novel lysine-dependent apolipoprotein(a)-binding site within the gamma chain 287-411 region.
Tsurupa G, Yakovlev S, Pechik I, Lamanuzzi LB, Anglés-Cano E, Medved L
Biochemistry. 2006
PubMed ID: 16939214
Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis.
Kontush A, Chapman MJ
Pharmacol Rev. 2006
PubMed ID: 16968945
Differential effects of oxidized LDL on apolipoprotein AI and B synthesis in HepG2 cells.
Bourdon E, Loreau N, Lagrost L, Davignon J, Bernier L, Blache D
Free Radic Biol Med. 2006
PubMed ID: 16895799
Consistent effects of genes involved in reverse cholesterol transport on plasma lipid and apolipoprotein levels in CARDIA participants.
Klos KL, Sing CF, Boerwinkle E, Hamon SC, Rea TJ, Clark A, Fornage M, Hixson JE
Arterioscler Thromb Vasc Biol. 2006
PubMed ID: 16763159
Isolation and characterization of human apolipoprotein M-containing lipoproteins.
Christoffersen C, Nielsen LB, Axler O, Andersson A, Johnsen AH, Dahlbäck B
J Lipid Res. 2006
PubMed ID: 16682745
Apolipoprotein A-I/apolipoprotein B ratio and aggression in violent and nonviolent young adult males.
Troisi A, D'Argenio A
J Psychiatr Res. 2006
PubMed ID: 16455106
Apolipoprotein A-I assumes a "looped belt" conformation on reconstituted high density lipoprotein.
Martin DD, Budamagunta MS, Ryan RO, Voss JC, Oda MN
J Biol Chem. 2006
PubMed ID: 16698792
ApoB-100 and ApoB/ApoA-1 ratio in children and adolescents from families with very early myocardial infarction.
Dirisamer A, Stadler A, Bucek RA, Widhalm K
Acta Paediatr. 2006
PubMed ID: 16801176
The contribution of individual and pairwise combinations of SNPs in the APOA1 and APOC3 genes to interindividual HDL-C variability.
Brown CM, Rea TJ, Hamon SC, Hixson JE, Boerwinkle E, Clark AG, Sing CF
J Mol Med. 2006
PubMed ID: 16705465
Serum lipoprotein(a) levels and apolipoprotein(a) isoform size and risk for first-ever acute ischaemic nonembolic stroke in elderly individuals.
Milionis HJ, Filippatos TD, Loukas T, Bairaktari ET, Tselepis AD, Elisaf MS
Atherosclerosis. 2006
PubMed ID: 16197951
Diversity of metabolic syndrome risk factors in obese children and adolescents.
Bueno G, Bueno O, Moreno LA, García R, Tresaco B, Garagorri JM, Bueno M
J Physiol Biochem. 2006
PubMed ID: 17217166
Adiponectin is an important determinant of apoA-I catabolism.
Vergès B, Petit JM, Duvillard L, Dautin G, Florentin E, Galland F, Gambert P
Arterioscler Thromb Vasc Biol. 2006
PubMed ID: 16574896
Active plasma phospholipid transfer protein is associated with apoA-I- but not apoE-containing lipoproteins.
Cheung MC, Albers JJ
J Lipid Res. 2006
PubMed ID: 16520487
Apolipoprotein A-I increases association of cytosolic cholesterol and caveolin-1 with microtubule cytoskeletons in rat astrocytes.
Ito J, Kheirollah A, Nagayasu Y, Lu R, Kato K, Yokoyama S
J Neurochem. 2006
PubMed ID: 16606364
Characterization of a new mouse model for human apolipoprotein A-I/C-III/A-IV deficiency.
Mezdour H, Larigauderie G, Castro G, Torpier G, Fruchart J, Nowak M, Fruchart JC, Rouis M, Maeda N
J Lipid Res. 2006
PubMed ID: 16497661
Persistent liver expression of murine apoA-l using vectors based on adeno-associated viral vectors serotypes 5 and 1.
Kitajima K, Marchadier DH, Burstein H, Rader DJ
Atherosclerosis. 2006
PubMed ID: 16099465
Lipoprotein(a), apolipoprotein(a) polymorphism and coronary atherosclerosis severity in type 2 diabetic patients.
Gazzaruso C, Bruno R, Pujia A, De Amici E, Fratino P, Solerte SB, Garzaniti A
Int J Cardiol. 2006
PubMed ID: 15961173
Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I.
Shao B, Oda MN, Bergt C, Fu X, Green PS, Brot N, Oram JF, Heinecke JW
J Biol Chem. 2006
PubMed ID: 16497665
Apolipoprotein A-I activates Cdc42 signaling through the ABCA1 transporter.
Nofer JR, Remaley AT, Feuerborn R, Wolinnska I, Engel T, von Eckardstein A, Assmann G
J Lipid Res. 2006
PubMed ID: 16443932
Characterization of nascent HDL particles and microparticles formed by ABCA1-mediated efflux of cellular lipids to apoA-I.
Duong PT, Collins HL, Nickel M, Lund-Katz S, Rothblat GH, Phillips MC
J Lipid Res. 2006
PubMed ID: 16418537
Human chromosome 11 DNA sequence and analysis including novel gene identification.
Taylor TD, Noguchi H, Totoki Y, Toyoda A, Kuroki Y, Dewar K, Lloyd C, Itoh T, Takeda T, Kim DW, She X, Barlow KF, Bloom T, Bruford E, Chang JL, Cuomo CA, Eichler E, FitzGerald MG, Jaffe DB, LaButti K, Nicol R, Park HS, Seaman C, Sougnez C, Yang X, Zimmer AR, Zody MC, Birren BW, Nusbaum C, Fujiyama A, Hattori M, Rogers J, Lander ES, Sakaki Y
Nature. 2006
PubMed ID: 16554811
In vivo role of the HNF4alpha AF-1 activation domain revealed by exon swapping.
Briançon N, Weiss MC
EMBO J. 2006
PubMed ID: 16498401
Serum opacity factor, a streptococcal virulence factor that binds to apolipoproteins A-I and A-II and disrupts high density lipoprotein structure.
Courtney HS, Zhang YM, Frank MW, Rock CO
J Biol Chem. 2006
PubMed ID: 16407233
Common variants of multiple genes that control reverse cholesterol transport together explain only a minor part of the variation of HDL cholesterol levels.
Boekholdt SM, Souverein OW, Tanck MW, Hovingh GK, Kuivenhoven JA, Peters RI, Jansen H, Schiffers PM, van der Wall EE, Doevendans PA, Reitsma PH, Zwinderman AH, Kastelein JJ, Jukema JW
Clin Genet. 2006
PubMed ID: 16542392
Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy.
Foulkes AS, Wohl DA, Frank I, Puleo E, Restine S, Wolfe ML, Dube MP, Tebas P, Reilly MP
PLoS Med. 2006
PubMed ID: 16417409
High-density lipoprotein (HDL) transport in the metabolic syndrome: application of a new model for HDL particle kinetics.
Ji J, Watts GF, Johnson AG, Chan DC, Ooi EM, Rye KA, Serone AP, Barrett PH
J Clin Endocrinol Metab. 2006
PubMed ID: 16368749
Description of the torcetrapib series of cholesteryl ester transfer protein inhibitors, including mechanism of action.
Clark RW, Ruggeri RB, Cunningham D, Bamberger MJ
J Lipid Res. 2006
PubMed ID: 16326978
A novel nonsense apolipoprotein A-I mutation (apoA-I(E136X)) causes low HDL cholesterol in French Canadians.
Dastani Z, Dangoisse C, Boucher B, Desbiens K, Krimbou L, Dufour R, Hegele RA, Pajukanta P, Engert JC, Genest J, Marcil M
Atherosclerosis. 2006
PubMed ID: 16023124
Apolipoprotein A1 genotype affects the change in high density lipoprotein cholesterol subfractions with exercise training.
Ruaño G, Seip RL, Windemuth A, Zöllner S, Tsongalis GJ, Ordovas J, Otvos J, Bilbie C, Miles M, Zoeller R, Visich P, Gordon P, Angelopoulos TJ, Pescatello L, Moyna N, Thompson PD
Atherosclerosis. 2006
PubMed ID: 16005460
Inhibition of apolipoprotein AI gene expression by tumor necrosis factor alpha: roles for MEK/ERK and JNK signaling.
Beers A, Haas MJ, Wong NC, Mooradian AD
Biochemistry. 2006
PubMed ID: 16475830
Crystal structure of human apolipoprotein A-I: insights into its protective effect against cardiovascular diseases.
Ajees AA, Anantharamaiah GM, Mishra VK, Hussain MM, Murthy HM
Proc Natl Acad Sci U S A. 2006
PubMed ID: 16452169
High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I.
Seetharam D, Mineo C, Gormley AK, Gibson LL, Vongpatanasin W, Chambliss KL, Hahner LD, Cummings ML, Kitchens RL, Marcel YL, Rader DJ, Shaul PW
Circ Res. 2006
PubMed ID: 16339487
Concordant association of lipid gene variation with a combined HDL/LDL-cholesterol phenotype in two European populations.
Bauerfeind A, Knoblauch H, Costanza MC, Luganskaja T, Toliat MR, Nürnberg P, Luft FC, Reich JG, Morabia A
Hum Hered. 2006
PubMed ID: 16770077
Evidence for consistent intragenic and intergenic interactions between SNP effects in the APOA1/C3/A4/A5 gene cluster.
Hamon SC, Kardia SL, Boerwinkle E, Liu K, Klos KL, Clark AG, Sing CF
Hum Hered. 2006
PubMed ID: 16710093
Apolipoprotein A-I lysine modification: effects on helical content, lipid binding and cholesterol acceptor activity.
Brubaker G, Peng DQ, Somerlot B, Abdollahian DJ, Smith JD
Biochim Biophys Acta. 2006
PubMed ID: 16495141
Förster resonance energy transfer measurements are consistent with a helical bundle model for lipid-free apolipoprotein A-I.
Brouillette CG, Dong WJ, Yang ZW, Ray MJ, Protasevich II, Cheung HC, Engler JA
Biochemistry. 2005
PubMed ID: 16342934
Apolipoprotein A-I induces IL-10 and PGE2 production in human monocytes and inhibits dendritic cell differentiation and maturation.
Kim KD, Lim HY, Lee HG, Yoon DY, Choe YK, Choi I, Paik SG, Kim YS, Yang Y, Lim JS
Biochem Biophys Res Commun. 2005
PubMed ID: 16259956
Intracellular lipidation of newly synthesized apolipoprotein A-I in primary murine hepatocytes.
Maric J, Kiss RS, Franklin V, Marcel YL
J Biol Chem. 2005
PubMed ID: 16204232
Apolipoprotein A-I and the molecular variant apoA-I(Milano): evaluation of the antiatherogenic effects in knock-in mouse model.
Parolini C, Chiesa G, Gong E, Caligari S, Cortese MM, Koga T, Forte TM, Rubin EM
Atherosclerosis. 2005
PubMed ID: 16285990
Reverse cholesterol transport and cholesterol efflux in atherosclerosis.
Ohashi R, Mu H, Wang X, Yao Q, Chen C
QJM. 2005
PubMed ID: 16258026
Oxidative susceptibility of apolipoprotein AI in serum.
Nakano T, Nagata A
Clin Chim Acta. 2005
PubMed ID: 16005451
Protective molecules--C-reactive protein (CRP), serum amyloid P (SAP), pentraxin3 (PTX3), mannose-binding lectin (MBL), and apolipoprotein A1 (Apo A1), and their autoantibodies: prevalence and clinical significance in autoimmunity.
Kravitz MS, Pitashny M, Shoenfeld Y
J Clin Immunol. 2005
PubMed ID: 16380821
Point mutations in apolipoprotein A-I mimic the phenotype observed in patients with classical lecithin:cholesterol acyltransferase deficiency.
Chroni A, Duka A, Kan HY, Liu T, Zannis VI
Biochemistry. 2005
PubMed ID: 16245952
Comparative effect of fish oil feeding and other dietary fatty acids on plasma lipoproteins, biliary lipids, and hepatic expression of proteins involved in reverse cholesterol transport in the rat.
Morgado N, Rigotti A, Valenzuela A
Ann Nutr Metab. 2005
PubMed ID: 16227687
Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I.
Shao B, Fu X, McDonald TO, Green PS, Uchida K, O'Brien KD, Oram JF, Heinecke JW
J Biol Chem. 2005
PubMed ID: 16126721
Inhibition of apolipoprotein AI gene expression by 1, 25-dihydroxyvitamin D3.
Wehmeier K, Beers A, Haas MJ, Wong NC, Steinmeyer A, Zugel U, Mooradian AD
Biochim Biophys Acta. 2005
PubMed ID: 16236546
Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation.
Moore RE, Navab M, Millar JS, Zimetti F, Hama S, Rothblat GH, Rader DJ
Circ Res. 2005
PubMed ID: 16151025
Tyrosine modification is not required for myeloperoxidase-induced loss of apolipoprotein A-I functional activities.
Peng DQ, Wu Z, Brubaker G, Zheng L, Settle M, Gross E, Kinter M, Hazen SL, Smith JD
J Biol Chem. 2005
PubMed ID: 16091367
Apolipoprotein A-I possessing activity of defensin proteins modifies structure of plasma membranes.
Panin LE, Ryazantseva NV, Novitskii VV, Tokareva NV
Bull Exp Biol Med. 2005
PubMed ID: 16671566
SR-BI-mediated selective lipid uptake segregates apoA-I and apoA-II catabolism.
de Beer MC, van der Westhuyzen DR, Whitaker NL, Webb NR, de Beer FC
J Lipid Res. 2005
PubMed ID: 16061955
Relationship between plasma HDL subclasses distribution and apoA-I gene polymorphisms.
Jia L, Bai H, Fu M, Xu Y, Yang Y, Long S
Clin Chim Acta. 2005
PubMed ID: 15925353
A human protein-protein interaction network: a resource for annotating the proteome.
Stelzl U, Worm U, Lalowski M, Haenig C, Brembeck FH, Goehler H, Stroedicke M, Zenkner M, Schoenherr A, Koeppen S, Timm J, Mintzlaff S, Abraham C, Bock N, Kietzmann S, Goedde A, Toksöz E, Droege A, Krobitsch S, Korn B, Birchmeier W, Lehrach H, Wanker EE
Cell. 2005
PubMed ID: 16169070
Intermolecular contact between globular N-terminal fold and C-terminal domain of ApoA-I stabilizes its lipid-bound conformation: studies employing chemical cross-linking and mass spectrometry.
Bhat S, Sorci-Thomas MG, Alexander ET, Samuel MP, Thomas MJ
J Biol Chem. 2005
PubMed ID: 15972827
ABCA1, ApoA-I and type II DM.
Saleheen D
Biochem Biophys Res Commun. 2005
PubMed ID: 16009332
High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I.
Gaidukov L, Tawfik DS
Biochemistry. 2005
PubMed ID: 16128586
Antisense transcription in the mammalian transcriptome.
Katayama S, Tomaru Y, Kasukawa T, Waki K, Nakanishi M, Nakamura M, Nishida H, Yap CC, Suzuki M, Kawai J, Suzuki H, Carninci P, Hayashizaki Y, Wells C, Frith M, Ravasi T, Pang KC, Hallinan J, Mattick J, Hume DA, Lipovich L, Batalov S, Engström PG, Mizuno Y, Faghihi MA, Sandelin A, Chalk AM, Mottagui-Tabar S, Liang Z, Lenhard B, Wahlestedt C, RIKEN Genome Exploration Research Group, Genome Science Group (Genome Network Project Core Group), FANTOM Consortium
Science. 2005
PubMed ID: 16141073
The transcriptional landscape of the mammalian genome.
Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, Maeda N, Oyama R, Ravasi T, Lenhard B, Wells C, Kodzius R, Shimokawa K, Bajic VB, Brenner SE, Batalov S, Forrest AR, Zavolan M, Davis MJ, Wilming LG, Aidinis V, Allen JE, Ambesi-Impiombato A, Apweiler R, Aturaliya RN, Bailey TL, Bansal M, Baxter L, Beisel KW, Bersano T, Bono H, Chalk AM, Chiu KP, Choudhary V, Christoffels A, Clutterbuck DR, Crowe ML, Dalla E, Dalrymple BP, de Bono B, Della Gatta G, di Bernardo D, Down T, Engstrom P, Fagiolini M, Faulkner G, Fletcher CF, Fukushima T, Furuno M, Futaki S, Gariboldi M, Georgii-Hemming P, Gingeras TR, Gojobori T, Green RE, Gustincich S, Harbers M, Hayashi Y, Hensch TK, Hirokawa N, Hill D, Huminiecki L, Iacono M, Ikeo K, Iwama A, Ishikawa T, Jakt M, Kanapin A, Katoh M, Kawasawa Y, Kelso J, Kitamura H, Kitano H, Kollias G, Krishnan SP, Kruger A, Kummerfeld SK, Kurochkin IV, Lareau LF, Lazarevic D, Lipovich L, Liu J, Liuni S, McWilliam S, Madan Babu M, Madera M, Marchionni L, Matsuda H, Matsuzawa S, Miki H, Mignone F, Miyake S, Morris K, Mottagui-Tabar S, Mulder N, Nakano N, Nakauchi H, Ng P, Nilsson R, Nishiguchi S, Nishikawa S, Nori F, Ohara O, Okazaki Y, Orlando V, Pang KC, Pavan WJ, Pavesi G, Pesole G, Petrovsky N, Piazza S, Reed J, Reid JF, Ring BZ, Ringwald M, Rost B, Ruan Y, Salzberg SL, Sandelin A, Schneider C, Schönbach C, Sekiguchi K, Semple CA, Seno S, Sessa L, Sheng Y, Shibata Y, Shimada H, Shimada K, Silva D, Sinclair B, Sperling S, Stupka E, Sugiura K, Sultana R, Takenaka Y, Taki K, Tammoja K, Tan SL, Tang S, Taylor MS, Tegner J, Teichmann SA, Ueda HR, van Nimwegen E, Verardo R, Wei CL, Yagi K, Yamanishi H, Zabarovsky E, Zhu S, Zimmer A, Hide W, Bult C, Grimmond SM, Teasdale RD, Liu ET, Brusic V, Quackenbush J, Wahlestedt C, Mattick JS, Hume DA, Kai C, Sasaki D, Tomaru Y, Fukuda S, Kanamori-Katayama M, Suzuki M, Aoki J, Arakawa T, Iida J, Imamura K, Itoh M, Kato T, Kawaji H, Kawagashira N, Kawashima T, Kojima M, Kondo S, Konno H, Nakano K, Ninomiya N, Nishio T, Okada M, Plessy C, Shibata K, Shiraki T, Suzuki S, Tagami M, Waki K, Watahiki A, Okamura-Oho Y, Suzuki H, Kawai J, Hayashizaki Y, FANTOM Consortium, RIKEN Genome Exploration Research Group and Genome Science Group (Genome Network Project Core Group)
Science. 2005
PubMed ID: 16141072
Apolipoproteins (apoproteins) and LPL variation in Mennonite populations of Kansas and Nebraska.
Demarchi DA, Mosher MJ, Crawford MH
Am J Hum Biol. 2005
PubMed ID: 16136540
APOA1 polymorphism influences risk for early-onset nonfamiliar AD.
Vollbach H, Heun R, Morris CM, Edwardson JA, McKeith IG, Jessen F, Schulz A, Maier W, Kölsch H
Ann Neurol. 2005
PubMed ID: 16130094
Persistence of high density lipoprotein particles in obese mice lacking apolipoprotein A-I.
Gruen ML, Plummer MR, Zhang W, Posey KA, Linton MF, Fazio S, Hasty AH
J Lipid Res. 2005
PubMed ID: 15995171
ABCG1 redistributes cell cholesterol to domains removable by high density lipoprotein but not by lipid-depleted apolipoproteins.
Vaughan AM, Oram JF
J Biol Chem. 2005
PubMed ID: 15994327
Effects of the core lipid on the energetics of binding of ApoA-I to model lipoprotein particles of different sizes.
Tanaka M, Saito H, Dhanasekaran P, Wehrli S, Handa T, Lund-Katz S, Phillips MC
Biochemistry. 2005
PubMed ID: 16060677
Evaluation of apolipoprotein E secretion by macrophages in type 2 diabetic patients: role of HDL and apolipoprotein A-I.
Yamato K, Tamasawa N, Murakami H, Matsui J, Tanabe J, Suda T, Yasujima M
Diabetes Res Clin Pract. 2005
PubMed ID: 16005361
NDRG1 interacts with APO A-I and A-II and is a functional candidate for the HDL-C QTL on 8q24.
Hunter M, Angelicheva D, Tournev I, Ingley E, Chan DC, Watts GF, Kremensky I, Kalaydjieva L
Biochem Biophys Res Commun. 2005
PubMed ID: 15922294
Association of two apolipoprotein A-I gene MspI polymorphisms with lipid and blood pressure levels.
Ma YQ, Thomas GN, Tomlinson B
Int J Cardiol. 2005
PubMed ID: 15982502
Interaction of human apolipoprotein A-I with model membranes exhibiting lipid domains.
Arnulphi C, Sánchez SA, Tricerri MA, Gratton E, Jonas A
Biophys J. 2005
PubMed ID: 15849246
Evidence for multiple complementary pathways for efficient cholesterol absorption in mice.
Iqbal J, Hussain MM
J Lipid Res. 2005
PubMed ID: 15834127
A mass spectrometric determination of the conformation of dimeric apolipoprotein A-I in discoidal high density lipoproteins.
Silva RA, Hilliard GM, Li L, Segrest JP, Davidson WS
Biochemistry. 2005
PubMed ID: 15952766
ApoA-I lipidation in primary mouse hepatocytes. Separate controls for phospholipid and cholesterol transfers.
Zheng H, Kiss RS, Franklin V, Wang MD, Haidar B, Marcel YL
J Biol Chem. 2005
PubMed ID: 15797865
Apolipoprotein(a) gene polymorphisms (TTTTA)n and G/A-914 affect Lp(a) levels in ischemic heart disease patients from Serbia.
Dincić D, Zivković M, Stanković A, Djurić T, Vujanić S, Gligić B, Alavantić D
Wien Klin Wochenschr. 2005
PubMed ID: 16053196
Association between MspI polymorphism of the APO AI gene and Type 2 diabetes mellitus.
Morcillo S, Cardona F, Rojo-Martínez G, Esteva I, Ruíz-de-Adana MS, Tinahones F, Gómez-Zumaquero JM, Soriguer F
Diabet Med. 2005
PubMed ID: 15910632
Paraoxonase-1 promoter polymorphism C--107T and serum apolipoprotein AI interact to modulate serum paraoxonase-1 status.
James RW, Kalix B, Bioletto S, Brulhart-Meynet MC
Pharmacogenet Genomics. 2005
PubMed ID: 15900219
Cysteine mutants of human apolipoprotein A-I: a study of secondary structural and functional properties.
Zhu X, Wu G, Zeng W, Xue H, Chen B
J Lipid Res. 2005
PubMed ID: 15805548
High-density lipoproteins induce transforming growth factor-beta2 expression in endothelial cells.
Norata GD, Callegari E, Marchesi M, Chiesa G, Eriksson P, Catapano AL
Circulation. 2005
PubMed ID: 15911702
Combined interaction of phospholipase C and apolipoprotein A-I with small unilamellar lecithin-cholesterol vesicles: influence of apolipoprotein A-I concentration and vesicle composition.
Gudheti MV, Lee SP, Danino D, Wrenn SP
Biochemistry. 2005
PubMed ID: 15882068
Response to a urate-lowering diet according to polymorphisms in the apolipoprotein AI-CIII-AIV cluster.
Cardona F, Tinahones FJ, Collantes E, Garcia-Fuentes E, Escudero A, Soriguer F
J Rheumatol. 2005
PubMed ID: 15868628
Apolipoprotein A-I/C-III/A-IV SstI and apolipoprotein B XbaI polymorphisms and their association with carotid artery intima-media thickness in the Finnish population. The Cardiovascular Risk in Young Finns Study.
Islam MS, Raitakari OT, Juonala M, Kähönen M, Hutri-Kähönen N, Collings A, Aalto-Setälä K, Kontula K, Marniemi J, Viikari JS, Lehtimäki T
Atherosclerosis. 2005
PubMed ID: 15823278
APOA1/C3/A4 gene cluster variability and lipid levels in Brazilian children.
de França E, Alves JG, Hutz MH
Braz J Med Biol Res. 2005
PubMed ID: 15962178
Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis.
Wolfrum C, Poy MN, Stoffel M
Nat Med. 2005
PubMed ID: 15793583
Polymorphisms in APOA1 and LPL genes are statistically independently associated with fasting TG in men with CAD.
Souverein OW, Jukema JW, Boekholdt SM, Zwinderman AH, Tanck MW
Eur J Hum Genet. 2005
PubMed ID: 15657615
Visualization and analysis of apolipoprotein A-I interaction with binary phospholipid bilayers.
Tricerri MA, Toledo JD, Sanchez SA, Hazlett TL, Gratton E, Jonas A, Garda HA
J Lipid Res. 2005
PubMed ID: 15654128
The expression of intact and mutant human apoAI/CIII/AIV/AV gene cluster in transgenic mice.
Gao J, Wei Y, Huang Y, Liu D, Liu G, Wu M, Wu L, Zhang Q, Zhang Z, Zhang R, Liang C
J Biol Chem. 2005
PubMed ID: 15649902
Combined N- and C-terminal truncation of human apolipoprotein A-I yields a folded, functional central domain.
Beckstead JA, Block BL, Bielicki JK, Kay CM, Oda MN, Ryan RO
Biochemistry. 2005
PubMed ID: 15766290
Deletions of helices 2 and 3 of human apoA-I are associated with severe dyslipidemia following adenovirus-mediated gene transfer in apoA-I-deficient mice.
Chroni A, Kan HY, Shkodrani A, Liu T, Zannis VI
Biochemistry. 2005
PubMed ID: 15751988
A three-dimensional molecular model of lipid-free apolipoprotein A-I determined by cross-linking/mass spectrometry and sequence threading.
Silva RA, Hilliard GM, Fang J, Macha S, Davidson WS
Biochemistry. 2005
PubMed ID: 15723520
Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport.
Shao B, Bergt C, Fu X, Green P, Voss JC, Oda MN, Oram JF, Heinecke JW
J Biol Chem. 2005
PubMed ID: 15574409
The interfacial properties of ApoA-I and an amphipathic alpha-helix consensus peptide of exchangeable apolipoproteins at the triolein/water interface.
Wang L, Atkinson D, Small DM
J Biol Chem. 2005
PubMed ID: 15695525
[Correlation between APOA gene polymorphism and intracranial aneurysm]
Zhao YL, Sun YM, Wang S, Zhao JZ, Chen BS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005
PubMed ID: 15782489
Gender-specific effects of estrogen receptor alpha gene haplotype on high-density lipoprotein cholesterol response to atorvastatin: interaction with apolipoprotein AI gene polymorphism.
Kajinami K, Brousseau ME, Lamon-Fava S, Ordovas JM, Schaefer EJ
Atherosclerosis. 2005
PubMed ID: 15694942
Apolipoprotein E is the major physiological activator of lecithin-cholesterol acyltransferase (LCAT) on apolipoprotein B lipoproteins.
Zhao Y, Thorngate FE, Weisgraber KH, Williams DL, Parks JS
Biochemistry. 2005
PubMed ID: 15654758
Assignment of the binding site for haptoglobin on apolipoprotein A-I.
Spagnuolo MS, Cigliano L, D'Andrea LD, Pedone C, Abrescia P
J Biol Chem. 2005
PubMed ID: 15533931
APOA1-75 G to A substitution associated with severe forms of CAD, lower levels of HDL and apoA-I among northern Indians.
Chhabra S, Narang R, Lakshmy R, Das N
Dis Markers. 2005
PubMed ID: 16403951
APOA1 polymorphisms are associated with variations in serum triglyceride concentrations in hypercholesterolemic individuals.
Sorkin SC, Forestiero FJ, Hirata MH, Guzmán EC, Cavalli SA, Bertolami MC, Salazar LA, Hirata RD
Clin Chem Lab Med. 2005
PubMed ID: 16309370
Inactivation of the Huntington's disease gene (Hdh) impairs anterior streak formation and early patterning of the mouse embryo.
Woda JM, Calzonetti T, Hilditch-Maguire P, Duyao MP, Conlon RA, MacDonald ME
BMC Dev Biol. 2005
PubMed ID: 16109169
SINGLE NUCLEOTIDE POLYMORPHISMS THAT INFLUENCE LIPID METABOLISM: Interaction with Dietary Factors.
Corella D, Ordovas JM
Annu Rev Nutr. 2005
PubMed ID: 16011471
ABCA1 gene deletion protects against cerebral malaria: potential pathogenic role of microparticles in neuropathology.
Combes V, Coltel N, Alibert M, van Eck M, Raymond C, Juhan-Vague I, Grau GE, Chimini G
Am J Pathol. 2005
PubMed ID: 15632021
Insights into developmental mechanisms and cancers in the mammalian intestine derived from serial analysis of gene expression and study of the hepatoma-derived growth factor (HDGF).
Lepourcelet M, Tou L, Cai L, Sawada J, Lazar AJ, Glickman JN, Williamson JA, Everett AD, Redston M, Fox EA, Nakatani Y, Shivdasani RA
Development. 2005
PubMed ID: 15604097
Relationship between gene polymorphisms and prevalence of myocardial infarction among diabetic and non-diabetic subjects.
Relvas WG, Izar MC, Helfenstein T, Fonseca MI, Colovati M, Oliveira A, Ihara SS, Han SW, Las Casas AA, Fonseca FA
Atherosclerosis. 2005
PubMed ID: 15585206
Potential role of ABCA7 in cellular lipid efflux to apoA-I.
Linsel-Nitschke P, Jehle AW, Shan J, Cao G, Bacic D, Lan D, Wang N, Tall AR
J Lipid Res. 2005
PubMed ID: 15520449
On the hepatic mechanism of HDL assembly by the ABCA1/apoA-I pathway.
Tsujita M, Wu CA, Abe-Dohmae S, Usui S, Okazaki M, Yokoyama S
J Lipid Res. 2005
PubMed ID: 15520446
Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout.
Cardona F, Tinahones FJ, Collantes E, Escudero A, García-Fuentes E, Soriguer FJ
Ann Rheum Dis. 2005
PubMed ID: 15115711
Stimulation of vascular smooth muscle cell proliferation and migration by apolipoprotein(a) is dependent on inhibition of transforming growth factor-beta activation and on the presence of kringle IV type 9.
O'Neil CH, Boffa MB, Hancock MA, Pickering JG, Koschinsky ML
J Biol Chem. 2004
PubMed ID: 15498766
Apolipoprotein E isoforms and apolipoprotein AI protect from amyloid precursor protein carboxy terminal fragment-associated cytotoxicity.
Maezawa I, Jin LW, Woltjer RL, Maeda N, Martin GM, Montine TJ, Montine KS
J Neurochem. 2004
PubMed ID: 15584908
Apolipoprotein A-I induces translocation of protein kinase C[alpha] to a cytosolic lipid-protein particle in astrocytes.
Ito J, Li H, Nagayasu Y, Kheirollah A, Yokoyama S
J Lipid Res. 2004
PubMed ID: 15375180
Effect of pitavastatin on apolipoprotein A-I production in HepG2 cell.
Maejima T, Yamazaki H, Aoki T, Tamaki T, Sato F, Kitahara M, Saito Y
Biochem Biophys Res Commun. 2004
PubMed ID: 15474503
A prospective study of the APOA1 XmnI and APOC3 SstI polymorphisms in the APOA1/C3/A4 gene cluster and risk of incident myocardial infarction in men.
Liu S, Song Y, Hu FB, Niu T, Ma J, Gaziano M, Stampfer MJ
Atherosclerosis. 2004
PubMed ID: 15488874
Conformation and lipid binding of the N-terminal (1-44) domain of human apolipoprotein A-I.
Zhu HL, Atkinson D
Biochemistry. 2004
PubMed ID: 15476409
A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease.
Hovingh GK, Brownlie A, Bisoendial RJ, Dube MP, Levels JH, Petersen W, Dullaart RP, Stroes ES, Zwinderman AH, de Groot E, Hayden MR, Kuivenhoven JA, Kastelein JJ
J Am Coll Cardiol. 2004
PubMed ID: 15464323
The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Morrin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J, MGC Project Team
Genome Res. 2004
PubMed ID: 15489334
ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis.
Fagan AM, Christopher E, Taylor JW, Parsadanian M, Spinner M, Watson M, Fryer JD, Wahrle S, Bales KR, Paul SM, Holtzman DM
Am J Pathol. 2004
PubMed ID: 15466405
Low plasma apolipoprotein A-I level is not a reliable marker of fibrosis in children with chronic hepatitis B.
Selimoglu MA, Yagcl RV, Yüce G
World J Gastroenterol. 2004
PubMed ID: 15334687
Intracellular cholesterol mobilization involved in the ABCA1/apolipoprotein-mediated assembly of high density lipoprotein in fibroblasts.
Yamauchi Y, Chang CC, Hayashi M, Abe-Dohmae S, Reid PC, Chang TY, Yokoyama S
J Lipid Res. 2004
PubMed ID: 15292375
Characterization of oligomeric human ATP binding cassette transporter A1. Potential implications for determining the structure of nascent high density lipoprotein particles.
Denis M, Haidar B, Marcil M, Bouvier M, Krimbou L, Genest J
J Biol Chem. 2004
PubMed ID: 15280376
Identification of liver receptor homolog-1 as a novel regulator of apolipoprotein AI gene transcription.
Delerive P, Galardi CM, Bisi JE, Nicodeme E, Goodwin B
Mol Endocrinol. 2004
PubMed ID: 15218078
Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain.
Hirsch-Reinshagen V, Zhou S, Burgess BL, Bernier L, McIsaac SA, Chan JY, Tansley GH, Cohn JS, Hayden MR, Wellington CL
J Biol Chem. 2004
PubMed ID: 15269218
Identification and structural ramifications of a hinge domain in apolipoprotein A-I discoidal high-density lipoproteins of different size.
Maiorano JN, Jandacek RJ, Horace EM, Davidson WS
Biochemistry. 2004
PubMed ID: 15362856
Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
Welty FK, Lichtenstein AH, Barrett PH, Dolnikowski GG, Schaefer EJ
Arterioscler Thromb Vasc Biol. 2004
PubMed ID: 15242863
Remodeling of HDL remnants generated by scavenger receptor class B type I.
Webb NR, de Beer MC, Asztalos BF, Whitaker N, van der Westhuyzen DR, de Beer FC
J Lipid Res. 2004
PubMed ID: 15210842
Human apoA-I/C-III/A-IV gene cluster transgenic rabbits: effects of a high-cholesterol diet.
Recalde D, Baroukh N, Viglietta C, Prince S, Verona J, Vergnes L, Pidoux J, Nazeem Nanjee M, Brites F, Ochoa A, Castro G, Zakin MM, Miller NE, Marie Houdebine L
FEBS Lett. 2004
PubMed ID: 15304365
Multiple rare alleles contribute to low plasma levels of HDL cholesterol.
Cohen JC, Kiss RS, Pertsemlidis A, Marcel YL, McPherson R, Hobbs HH
Science. 2004
PubMed ID: 15297675
Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.
Zheng L, Nukuna B, Brennan ML, Sun M, Goormastic M, Settle M, Schmitt D, Fu X, Thomson L, Fox PL, Ischiropoulos H, Smith JD, Kinter M, Hazen SL
J Clin Invest. 2004
PubMed ID: 15314690
Distribution of the lipolysis stimulated receptor in adult and embryonic murine tissues and lethality of LSR-/- embryos at 12.5 to 14.5 days of gestation.
Mesli S, Javorschi S, Bérard AM, Landry M, Priddle H, Kivlichan D, Smith AJ, Yen FT, Bihain BE, Darmon M
Eur J Biochem. 2004
PubMed ID: 15265030
Characterization of apoM in normal and genetically modified mice.
Faber K, Axler O, Dahlbäck B, Nielsen LB
J Lipid Res. 2004
PubMed ID: 15102887
Quality control in the apoA-I secretory pathway: deletion of apoA-I helix 6 leads to the formation of cytosolic phospholipid inclusions.
Bhat S, Zabalawi M, Willingham MC, Shelness GS, Thomas MJ, Sorci-Thomas MG
J Lipid Res. 2004
PubMed ID: 15060083
Apolipoprotein A-I-stimulated apolipoprotein E secretion from human macrophages is independent of cholesterol efflux.
Kockx M, Rye KA, Gaus K, Quinn CM, Wright J, Sloane T, Sviridov D, Fu Y, Sullivan D, Burnett JR, Rust S, Assmann G, Anantharamaiah GM, Palgunachari MN, Katz SL, Phillips MC, Dean RT, Jessup W, Kritharides L
J Biol Chem. 2004
PubMed ID: 15066991
Identification of an apolipoprotein A-I structural element that mediates cellular cholesterol efflux and stabilizes ATP binding cassette transporter A1.
Natarajan P, Forte TM, Chu B, Phillips MC, Oram JF, Bielicki JK
J Biol Chem. 2004
PubMed ID: 15051721
Role of apolipoprotein A-I in protecting against endotoxin toxicity.
Ma J, Liao XL, Lou B, Wu MP
Acta Biochim Biophys Sin (Shanghai). 2004
PubMed ID: 15188057
The effects of scale: variation in the APOA1/C3/A4/A5 gene cluster.
Fullerton SM, Buchanan AV, Sonpar VA, Taylor SL, Smith JD, Carlson CS, Salomaa V, Stengård JH, Boerwinkle E, Clark AG, Nickerson DA, Weiss KM
Hum Genet. 2004
PubMed ID: 15108119
ABCA1-dependent lipid efflux to apolipoprotein A-I mediates HDL particle formation and decreases VLDL secretion from murine hepatocytes.
Sahoo D, Trischuk TC, Chan T, Drover VA, Ho S, Chimini G, Agellon LB, Agnihotri R, Francis GA, Lehner R
J Lipid Res. 2004
PubMed ID: 14993246
Alpha-helix formation is required for high affinity binding of human apolipoprotein A-I to lipids.
Saito H, Dhanasekaran P, Nguyen D, Deridder E, Holvoet P, Lund-Katz S, Phillips MC
J Biol Chem. 2004
PubMed ID: 15020600
The establishment of telomerase-immortalized Tangier disease cell lines indicates the existence of an apolipoprotein A-I-inducible but ABCA1-independent cholesterol efflux pathway.
Walter M, Forsyth NR, Wright WE, Shay JW, Roth MG
J Biol Chem. 2004
PubMed ID: 15001567
The genetic association database.
Becker KG, Barnes KC, Bright TJ, Wang SA
Nat Genet. 2004
PubMed ID: 15118671
Apolipoprotein A-II regulates HDL stability and affects hepatic lipase association and activity.
Boucher J, Ramsamy TA, Braschi S, Sahoo D, Neville TA, Sparks DL
J Lipid Res. 2004
PubMed ID: 14967812
The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier disease.
Neufeld EB, Stonik JA, Demosky SJ, Knapper CL, Combs CA, Cooney A, Comly M, Dwyer N, Blanchette-Mackie J, Remaley AT, Santamarina-Fojo S, Brewer HB
J Biol Chem. 2004
PubMed ID: 14747463
Apolipoprotein A1 gene polymorphisms at the -75 bp and +83/ 84 bp polymorphic sites in healthy Omanis compared with world populations.
Al-Yahyaee SA, Al-Kindi MN, Al-Bahrani AI
Hum Biol. 2004
PubMed ID: 15359539
Regulation of mammalian epithelial differentiation and intestine development by class I histone deacetylases.
Tou L, Liu Q, Shivdasani RA
Mol Cell Biol. 2004
PubMed ID: 15060137
High-density rat radiation hybrid maps containing over 24,000 SSLPs, genes, and ESTs provide a direct link to the rat genome sequence.
Kwitek AE, Gullings-Handley J, Yu J, Carlos DC, Orlebeke K, Nie J, Eckert J, Lemke A, Andrae JW, Bromberg S, Pasko D, Chen D, Scheetz TE, Casavant TL, Soares MB, Sheffield VC, Tonellato PJ, Jacob HJ
Genome Res. 2004
PubMed ID: 15060019
Prebeta high density lipoprotein has two metabolic fates in human apolipoprotein A-I transgenic mice.
Lee JY, Lanningham-Foster L, Boudyguina EY, Smith TL, Young ER, Colvin PL, Thomas MJ, Parks JS
J Lipid Res. 2004
PubMed ID: 14729861
Potential involvement of dissociated apoA-I in the ABCA1-dependent cellular lipid release by HDL.
Okuhira K, Tsujita M, Yamauchi Y, Abe-Dohmae S, Kato K, Handa T, Yokoyama S
J Lipid Res. 2004
PubMed ID: 14729855
The human plasma proteome: a nonredundant list developed by combination of four separate sources.
Anderson NL, Polanski M, Pieper R, Gatlin T, Tirumalai RS, Conrads TP, Veenstra TD, Adkins JN, Pounds JG, Fagan R, Lobley A
Mol Cell Proteomics. 2004
PubMed ID: 14718574
ABCA1 mediates concurrent cholesterol and phospholipid efflux to apolipoprotein A-I.
Smith JD, Le Goff W, Settle M, Brubaker G, Waelde C, Horwitz A, Oda MN
J Lipid Res. 2004
PubMed ID: 14703508
Scavenger receptor class B type I-mediated cholesteryl ester-selective uptake and efflux of unesterified cholesterol. Influence of high density lipoprotein size and structure.
Thuahnai ST, Lund-Katz S, Dhanasekaran P, de la Llera-Moya M, Connelly MA, Williams DL, Rothblat GH, Phillips MC
J Biol Chem. 2004
PubMed ID: 14718538
Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions.
Coppinger JA, Cagney G, Toomey S, Kislinger T, Belton O, McRedmond JP, Cahill DJ, Emili A, Fitzgerald DJ, Maguire PB
Blood. 2004
PubMed ID: 14630798
Apolipoprotein A-I activates cellular cAMP signaling through the ABCA1 transporter.
Haidar B, Denis M, Marcil M, Krimbou L, Genest J
J Biol Chem. 2004
PubMed ID: 14701824
Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease.
Szalai C, Keszei M, Duba J, Prohászka Z, Kozma GT, Császár A, Balogh S, Almássy Z, Fust G, Czinner A
Atherosclerosis. 2004
PubMed ID: 15177130
Transcriptional control of apolipoprotein A-I gene expression in diabetes.
Mooradian AD, Haas MJ, Wong NC
Diabetes. 2004
PubMed ID: 14988232
Apolipoprotein A-1 interaction with plasma membrane lipid rafts controls cholesterol export from macrophages.
Gaus K, Kritharides L, Schmitz G, Boettcher A, Drobnik W, Langmann T, Quinn CM, Death A, Dean RT, Jessup W
FASEB J. 2004
PubMed ID: 14734645
Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I.
Rye KA, Barter PJ
Arterioscler Thromb Vasc Biol. 2004
PubMed ID: 14592845
Molecular and cellular physiology of apolipoprotein A-I lipidation by the ATP-binding cassette transporter A1 (ABCA1).
Denis M, Haidar B, Marcil M, Bouvier M, Krimbou L, Genest J
J Biol Chem. 2004
PubMed ID: 14660648
Apolipoprotein(a) null phenotype is related to a delayed age at onset of Alzheimer's disease.
Emanuele E, Peros E, Tomaino C, Feudatari E, Bernardi L, Binetti G, Maletta R, D'Angelo A, Montagna L, Bruni AC, Geroldi D
Neurosci Lett. 2004
PubMed ID: 15036610
Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3.
Gharavi AG, Ahmad T, Wong RD, Hooshyar R, Vaughn J, Oller S, Frankel RZ, Bruggeman LA, D'Agati VD, Klotman PE, Lifton RP
Proc Natl Acad Sci U S A. 2004
PubMed ID: 14983036
Cross-linking and lipid efflux properties of apoA-I mutants suggest direct association between apoA-I helices and ABCA1.
Chroni A, Liu T, Fitzgerald ML, Freeman MW, Zannis VI
Biochemistry. 2004
PubMed ID: 14967052
Quantitative trait Loci specifying the response of body temperature to dietary restriction.
Rikke BA, Yerg JE, Battaglia ME, Nagy TR, Allison DB, Johnson TE
J Gerontol A Biol Sci Med Sci. 2004
PubMed ID: 14999024
Influence of apoA-I and apoE on the formation of serum amyloid A-containing lipoproteins in vivo and in vitro.
Cabana VG, Feng N, Reardon CA, Lukens J, Webb NR, de Beer FC, Getz GS
J Lipid Res. 2004
PubMed ID: 14595002
Expression and secretion of human apolipoprotein A-I in the heart.
Baroukh N, Lopez CE, Saleh MC, Recalde D, Vergnes L, Ostos MA, Fiette L, Fruchart JC, Castro G, Zakin MM, Ochoa A
FEBS Lett. 2004
PubMed ID: 14741338
Apolipoprotein A-I infiltration in rheumatoid arthritis synovial tissue: a control mechanism of cytokine production?
Bresnihan B, Gogarty M, FitzGerald O, Dayer JM, Burger D
Arthritis Res Ther. 2004
PubMed ID: 15540281
An association analysis between ApoA1 polymorphisms and the high-density lipoprotein (HDL) cholesterol level and myocardial infarction (MI) in Japanese.
Shioji K, Mannami T, Kokubo Y, Goto Y, Nonogi H, Iwai N
J Hum Genet. 2004
PubMed ID: 15258834
A promoter variant of the ATP-binding cassette transporter A1 gene alters the HDL cholesterol level in the general Japanese population.
Shioji K, Nishioka J, Naraba H, Kokubo Y, Mannami T, Inamoto N, Kamide K, Takiuchi S, Yoshii M, Miwa Y, Kawano Y, Miyata T, Miyazaki S, Goto Y, Nonogi H, Tago N, Iwai N
J Hum Genet. 2004
PubMed ID: 14986172
Complete sequencing and characterization of 21,243 full-length human cDNAs.
Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S
Nat Genet. 2004
PubMed ID: 14702039
Quantitative trait loci analysis for plasma HDL-cholesterol concentrations and atherosclerosis susceptibility between inbred mouse strains C57BL/6J and 129S1/SvImJ.
Ishimori N, Li R, Kelmenson PM, Korstanje R, Walsh KA, Churchill GA, Forsman-Semb K, Paigen B
Arterioscler Thromb Vasc Biol. 2004
PubMed ID: 14592847
Regulation of apoA-I gene expression: mechanism of action of estrogen and genistein.
Lamon-Fava S, Micherone D
J Lipid Res. 2004
PubMed ID: 14563824
Association between small apolipoprotein(a) isoforms and frontotemporal dementia in humans.
Emanuele E, Peros E, Tomaino C, Feudatari E, Bernardi L, Binetti G, Maletta R, Micieli G, Bruni AC, Geroldi D
Neurosci Lett. 2003
PubMed ID: 14665416
Phospholipid transfer protein interacts with and stabilizes ATP-binding cassette transporter A1 and enhances cholesterol efflux from cells.
Oram JF, Wolfbauer G, Vaughan AM, Tang C, Albers JJ
J Biol Chem. 2003
PubMed ID: 14559902
Ontogenesis and regulation of cholesterol metabolism in the central nervous system of the mouse.
Quan G, Xie C, Dietschy JM, Turley SD
Brain Res Dev Brain Res. 2003
PubMed ID: 14643015
Molecular variation at functional genes and the history of human populations--data on candidate genes for cardiovascular risk in the Mediterranean.
Moral P, Valveny N, López-Alomar A, Calo C, Kandil M, Harich N, González-Pérez E, Via M, Esteban E, Dugoujon JM, Vona G
Coll Antropol. 2003
PubMed ID: 14746139
Testing the role of apoA-I, HDL, and cholesterol efflux in the atheroprotective action of low-level apoE expression.
Thorngate FE, Yancey PG, Kellner-Weibel G, Rudel LL, Rothblat GH, Williams DL
J Lipid Res. 2003
PubMed ID: 12951361
Apolipoprotein A-I activates protein kinase C alpha signaling to phosphorylate and stabilize ATP binding cassette transporter A1 for the high density lipoprotein assembly.
Yamauchi Y, Hayashi M, Abe-Dohmae S, Yokoyama S
J Biol Chem. 2003
PubMed ID: 12952980
Wnk1 kinase deficiency lowers blood pressure in mice: a gene-trap screen to identify potential targets for therapeutic intervention.
Zambrowicz BP, Abuin A, Ramirez-Solis R, Richter LJ, Piggott J, BeltrandelRio H, Buxton EC, Edwards J, Finch RA, Friddle CJ, Gupta A, Hansen G, Hu Y, Huang W, Jaing C, Key BW, Kipp P, Kohlhauff B, Ma ZQ, Markesich D, Payne R, Potter DG, Qian N, Shaw J, Schrick J, Shi ZZ, Sparks MJ, Van Sligtenhorst I, Vogel P, Walke W, Xu N, Zhu Q, Person C, Sands AT
Proc Natl Acad Sci U S A. 2003
PubMed ID: 14610273
Lipid-binding studies of human apolipoprotein A-I and its terminally truncated mutants.
Fang Y, Gursky O, Atkinson D
Biochemistry. 2003
PubMed ID: 14609337
Association of extreme blood lipid profile phenotypic variation with 11 reverse cholesterol transport genes and 10 non-genetic cardiovascular disease risk factors.
Morabia A, Cayanis E, Costanza MC, Ross BM, Flaherty MS, Alvin GB, Das K, Gilliam TC
Hum Mol Genet. 2003
PubMed ID: 12966036
Effects of apolipoprotein A-I on ATP-binding cassette transporter A1-mediated efflux of macrophage phospholipid and cholesterol: formation of nascent high density lipoprotein particles.
Liu L, Bortnick AE, Nickel M, Dhanasekaran P, Subbaiah PV, Lund-Katz S, Rothblat GH, Phillips MC
J Biol Chem. 2003
PubMed ID: 12928428
Quantitative trait locus analysis of plasma cholesterol and triglyceride levels in KK x RR F2 mice.
Suto J, Sekikawa K
Biochem Genet. 2003
PubMed ID: 14974682
Differences between genotyping and phenotyping methods for assessing apolipoprotein(a) size polymorphisms.
Simó JM, Camps J, Martín S, Pedro-Botet J, Ferré N, Gómez F, Joven J
Clin Chem Lab Med. 2003
PubMed ID: 14580163
Association of two apolipoprotein A-I gene MspI polymorphisms with high density lipoprotein (HDL)-cholesterol levels and indices of obesity in selected healthy Chinese subjects and in patients with early-onset type 2 diabetes.
Ma YQ, Thomas GN, Ng MC, Critchley JA, Cockram CS, Chan JC, Tomlinson B
Clin Endocrinol (Oxf). 2003
PubMed ID: 14510906
Phosphorylation of a pest sequence in ABCA1 promotes calpain degradation and is reversed by ApoA-I.
Martinez LO, Agerholm-Larsen B, Wang N, Chen W, Tall AR
J Biol Chem. 2003
PubMed ID: 12869555
Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD.
Baroni MG, Berni A, Romeo S, Arca M, Tesorio T, Sorropago G, Di Mario U, Galton DJ
BMC Med Genet. 2003
PubMed ID: 12964943
Structure and interfacial properties of human apolipoprotein A-V.
Weinberg RB, Cook VR, Beckstead JA, Martin DD, Gallagher JW, Shelness GS, Ryan RO
J Biol Chem. 2003
PubMed ID: 12810715
Expression of apolipoprotein A1 in colonic adenocarcinoma.
Tachibana M, Ohkura Y, Kobayashi Y, Sakamoto H, Tanaka Y, Watanabe J, Amikura K, Nishimura Y, Akagi K
Anticancer Res. 2003
PubMed ID: 14666619
Induction of fatal inflammation in LDL receptor and ApoA-I double-knockout mice fed dietary fat and cholesterol.
Zabalawi M, Bhat S, Loughlin T, Thomas MJ, Alexander E, Cline M, Bullock B, Willingham M, Sorci-Thomas MG
Am J Pathol. 2003
PubMed ID: 12937162
Loci controlling plasma non-HDL and HDL cholesterol levels in a C57BL /6J x CASA /Rk intercross.
Sehayek E, Duncan EM, Yu HJ, Petukhova L, Breslow JL
J Lipid Res. 2003
PubMed ID: 12810823
Effect of apolipoprotein polymorphisms in renal transplant recipients.
Cofan M, Cofan F, Campos B, Casals E, Zambon D, Ros E, Campistol JM, Oppenheimer F
Transplant Proc. 2003
PubMed ID: 12962772
Abnormal phospholipid composition impairs HDL biogenesis and maturation in mice lacking Abca1.
Francone OL, Subbaiah PV, van Tol A, Royer L, Haghpassand M
Biochemistry. 2003
PubMed ID: 12859204
Genetic risk factors for cerebrovascular disease in children with sickle cell disease: design of a case-control association study and genomewide screen.
Adams GT, Snieder H, McKie VC, Clair B, Brambilla D, Adams RJ, Kutlar F, Kutlar A
BMC Med Genet. 2003
PubMed ID: 12871600
The spatial organization of apolipoprotein A-I on the edge of discoidal high density lipoprotein particles: a mass specrometry study.
Davidson WS, Hilliard GM
J Biol Chem. 2003
PubMed ID: 12724319
Pentanucleotide TTTTA repeat polymorphism of apolipoprotein(a) gene and plasma lipoprotein(a) are associated with ischemic and hemorrhagic stroke in Chinese: a multicenter case-control study in China.
Sun L, Li Z, Zhang H, Ma A, Liao Y, Wang D, Zhao B, Zhu Z, Zhao J, Zhang Z, Wang W, Hui R
Stroke. 2003
PubMed ID: 12791946
Domain structure and lipid interaction in human apolipoproteins A-I and E, a general model.
Saito H, Dhanasekaran P, Nguyen D, Holvoet P, Lund-Katz S, Phillips MC
J Biol Chem. 2003
PubMed ID: 12709430
Apolipoprotein A-II inhibits high density lipoprotein remodeling and lipid-poor apolipoprotein A-I formation.
Rye KA, Wee K, Curtiss LK, Bonnet DJ, Barter PJ
J Biol Chem. 2003
PubMed ID: 12690114
Binding and internalization of lipopolysaccharide by Cla-1, a human orthologue of rodent scavenger receptor B1.
Vishnyakova TG, Bocharov AV, Baranova IN, Chen Z, Remaley AT, Csako G, Eggerman TL, Patterson AP
J Biol Chem. 2003
PubMed ID: 12651854
Effects of plasma apolipoproteins on lipoprotein lipase-mediated lipolysis of small and large lipid emulsions.
Yamamoto M, Morita SY, Kumon M, Kawabe M, Nishitsuji K, Saito H, Vertut-Doï A, Nakano M, Handa T
Biochim Biophys Acta. 2003
PubMed ID: 12782148
Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: the Copenhagen City Heart Study.
Andersen RV, Wittrup HH, Tybjaerg-Hansen A, Steffensen R, Schnohr P, Nordestgaard BG
J Am Coll Cardiol. 2003
PubMed ID: 12798568
Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia.
Belalcazar LM, Merched A, Carr B, Oka K, Chen KH, Pastore L, Beaudet A, Chan L
Circulation. 2003
PubMed ID: 12742997
A pentanucleotide repeat polymorphism (TTTTA) in the apolipoprotein (a) gene--its distribution and its association with the risk of cardiovascular disease.
Calò CM, Varesi L, Memmi M, Moral P, Vona G
Coll Antropol. 2003
PubMed ID: 12974138
Expansion of hematopoietic stem cell phenotype and activity in Trp53-null mice.
TeKippe M, Harrison DE, Chen J
Exp Hematol. 2003
PubMed ID: 12829028
Apo A-I promoter polymorphism influences basal HDL-cholesterol and its response to pravastatin therapy.
Lahoz C, Peña R, Mostaza JM, Jiménez J, Subirats E, Pintó X, Taboada M, López-Pastor A, RAP Study Group
Atherosclerosis. 2003
PubMed ID: 12801612
The C-terminal domain of apolipoprotein A-I contains a lipid-sensitive conformational trigger.
Oda MN, Forte TM, Ryan RO, Voss JC
Nat Struct Biol. 2003
PubMed ID: 12754494
Association between serum concentration of apolipoproteins A-I and B with gallbladder disease.
Morán S, Duque-López MX, Salmerón-Castro J, Rodríguez-Leal G, Martínez-Salgado H, Uribe M
Arch Med Res. 2003
PubMed ID: 14567398
Relationships among apolipoprotein A1 gene polymorphisms, lipid levels and coronary atherosclerosis disease.
Zou Y, Hu D, Yang X, Jia X, Wang L, Cui L, Liu X, Gao M, Wei Y, Xu Z
Chin Med J (Engl). 2003
PubMed ID: 12875674
Targeted disruption of the heat shock transcription factor (hsf)-2 gene results in increased embryonic lethality, neuronal defects, and reduced spermatogenesis.
Wang G, Zhang J, Moskophidis D, Mivechi NF
Genesis. 2003
PubMed ID: 12748967
A study to survey susceptible genetic factors responsible for troglitazone-associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus.
Watanabe I, Tomita A, Shimizu M, Sugawara M, Yasumo H, Koishi R, Takahashi T, Miyoshi K, Nakamura K, Izumi T, Matsushita Y, Furukawa H, Haruyama H, Koga T
Clin Pharmacol Ther. 2003
PubMed ID: 12732844
Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders.
Jones B, Jones EL, Bonney SA, Patel HN, Mensenkamp AR, Eichenbaum-Voline S, Rudling M, Myrdal U, Annesi G, Naik S, Meadows N, Quattrone A, Islam SA, Naoumova RP, Angelin B, Infante R, Levy E, Roy CC, Freemont PS, Scott J, Shoulders CC
Nat Genet. 2003
PubMed ID: 12692552
Hepatitis B virus-mediated changes of apolipoprotein mRNA abundance in cultured hepatoma cells.
Norton PA, Gong Q, Mehta AS, Lu X, Block TM
J Virol. 2003
PubMed ID: 12692252
Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides.
Gevaert K, Goethals M, Martens L, Van Damme J, Staes A, Thomas GR, Vandekerckhove J
Nat Biotechnol. 2003
PubMed ID: 12665801
Degradation of phospholipid transfer protein (PLTP) and PLTP-generated pre-beta-high density lipoprotein by mast cell chymase impairs high affinity efflux of cholesterol from macrophage foam cells.
Lee M, Metso J, Jauhiainen M, Kovanen PT
J Biol Chem. 2003
PubMed ID: 12531890
Recurrent mutations of the apolipoprotein A-I gene in three kindreds with severe HDL deficiency.
Pisciotta L, Miccoli R, Cantafora A, Calabresi L, Tarugi P, Alessandrini P, Bittolo Bon G, Franceschini G, Cortese C, Calandra S, Bertolini S
Atherosclerosis. 2003
PubMed ID: 12818417
Risk Factors, biochemical markers, and genetic polymorphisms in early coronary artery disease.
Izar MC, Fonseca FA, Ihara SS, Kasinski N, Sang WH, Lopes IE, Pinto Ldo E, Relvas WG, Lourenço D, Tufik S, de Paola AA, Carvalho AC
Arq Bras Cardiol. 2003
PubMed ID: 12754559
Apolipoprotein A-I(Milano): current perspectives.
Chiesa G, Sirtori CR
Curr Opin Lipidol. 2003
PubMed ID: 12642784
The lipidation by hepatocytes of human apolipoprotein A-I occurs by both ABCA1-dependent and -independent pathways.
Kiss RS, McManus DC, Franklin V, Tan WL, McKenzie A, Chimini G, Marcel YL
J Biol Chem. 2003
PubMed ID: 12547832
[Pathology and chemical verification and detection of "risk group" of endogenous psychosis]
Kartelishev AV, Kolupaev GP, Kliuzhev VM, Lakosina ND, Vernekina NS, Chebotkov AA, Suslov LS
Voen Med Zh. 2003
PubMed ID: 12722515
Novel mass spectrometric immunoassays for the rapid structural characterization of plasma apolipoproteins.
Niederkofler EE, Tubbs KA, Kiernan UA, Nedelkov D, Nelson RW
J Lipid Res. 2003
PubMed ID: 12562854
The central helices of ApoA-I can promote ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux. Amino acid residues 220-231 of the wild-type ApoA-I are required for lipid efflux in vitro and high density lipoprotein formation in vivo.
Chroni A, Liu T, Gorshkova I, Kan HY, Uehara Y, Von Eckardstein A, Zannis VI
J Biol Chem. 2003
PubMed ID: 12488454
Natural mutations of apolipoprotein A-I impairing activation of lecithin:cholesterol acyltransferase.
Hoang A, Huang W, Sasaki J, Sviridov D
Biochim Biophys Acta. 2003
PubMed ID: 12573451
Targeted replacement of mouse apolipoprotein A-I with human ApoA-I or the mutant ApoA-IMilano. Evidence of APOA-IM impaired hepatic secretion.
Parolini C, Chiesa G, Zhu Y, Forte T, Caligari S, Gianazza E, Sacco MG, Sirtori CR, Rubin EM
J Biol Chem. 2003
PubMed ID: 12471038
The apo A-I gene promoter region polymorphism determines the severity of hyperlipidemia after heart transplantation.
González-Amieva A, López-Miranda J, Marín C, Pérez-Martinez P, Gómez P, Paz-Rojas E, Arizón JM, Jiménez-Perepérez JA, Concha M, Pérez-Jiménez F
Clin Transplant. 2003
PubMed ID: 12588323
Characterization of specifically oxidized apolipoproteins in mildly oxidized high density lipoprotein.
Pankhurst G, Wang XL, Wilcken DE, Baernthaler G, Panzenböck U, Raftery M, Stocker R
J Lipid Res. 2003
PubMed ID: 12576517
Conformational switching and fibrillogenesis in the amyloidogenic fragment of apolipoprotein a-I.
Andreola A, Bellotti V, Giorgetti S, Mangione P, Obici L, Stoppini M, Torres J, Monzani E, Merlini G, Sunde M
J Biol Chem. 2003
PubMed ID: 12421824
[Interaction of human apolipoprotein AI and HIV-1 envelope proteins with the native and recombinant CD4 receptors]
Panin LE, Kostina NE
Vopr Virusol. 2003
PubMed ID: 12608057
The study of APOA1, APOC3 and APOA4 variability in healthy ageing people reveals another paradox in the oldest old subjects.
Garasto S, Rose G, Derango F, Berardelli M, Corsonello A, Feraco E, Mari V, Maletta R, Bruni A, Franceschi C, Carotenuto L, De Benedictis G
Ann Hum Genet. 2003
PubMed ID: 12556235
A microarray minisequencing system for pharmacogenetic profiling of antihypertensive drug response.
Liljedahl U, Karlsson J, Melhus H, Kurland L, Lindersson M, Kahan T, Nyström F, Lind L, Syvänen AC
Pharmacogenetics. 2003
PubMed ID: 12544508
A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I.
Wang N, Chen W, Linsel-Nitschke P, Martinez LO, Agerholm-Larsen B, Silver DL, Tall AR
J Clin Invest. 2003
PubMed ID: 12511593
Restenosis after intracoronary stent placement: can apolipoprotein(a) polymorphism play a role?
Gazzaruso C, Garzaniti A, Falcone C, Geroldi D, Turpini C, Fratino P
Int J Cardiol. 2003
PubMed ID: 12468059
Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.
Strausberg RL, Feingold EA, Grouse LH, Derge JG, Klausner RD, Collins FS, Wagner L, Shenmen CM, Schuler GD, Altschul SF, Zeeberg B, Buetow KH, Schaefer CF, Bhat NK, Hopkins RF, Jordan H, Moore T, Max SI, Wang J, Hsieh F, Diatchenko L, Marusina K, Farmer AA, Rubin GM, Hong L, Stapleton M, Soares MB, Bonaldo MF, Casavant TL, Scheetz TE, Brownstein MJ, Usdin TB, Toshiyuki S, Carninci P, Prange C, Raha SS, Loquellano NA, Peters GJ, Abramson RD, Mullahy SJ, Bosak SA, McEwan PJ, McKernan KJ, Malek JA, Gunaratne PH, Richards S, Worley KC, Hale S, Garcia AM, Gay LJ, Hulyk SW, Villalon DK, Muzny DM, Sodergren EJ, Lu X, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madan A, Young AC, Shevchenko Y, Bouffard GG, Blakesley RW, Touchman JW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Krzywinski MI, Skalska U, Smailus DE, Schnerch A, Schein JE, Jones SJ, Marra MA, Mammalian Gene Collection Program Team
Proc Natl Acad Sci U S A. 2002
PubMed ID: 12477932
Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs.
Okazaki Y, Furuno M, Kasukawa T, Adachi J, Bono H, Kondo S, Nikaido I, Osato N, Saito R, Suzuki H, Yamanaka I, Kiyosawa H, Yagi K, Tomaru Y, Hasegawa Y, Nogami A, Schönbach C, Gojobori T, Baldarelli R, Hill DP, Bult C, Hume DA, Quackenbush J, Schriml LM, Kanapin A, Matsuda H, Batalov S, Beisel KW, Blake JA, Bradt D, Brusic V, Chothia C, Corbani LE, Cousins S, Dalla E, Dragani TA, Fletcher CF, Forrest A, Frazer KS, Gaasterland T, Gariboldi M, Gissi C, Godzik A, Gough J, Grimmond S, Gustincich S, Hirokawa N, Jackson IJ, Jarvis ED, Kanai A, Kawaji H, Kawasawa Y, Kedzierski RM, King BL, Konagaya A, Kurochkin IV, Lee Y, Lenhard B, Lyons PA, Maglott DR, Maltais L, Marchionni L, McKenzie L, Miki H, Nagashima T, Numata K, Okido T, Pavan WJ, Pertea G, Pesole G, Petrovsky N, Pillai R, Pontius JU, Qi D, Ramachandran S, Ravasi T, Reed JC, Reed DJ, Reid J, Ring BZ, Ringwald M, Sandelin A, Schneider C, Semple CA, Setou M, Shimada K, Sultana R, Takenaka Y, Taylor MS, Teasdale RD, Tomita M, Verardo R, Wagner L, Wahlestedt C, Wang Y, Watanabe Y, Wells C, Wilming LG, Wynshaw-Boris A, Yanagisawa M, Yang I, Yang L, Yuan Z, Zavolan M, Zhu Y, Zimmer A, Carninci P, Hayatsu N, Hirozane-Kishikawa T, Konno H, Nakamura M, Sakazume N, Sato K, Shiraki T, Waki K, Kawai J, Aizawa K, Arakawa T, Fukuda S, Hara A, Hashizume W, Imotani K, Ishii Y, Itoh M, Kagawa I, Miyazaki A, Sakai K, Sasaki D, Shibata K, Shinagawa A, Yasunishi A, Yoshino M, Waterston R, Lander ES, Rogers J, Birney E, Hayashizaki Y, FANTOM Consortium, RIKEN Genome Exploration Research Group Phase I & II Team
Nature. 2002
PubMed ID: 12466851
Silent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphism.
Gazzaruso C, Garzaniti A, Giordanetti S, Falcone C, Fratino P
Cardiovasc Diabetol. 2002
PubMed ID: 12473160
Evidence for differential effects of apoE3 and apoE4 on HDL metabolism.
Hopkins PC, Huang Y, McGuire JG, Pitas RE
J Lipid Res. 2002
PubMed ID: 12401887
[Relation of pentanucleotide repeat polymorphism of apolipoprotein (a) gene to plasma lipoprotein (a) level among Chinese patients with myocardial infarction and cerebral infarction]
Liu X, Sun L, Li Z, Gao Y, Hui R
Zhonghua Yi Xue Za Zhi. 2002
PubMed ID: 12509922
The role of apolipoprotein A-I helix 10 in apolipoprotein-mediated cholesterol efflux via the ATP-binding cassette transporter ABCA1.
Panagotopulos SE, Witting SR, Horace EM, Hui DY, Maiorano JN, Davidson WS
J Biol Chem. 2002
PubMed ID: 12181325
ApoA-I structure on discs and spheres. Variable helix registry and conformational states.
Li HH, Lyles DS, Pan W, Alexander E, Thomas MJ, Sorci-Thomas MG
J Biol Chem. 2002
PubMed ID: 12167653
Evidence that phospholipids play a key role in pre-beta apoA-I formation and high-density lipoprotein remodeling.
Rye KA, Duong M, Psaltis MK, Curtiss LK, Bonnet DJ, Stocker R, Barter PJ
Biochemistry. 2002
PubMed ID: 12369845
The roles of circulating high-density lipoproteins and trophic hormones in the phenotype of knockout mice lacking the steroidogenic acute regulatory protein.
Ishii T, Hasegawa T, Pai CI, Yvgi-Ohana N, Timberg R, Zhao L, Majdic G, Chung BC, Orly J, Parker KL
Mol Endocrinol. 2002
PubMed ID: 12351695
Evaluation of a Apo-1/Fas promoter polymorphism in Korean stroke patients.
Seo JC, Han SW, Yin CS, Koh HK, Kim CH, Kim EH, Leem KH, Lee HS, Park HJ, Kim SA, Choe BK, Lee HJ, Yim SV, Kim CJ, Chung JH
Exp Mol Med. 2002
PubMed ID: 12515395
Naturally occurring mutations in the largest extracellular loops of ABCA1 can disrupt its direct interaction with apolipoprotein A-I.
Fitzgerald ML, Morris AL, Rhee JS, Andersson LP, Mendez AJ, Freeman MW
J Biol Chem. 2002
PubMed ID: 12084722
Apolipoproteins A-I and A-II downregulate neutrophil functions.
Furlaneto CJ, Ribeiro FP, Hatanaka E, Souza GM, Cassatella MA, Campa A
Lipids. 2002
PubMed ID: 12458630
Overexpression of SR-BI by adenoviral vector promotes clearance of apoA-I, but not apoB, in human apoB transgenic mice.
Webb NR, de Beer MC, Yu J, Kindy MS, Daugherty A, van der Westhuyzen DR, de Beer FC
J Lipid Res. 2002
PubMed ID: 12235173
Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux.
Lee M, Calabresi L, Chiesa G, Franceschini G, Kovanen PT
Arterioscler Thromb Vasc Biol. 2002
PubMed ID: 12231569
Quantitative trait loci and candidate genes regulating HDL cholesterol: a murine chromosome map.
Wang X, Paigen B
Arterioscler Thromb Vasc Biol. 2002
PubMed ID: 12231556
Trypsin-sensitive and lipid-containing sites of the macrophage extracellular matrix bind apolipoprotein A-I and participate in ABCA1-dependent cholesterol efflux.
Burgess JW, Kiss RS, Zheng H, Zachariah S, Marcel YL
J Biol Chem. 2002
PubMed ID: 12050168
Lipid-free structure and stability of apolipoprotein A-I: probing the central region by mutation.
Gorshkova IN, Liu T, Zannis VI, Atkinson D
Biochemistry. 2002
PubMed ID: 12173940
Structure-function studies of apoA-I variants: site-directed mutagenesis and natural mutations.
Sviridov D, Hoang A, Huang W, Sasaki J
J Lipid Res. 2002
PubMed ID: 12177172
Assessment of asymptomatic coronary artery disease in apparently uncomplicated type 2 diabetic patients: a role for lipoprotein(a) and apolipoprotein(a) polymorphism.
Gazzaruso C, Garzaniti A, Giordanetti S, Falcone C, De Amici E, Geroldi D, Fratino P
Diabetes Care. 2002
PubMed ID: 12145244
Apolipoprotein A-I is necessary for the in vivo formation of high density lipoprotein competent for scavenger receptor BI-mediated cholesteryl ester-selective uptake.
Temel RE, Walzem RL, Banka CL, Williams DL
J Biol Chem. 2002
PubMed ID: 12000760
The role of structural and functional homology between human apolipoprotein A-I and envelope proteins of human immunodeficiency virus type 1 in CD4 receptor binding.
Panin LE, Kostina NE, Lukashev VA
Dokl Biochem Biophys. 2002
PubMed ID: 12462973
Gene-drug interaction: additive influence of mutant APOA1 and testosterone on plasma HDL-cholesterol.
Keyhan G, Rosset J, Wang J, Miller D, McManus R, Hegele RA
Clin Biochem. 2002
PubMed ID: 12270762
Human secretory phospholipase A2 mediates decreased plasma levels of HDL cholesterol and apoA-I in response to inflammation in human apoA-I transgenic mice.
Tietge UJ, Maugeais C, Lund-Katz S, Grass D, deBeer FC, Rader DJ
Arterioscler Thromb Vasc Biol. 2002
PubMed ID: 12117740
Candidate genes involved in cardiovascular risk factors by a family-based association study on the island of Kosrae, Federated States of Micronesia.
Han Z, Heath SC, Shmulewitz D, Li W, Auerbach SB, Blundell ML, Lehner T, Ott J, Stoffel M, Friedman JM, Breslow JL
Am J Med Genet. 2002
PubMed ID: 12116231
Analysis of apolipoprotein A-I, lecithin:cholesterol acyltransferase and glucocerebrosidase genes in hypoalphalipoproteinemia.
Recalde D, Cenarro A, García-Otín AL, Gómez-Coronado D, Civeira F, Pocoví M
Atherosclerosis. 2002
PubMed ID: 12048121
Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis.
Lachmann HJ, Booth DR, Booth SE, Bybee A, Gilbertson JA, Gillmore JD, Pepys MB, Hawkins PN
N Engl J Med. 2002
PubMed ID: 12050338
Isolation and partial characterization of the inactive and active forms of human plasma phospholipid transfer protein (PLTP).
Kärkkäinen M, Oka T, Olkkonen VM, Metso J, Hattori H, Jauhiainen M, Ehnholm C
J Biol Chem. 2002
PubMed ID: 11854286
Coronary artery disease and dyslipidemia within Europe: genetic variants in lipid transport gene loci in German subjects with premature coronary artery disease.
Kay A, März W, Hoffmann MM, Zhang Q, Masana L, Cavanna J, Baroni MG, Shine B, Galton DJ
Atheroscler Suppl. 2002
PubMed ID: 12044583
Apolipoproteins A-1 and B and the likelihood of non-fatal stroke and myocardial infarction -- data from The Third National Health and Nutrition Examination Survey.
Qureshi AI, Giles WH, Croft JB, Guterman LR, Hopkins LN
Med Sci Monit. 2002
PubMed ID: 12011770
Cloning and characterization of a novel apolipoprotein A-I binding protein, AI-BP, secreted by cells of the kidney proximal tubules in response to HDL or ApoA-I.
Ritter M, Buechler C, Boettcher A, Barlage S, Schmitz-Madry A, Orsó E, Bared SM, Schmiedeknecht G, Baehr CH, Fricker G, Schmitz G
Genomics. 2002
PubMed ID: 11991719
Fructose intake increases hyperlipidemia and modifies apolipoprotein expression in apolipoprotein AI-CIII-AIV transgenic mice.
Ostos MA, Recalde D, Baroukh N, Callejo A, Rouis M, Castro G, Zakin MM
J Nutr. 2002
PubMed ID: 11983814
Heteronuclear NMR studies of human serum apolipoprotein A-I. Part I. Secondary structure in lipid-mimetic solution.
Okon M, Frank PG, Marcel YL, Cushley RJ
FEBS Lett. 2002
PubMed ID: 12062424
Effects of enrichment of fibroblasts with unesterified cholesterol on the efflux of cellular lipids to apolipoprotein A-I.
Gillotte-Taylor K, Nickel M, Johnson WJ, Francone OL, Holvoet P, Lund-Katz S, Rothblat GH, Phillips MC
J Biol Chem. 2002
PubMed ID: 11805090
Apolipoprotein(a) gene polymorphism in the Korean population: is there any relevance to essential hypertension?
Kang BY, Bae JS, Kim KT, Kim JH, Shin JH, Lee CC
Med Princ Pract. 2002
PubMed ID: 12123106
Apolipoprotein AI promoter variant in blood pressure determination.
Sadaf A, Siddiqui S, Lestringant GG, Frossard PM
Clin Genet. 2002
PubMed ID: 12030900
Apo AI/ABCA1-dependent and HDL3-mediated lipid efflux from compositionally distinct cholesterol-based microdomains.
Drobnik W, Borsukova H, Böttcher A, Pfeiffer A, Liebisch G, Schütz GJ, Schindler H, Schmitz G
Traffic. 2002
PubMed ID: 11929608
Dietary oxidized fatty acids may enhance intestinal apolipoprotein A-I production.
Rong R, Ramachandran S, Penumetcha M, Khan N, Parthasarathy S
J Lipid Res. 2002
PubMed ID: 11907138
Apolipoprotein A-I alpha -helices 7 and 8 modulate high density lipoprotein subclass distribution.
Reschly EJ, Sorci-Thomas MG, Davidson WS, Meredith SC, Reardon CA, Getz GS
J Biol Chem. 2002
PubMed ID: 11744719
Macrophage metalloproteinases degrade high-density-lipoprotein-associated apolipoprotein A-I at both the N- and C-termini.
Eberini I, Calabresi L, Wait R, Tedeschi G, Pirillo A, Puglisi L, Sirtori CR, Gianazza E
Biochem J. 2002
PubMed ID: 11879189
Apolipoprotein A-I induces translocation of cholesterol, phospholipid, and caveolin-1 to cytosol in rat astrocytes.
Ito J, Nagayasu Y, Kato K, Sato R, Yokoyama S
J Biol Chem. 2002
PubMed ID: 11773045
Effects of apolipoprotein A-I genetic variations on plasma apolipoprotein, serum lipoprotein and glucose levels.
Larson IA, Ordovas JM, Barnard JR, Hoffmann MM, Feussner G, Lamon-Fava S, Schaefer EJ
Clin Genet. 2002
PubMed ID: 12000358
[Analysis of gene complexes predisposing to coronary atherosclerosis]
Spiridonova MG, Stepanov VA, Puzyrev VP, Karpov RS
Genetika. 2002
PubMed ID: 11963567
Factor VII activation, apolipoprotein A-I and reverse cholesterol transport: possible relevance for postprandial lipaemia.
Miller GJ, Cooke CJ, Nanjee MN, Howarth DJ, Cooper JA, Stepanova IP, Morrissey JH, Miller NE
Thromb Haemost. 2002
PubMed ID: 11916081
The relationship among apolipoprotein(a) polymorphisms, the low-density lipoprotein receptor-related protein, and the very low density lipoprotein receptor genes, and plasma lipoprotein(A) concentration in the Czech population.
Benes P, Muzík J, Benedík J, Znojil V, Vácha J
Hum Biol. 2002
PubMed ID: 11931574
[A preliminary study of pentanucleotide repeat polymorphism of apolipoprotein(a) gene in coronary atherosclerotic heart disease]
Hu B, Zhou X, Li L, Li X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2002
PubMed ID: 11836686
Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins.
Shi ST, Polyak SJ, Tu H, Taylor DR, Gretch DR, Lai MM
Virology. 2002
PubMed ID: 11878923
Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: the Framingham Study.
Ordovas JM, Corella D, Cupples LA, Demissie S, Kelleher A, Coltell O, Wilson PW, Schaefer EJ, Tucker K
Am J Clin Nutr. 2002
PubMed ID: 11756058
The apolipoprotein(a) size, pentanucleotide repeat, C/T(+93) polymorphisms of apolipoprotein(a) gene, serum lipoprotein(a) concentrations and their relationship in a Korean population.
Kim JH, Roh KH, Nam SM, Park HY, Jang Y, Kim DK, Song KS
Clin Chim Acta. 2001
PubMed ID: 11718686
Apolipoproteins AI, B, and E polymorphisms in severe aortic valve stenosis.
Avakian SD, Annicchino-Bizzacchi JM, Grinberg M, Ramires JA, Mansura AP
Clin Genet. 2001
PubMed ID: 11903341
Increased cholesterol efflux in apolipoprotein AI (ApoAI)-producing macrophages as a mechanism for reduced atherosclerosis in ApoAI((-/-)) mice.
Major AS, Dove DE, Ishiguro H, Su YR, Brown AM, Liu L, Carter KJ, Linton MF, Fazio S
Arterioscler Thromb Vasc Biol. 2001
PubMed ID: 11701467
Two newly identified SNPs in the APO AI-CIII intergenic region are strongly associated with familial combined hyperlipidaemia.
Groenendijk M, Cantor RM, Funke H, Dallinga-Thie GM
Eur J Clin Invest. 2001
PubMed ID: 11737222
Retrovirus-mediated expression of apolipoprotein A-I in the macrophage protects against atherosclerosis in vivo.
Ishiguro H, Yoshida H, Major AS, Zhu T, Babaev VR, Linton MF, Fazio S
J Biol Chem. 2001
PubMed ID: 11477092
Apolipoprotein AI and CIII gene polymorphisms and their association with lipid levels in Italian, Greek and Anglo-Irish populations of Australia.
Buzza M, Fripp Y, Mitchell RJ
Ann Hum Biol. 2001
PubMed ID: 11572515
Excess coronary heart disease in Familial Combined Hyperlipidemia, in relation to genetic factors and central obesity.
Voors-Pette C, de Bruin TW
Atherosclerosis. 2001
PubMed ID: 11472750
Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice reduces atherogenesis in response to a high fat-high cholesterol diet.
Baroukh N, Ostos MA, Vergnes L, Recalde D, Staels B, Fruchart J, Ochoa A, Castro G, Zakin MM
FEBS Lett. 2001
PubMed ID: 11478940
Effect of up-regulating individual steps in the reverse cholesterol transport pathway on reverse cholesterol transport in normolipidemic mice.
Alam K, Meidell RS, Spady DK
J Biol Chem. 2001
PubMed ID: 11278646
The estimation of gametic disequilibrium between DNA markers in candidate genes for coronary artery disease (CAD) and the associations of gene complexes with risk factors for CAD.
Spiridonova MG, Stepanov VA, Puzyrev VP, Karpov RS
Int J Circumpolar Health. 2001
PubMed ID: 11507973
Variations in the promoter region of the apolipoprotein A-1 gene influence plasma lipoprotein(a) levels in Asian Indian neonates from Singapore.
Heng CK, Low PS, Saha N
Pediatr Res. 2001
PubMed ID: 11264435
Apolipoprotein A-I directly interacts with amyloid precursor protein and inhibits A beta aggregation and toxicity.
Koldamova RP, Lefterov IM, Lefterova MI, Lazo JS
Biochemistry. 2001
PubMed ID: 11297421
GPI-specific phospholipase D associates with an apoA-I- and apoA-IV-containing complex.
Deeg MA, Bierman EL, Cheung MC
J Lipid Res. 2001
PubMed ID: 11254757
Coronary artery disease in patients at low risk--apolipoprotein AI as an independent risk factor.
Francis MC, Frohlich JJ
Atherosclerosis. 2001
PubMed ID: 11223438
Functional annotation of a full-length mouse cDNA collection.
Kawai J, Shinagawa A, Shibata K, Yoshino M, Itoh M, Ishii Y, Arakawa T, Hara A, Fukunishi Y, Konno H, Adachi J, Fukuda S, Aizawa K, Izawa M, Nishi K, Kiyosawa H, Kondo S, Yamanaka I, Saito T, Okazaki Y, Gojobori T, Bono H, Kasukawa T, Saito R, Kadota K, Matsuda H, Ashburner M, Batalov S, Casavant T, Fleischmann W, Gaasterland T, Gissi C, King B, Kochiwa H, Kuehl P, Lewis S, Matsuo Y, Nikaido I, Pesole G, Quackenbush J, Schriml LM, Staubli F, Suzuki R, Tomita M, Wagner L, Washio T, Sakai K, Okido T, Furuno M, Aono H, Baldarelli R, Barsh G, Blake J, Boffelli D, Bojunga N, Carninci P, de Bonaldo MF, Brownstein MJ, Bult C, Fletcher C, Fujita M, Gariboldi M, Gustincich S, Hill D, Hofmann M, Hume DA, Kamiya M, Lee NH, Lyons P, Marchionni L, Mashima J, Mazzarelli J, Mombaerts P, Nordone P, Ring B, Ringwald M, Rodriguez I, Sakamoto N, Sasaki H, Sato K, Schönbach C, Seya T, Shibata Y, Storch KF, Suzuki H, Toyo-oka K, Wang KH, Weitz C, Whittaker C, Wilming L, Wynshaw-Boris A, Yoshida K, Hasegawa Y, Kawaji H, Kohtsuki S, Hayashizaki Y, RIKEN Genome Exploration Research Group Phase II Team and the FANTOM Consortium
Nature. 2001
PubMed ID: 11217851
New genetic variants in the apoA-I and apoC-III genes and familial combined hyperlipidemia.
Groenendijk M, Cantor RM, De Bruin TW, Dallinga-Thie GM
J Lipid Res. 2001
PubMed ID: 11181747
Common genetic variants that relate to disorders of lipid transport in Spanish subjects with premature coronary artery disease.
Masana L, Febrer G, Cavanna J, Baroni MG, Marz W, Hoffmann MM, Shine B, Galton DJ
Clin Sci (Lond). 2001
PubMed ID: 11171287
Apolipoprotein specificity for lipid efflux by the human ABCAI transporter.
Remaley AT, Stonik JA, Demosky SJ, Neufeld EB, Bocharov AV, Vishnyakova TG, Eggerman TL, Patterson AP, Duverger NJ, Santamarina-Fojo S, Brewer HB
Biochem Biophys Res Commun. 2001
PubMed ID: 11162594
Significance of a polymorphism (G-->A transition) in the -75 position of the apolipoprotein A-I gene promoter on serum high density lipoprotein-cholesterol levels in Japanese hyperlipidemic subjects.
Tashiro J, Morisaki N, Kobayashi J, Bujo H, Kanzaki T, Murano S, Saito Y
J Atheroscler Thromb. 2001
PubMed ID: 11866037
Microarray expression profiling identifies genes with altered expression in HDL-deficient mice.
Callow MJ, Dudoit S, Gong EL, Speed TP, Rubin EM
Genome Res. 2000
PubMed ID: 11116096
Induction of bile acid synthesis by cholesterol and cholestyramine feeding is unimpaired in mice deficient in apolipoprotein AI.
Jolley CD, Dietschy JM, Turley SD
Hepatology. 2000
PubMed ID: 11093738
RIKEN integrated sequence analysis (RISA) system--384-format sequencing pipeline with 384 multicapillary sequencer.
Shibata K, Itoh M, Aizawa K, Nagaoka S, Sasaki N, Carninci P, Konno H, Akiyama J, Nishi K, Kitsunai T, Tashiro H, Itoh M, Sumi N, Ishii Y, Nakamura S, Hazama M, Nishine T, Harada A, Yamamoto R, Matsumoto H, Sakaguchi S, Ikegami T, Kashiwagi K, Fujiwake S, Inoue K, Togawa Y
Genome Res. 2000
PubMed ID: 11076861
Influence of genetic polymorphisms on responsiveness to dietary fat and cholesterol.
Ye SQ, Kwiterovich PO
Am J Clin Nutr. 2000
PubMed ID: 11063469
[Influence of a G/A substitution at -75 bp promoter region of apolipoprotein A I gene and wine consumption on the plasma apolipoprotein A I levels in Yi and Han Chinese]
Zhao Q, Shen P, Zhang H, Zhou M, She M
Zhonghua Bing Li Xue Za Zhi. 2000
PubMed ID: 11866932
Normalization and subtraction of cap-trapper-selected cDNAs to prepare full-length cDNA libraries for rapid discovery of new genes.
Carninci P, Shibata Y, Hayatsu N, Sugahara Y, Shibata K, Itoh M, Konno H, Okazaki Y, Muramatsu M, Hayashizaki Y
Genome Res. 2000
PubMed ID: 11042159
Transcriptional regulation of liver development.
Duncan SA
Dev Dyn. 2000
PubMed ID: 11002334
A key point mutation (V156E) affects the structure and functions of human apolipoprotein A-I.
Cho KH, Jonas A
J Biol Chem. 2000
PubMed ID: 10858436
Homeodomain factor Nkx2-3 controls regional expression of leukocyte homing coreceptor MAdCAM-1 in specialized endothelial cells of the viscera.
Wang CC, Biben C, Robb L, Nassir F, Barnett L, Davidson NO, Koentgen F, Tarlinton D, Harvey RP
Dev Biol. 2000
PubMed ID: 10926756
Binding of high density lipoprotein (HDL) and discoidal reconstituted HDL to the HDL receptor scavenger receptor class B type I. Effect of lipid association and APOA-I mutations on receptor binding.
Liadaki KN, Liu T, Xu S, Ishida BY, Duchateaux PN, Krieger JP, Kane J, Krieger M, Zannis VI
J Biol Chem. 2000
PubMed ID: 10801839
Hepatocyte nuclear factor 3beta (Foxa2) is dispensable for maintaining the differentiated state of the adult hepatocyte.
Sund NJ, Ang SL, Sackett SD, Shen W, Daigle N, Magnuson MA, Kaestner KH
Mol Cell Biol. 2000
PubMed ID: 10866673
Characterization and functional studies of lipoproteins, lipid transfer proteins, and lecithin:cholesterol acyltransferase in CSF of normal individuals and patients with Alzheimer's disease.
Demeester N, Castro G, Desrumaux C, De Geitere C, Fruchart JC, Santens P, Mulleners E, Engelborghs S, De Deyn PP, Vandekerckhove J, Rosseneu M, Labeur C
J Lipid Res. 2000
PubMed ID: 10828089
Interaction of alcohol and the G to a substitution at the promoter region of the apolipoprotein AI gene in determining plasma apolipoprotein AI levels in Yi and Han Chinese.
Zhao Q, She M, Shen P, Zhang H, Zhou M
Chin Med J (Engl). 2000
PubMed ID: 11776109
Single repeat deletion in ApoA-I blocks cholesterol esterification and results in rapid catabolism of delta6 and wild-type ApoA-I in transgenic mice.
Sorci-Thomas MG, Thomas M, Curtiss L, Landrum M
J Biol Chem. 2000
PubMed ID: 10766851
Apolipoprotein AII enrichment of HDL enhances their affinity for class B type I scavenger receptor but inhibits specific cholesteryl ester uptake.
Pilon A, Briand O, Lestavel S, Copin C, Majd Z, Fruchart JC, Castro G, Clavey V
Arterioscler Thromb Vasc Biol. 2000
PubMed ID: 10764676
[Study on plasma lipids, apolipoprotein A1, apolipoprotein B100 in simple obese children].
Zhu H, Wang S, Xu Y, Chen Y
Wei Sheng Yan Jiu. 2000
PubMed ID: 12725089
[A case control study on the distribution of apolipoprotein AI gene polymorphisms in the survivors of atherosclerosis cerebral infarction]
Wang L, Gu Y, Wu G, Wang W, Liu J, Liu J, Wu Z
Zhonghua Liu Xing Bing Xue Za Zhi. 2000
PubMed ID: 11860752
An essential role in liver development for transcription factor XBP-1.
Reimold AM, Etkin A, Clauss I, Perkins A, Friend DS, Zhang J, Horton HF, Scott A, Orkin SH, Byrne MC, Grusby MJ, Glimcher LH
Genes Dev. 2000
PubMed ID: 10652269
Effect of apolipoprotein E polymorphism and apolipoprotein A-1 gene promoter polymorphism on lipid parameters and premature coronary artery disease.
Petrovic D, Zorc M, Peterlin B
Folia Biol (Praha). 2000
PubMed ID: 11055796
Conserved protein motifs and structural organization of a fish gene homologous to mammalian apolipoprotein E.
Durliat M, André M, Babin PJ
Eur J Biochem. 2000
PubMed ID: 10632725
Transthyretin in high density lipoproteins: association with apolipoprotein A-I.
Sousa MM, Berglund L, Saraiva MJ
J Lipid Res. 2000
PubMed ID: 10627502
Fractional efflux and net change in cellular cholesterol content mediated by sera from mice expressing both human apolipoprotein AI and human lecithin:cholesterol acyltransferase genes.
Fournier N, Atger V, Paul JP, de la Llera Moya M, Rothblat G, Moatti N
Atherosclerosis. 1999
PubMed ID: 10559507
Hepatic scavenger receptor BI promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bile.
Ji Y, Wang N, Ramakrishnan R, Sehayek E, Huszar D, Breslow JL, Tall AR
J Biol Chem. 1999
PubMed ID: 10559220
Inhibition of intimal lipid deposition in human apolipoprotein A1 transgenic mice.
She M, Li H, Yu L, Gu S, Wang Z
Clin Exp Pharmacol Physiol. 1999
PubMed ID: 10549415
Human growth hormone increases apo(a) expression in transgenic mice.
Tao R, Acquati F, Marcovina SM, Hobbs HH
Arterioscler Thromb Vasc Biol. 1999
PubMed ID: 10521374
The new apolipoprotein A-I variant leu(174) --> Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93-residue N-terminal polypeptide.
Obici L, Bellotti V, Mangione P, Stoppini M, Arbustini E, Verga L, Zorzoli I, Anesi E, Zanotti G, Campana C, Viganò M, Merlini G
Am J Pathol. 1999
PubMed ID: 10487826
Lack of association between genetic variations of apo A-I-C-III-A-IV gene cluster and myocardial infarction in a sample of European male: ECTIM study.
Kee F, Amouyel P, Fumeron F, Arveiler D, Cambou JP, Evans A, Cambien F, Fruchart JC, Ducimetière P, Dallongeville J
Atherosclerosis. 1999
PubMed ID: 10428310
SAA-only HDL formed during the acute phase response in apoA-I+/+ and apoA-I-/- mice.
Cabana VG, Reardon CA, Wei B, Lukens JR, Getz GS
J Lipid Res. 1999
PubMed ID: 10357841
Inhibition of the acid lipase activity by apolipoprotein A-I in the presence of lysosomal proteases.
Inoue Y, Ose T, Mukai S, Ehira S, Yonekura M, Hou DX, Fujii M
Biosci Biotechnol Biochem. 1999
PubMed ID: 10419291
A novel apolipoprotein A-1 variant, Arg173Pro, associated with cardiac and cutaneous amyloidosis.
Hamidi Asl K, Liepnieks JJ, Nakamura M, Parker F, Benson MD
Biochem Biophys Res Commun. 1999
PubMed ID: 10198255
Phospholipid transfer protein (PLTP) causes proteolytic cleavage of apolipoprotein A-I.
Jauhiainen M, Huuskonen J, Baumann M, Metso J, Oka T, Egashira T, Hattori H, Olkkonen VM, Ehnholm C
J Lipid Res. 1999
PubMed ID: 10191289
Genotyping new BXD recombinant inbred mouse strains and comparison of BXD and consensus maps.
Taylor BA, Wnek C, Kotlus BS, Roemer N, MacTaggart T, Phillips SJ
Mamm Genome. 1999
PubMed ID: 10087289
Characterization of a novel trypanosome lytic factor from human serum.
Raper J, Fung R, Ghiso J, Nussenzweig V, Tomlinson S
Infect Immun. 1999
PubMed ID: 10085035
ApoA1 reduces free cholesterol accumulation in atherosclerotic lesions of ApoE-deficient mice transplanted with ApoE-expressing macrophages.
Boisvert WA, Black AS, Curtiss LK
Arterioscler Thromb Vasc Biol. 1999
PubMed ID: 10073953
Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover.
Silver DL, Jiang XC, Tall AR
J Biol Chem. 1999
PubMed ID: 9933608
Frequent occurrence of hypoalphalipoproteinemia due to mutant apolipoprotein A-I gene in the population: a population-based survey.
Yamakawa-Kobayashi K, Yanagi H, Fukayama H, Hirano C, Shimakura Y, Yamamoto N, Arinami T, Tsuchiya S, Hamaguchi H
Hum Mol Genet. 1999
PubMed ID: 9931341
Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein A1.
Hamidi Asl L, Liepnieks JJ, Hamidi Asl K, Uemichi T, Moulin G, Desjoyaux E, Loire R, Delpech M, Grateau G, Benson MD
Am J Pathol. 1999
PubMed ID: 9916936
High-efficiency full-length cDNA cloning.
Carninci P, Hayashizaki Y
Methods Enzymol. 1999
PubMed ID: 10349636
Structural and functional properties of two mutants of lecithin-cholesterol acyltransferase (T123I and N228K).
Adimoolam S, Jin L, Grabbe E, Shieh JJ, Jonas A
J Biol Chem. 1998
PubMed ID: 9829992
GATA6 regulates HNF4 and is required for differentiation of visceral endoderm in the mouse embryo.
Morrisey EE, Tang Z, Sigrist K, Lu MM, Jiang F, Ip HS, Parmacek MS
Genes Dev. 1998
PubMed ID: 9832509
The acute phase response in apolipoprotein A-1 knockout mice: apolipoprotein serum amyloid A and lipid distribution in plasma high density lipoproteins.
Hajri T, Elliott-Bryant R, Sipe JD, Liang JS, Hayes KC, Cathcart ES
Biochim Biophys Acta. 1998
PubMed ID: 9795222
The compositional abnormalities of lipoproteins in diabetic renal failure.
Attman PO, Knight-Gibson C, Tavella M, Samuelsson O, Alaupovic P
Nephrol Dial Transplant. 1998
PubMed ID: 9829487
Human apolipoproteins A-I and A-II in cell cholesterol efflux: studies with transgenic mice.
Chiesa G, Parolini C, Canavesi M, Colombo N, Sirtori CR, Fumagalli R, Franceschini G, Bernini F
Arterioscler Thromb Vasc Biol. 1998
PubMed ID: 9743230
Gene-based anchoring of the rat genetic linkage and cytogenetic maps: new regional localizations, orientation of the linkage groups, and insights into mammalian chromosome evolution.
Szpirer C, Szpirer J, Van Vooren P, Tissir F, Simon JS, Koike G, Jacob HJ, Lander ES, Helou K, Klinga-Levan K, Levan G
Mamm Genome. 1998
PubMed ID: 9716657
Enhanced cholesterol efflux by tyrosyl radical-oxidized high density lipoprotein is mediated by apolipoprotein AI-AII heterodimers.
Wang WQ, Merriam DL, Moses AS, Francis GA
J Biol Chem. 1998
PubMed ID: 9651324
Influence of genetic variation at the apo A-I gene locus on lipid levels and response to diet in familial hypercholesterolemia.
Carmena-Ramon RF, Ordovas JM, Ascaso JF, Real J, Priego MA, Carmena R
Atherosclerosis. 1998
PubMed ID: 9699897
Kinetic characteristics and regulation of HDL cholesteryl ester and apolipoprotein transport in the apoA-I-/- mouse.
Spady DK, Woollett LA, Meidell RS, Hobbs HH
J Lipid Res. 1998
PubMed ID: 9684752
Use of RDA analysis of knockout mice to identify myeloid genes regulated in vivo by PU.1 and C/EBPalpha.
Iwama A, Zhang P, Darlington GJ, McKercher SR, Maki R, Tenen DG
Nucleic Acids Res. 1998
PubMed ID: 9611252
Genetic loci controlling body fat, lipoprotein metabolism, and insulin levels in a multifactorial mouse model.
Mehrabian M, Wen PZ, Fisler J, Davis RC, Lusis AJ
J Clin Invest. 1998
PubMed ID: 9616220
Apolipoprotein-mediated cellular cholesterol efflux.
Yokoyama S
Biochim Biophys Acta. 1998
PubMed ID: 9593801
Quantification of apolipoprotein AI-containing lipoprotein particles in non-insulin-dependent diabetes mellitus.
Contiero E, Ferrari R, Vaselli GM, Folin M
Diabetes Res Clin Pract. 1998
PubMed ID: 9649952
A novel homozygous missense mutation in the apo A-I gene with apo A-I deficiency.
Huang W, Sasaki J, Matsunaga A, Nanimatsu H, Moriyama K, Han H, Kugi M, Koga T, Yamaguchi K, Arakawa K
Arterioscler Thromb Vasc Biol. 1998
PubMed ID: 9514407
ApoA-I deficiency causes both hypertriglyceridemia and increased atherosclerosis in human apoB transgenic mice.
Voyiaziakis E, Goldberg IJ, Plump AS, Rubin EM, Breslow JL, Huang LS
J Lipid Res. 1998
PubMed ID: 9507992
Distribution of tocopherol and apolipoprotein A-I immunoreactivity in rat liver chromatin.
Panin LE, Polyakov LM, Kolosova NG, Russkikh GS, Poteryaeva ON
Membr Cell Biol. 1998
PubMed ID: 9672881
Binding of phospholipid transfer protein (PLTP) to apolipoproteins A-I and A-II: location of a PLTP binding domain in the amino terminal region of apoA-I.
Pussinen PJ, Jauhiainen M, Metso J, Pyle LE, Marcel YL, Fidge NH, Ehnholm C
J Lipid Res. 1998
PubMed ID: 9469594
Effects of adenovirus-mediated human apo A-I gene transfer on neointima formation after endothelial denudation in apo E-deficient mice.
De Geest B, Zhao Z, Collen D, Holvoet P
Circulation. 1997
PubMed ID: 9416903
Repetitive elements in the third intron of murine apolipoprotein A-I gene.
Chiang AN, Fan KC, Shaw GC, Yang UC
Biochem Mol Biol Int. 1997
PubMed ID: 9415807
Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation.
Borhani DW, Rogers DP, Engler JA, Brouillette CG
Proc Natl Acad Sci U S A. 1997
PubMed ID: 9356442
Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of apolipoprotein L.
Duchateau PN, Pullinger CR, Orellana RE, Kunitake ST, Naya-Vigne J, O'Connor PM, Malloy MJ, Kane JP
J Biol Chem. 1997
PubMed ID: 9325276
Apolipoprotein E and apolipoprotein A-1 knock-out mice readily develop amyloid A protein amyloidosis.
Elliott-Bryant R, Cathcart ES
Clin Immunol Immunopathol. 1997
PubMed ID: 9325076
Differential interaction of the human cholesteryl ester transfer protein with plasma high density lipoproteins (HDLs) from humans, control mice, and transgenic mice to human HDL apolipoproteins. Lack of lipid transfer inhibitory activity in transgenic mic
Masson D, Duverger N, Emmanuel F, Lagrost L
J Biol Chem. 1997
PubMed ID: 9305883
Delayed loss of cholesterol from a localized lipoprotein depot in apolipoprotein A-I-deficient mice.
Stein O, Dabach Y, Hollander G, Ben-Naim M, Halperin G, Breslow JL, Stein Y
Proc Natl Acad Sci U S A. 1997
PubMed ID: 9275209
HDL deficiency in genetically engineered mice requires elevated LDL to accelerate atherogenesis.
Hughes SD, Verstuyft J, Rubin EM
Arterioscler Thromb Vasc Biol. 1997
PubMed ID: 9327769
Adenoviral vector-mediated overexpression of serum amyloid A in apoA-I-deficient mice.
Webb NR, de Beer MC, van der Westhuyzen DR, Kindy MS, Banka CL, Tsukamoto K, Rader DL, de Beer FC
J Lipid Res. 1997
PubMed ID: 9300780
Characterization of CLA-1, a human homologue of rodent scavenger receptor BI, as a receptor for high density lipoprotein and apoptotic thymocytes.
Murao K, Terpstra V, Green SR, Kondratenko N, Steinberg D, Quehenberger O
J Biol Chem. 1997
PubMed ID: 9211901
Structural analysis of apolipoprotein A-I: limited proteolysis of methionine-reduced and -oxidized lipid-free and lipid-bound human apo A-I.
Roberts LM, Ray MJ, Shih TW, Hayden E, Reader MM, Brouillette CG
Biochemistry. 1997
PubMed ID: 9200714
Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation.
Marin M, Karis A, Visser P, Grosveld F, Philipsen S
Cell. 1997
PubMed ID: 9160753
ApoA-I knockout mice: characterization of HDL metabolism in homozygotes and identification of a post-RNA mechanism of apoA-I up-regulation in heterozygotes.
Plump AS, Azrolan N, Odaka H, Wu L, Jiang X, Tall A, Eisenberg S, Breslow JL
J Lipid Res. 1997
PubMed ID: 9186920
Evolution of mammalian apolipoprotein A-I and conservation of antigenicity: correlation with primary and secondary structure.
Collet X, Marcel YL, Tremblay N, Lazure C, Milne RW, Perret B, Weech PK
J Lipid Res. 1997
PubMed ID: 9144079
Truncation of the amino terminus of human apolipoprotein A-I substantially alters only the lipid-free conformation.
Rogers DP, Brouillette CG, Engler JA, Tendian SW, Roberts L, Mishra VK, Anantharamaiah GM, Lund-Katz S, Phillips MC, Ray MJ
Biochemistry. 1997
PubMed ID: 9003180
Feedback mechanism of focal vascular lesion formation in transgenic apolipoprotein(a) mice.
Lawn RM, Pearle AD, Kunz LL, Rubin EM, Reckless J, Metcalfe JC, Grainger DJ
J Biol Chem. 1996
PubMed ID: 8940144
Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a.
Shimano H, Horton JD, Hammer RE, Shimomura I, Brown MS, Goldstein JL
J Clin Invest. 1996
PubMed ID: 8833906
Scavenger receptor BI (SR-BI) is up-regulated in adrenal gland in apolipoprotein A-I and hepatic lipase knock-out mice as a response to depletion of cholesterol stores. In vivo evidence that SR-BI is a functional high density lipoprotein receptor under fe
Wang N, Weng W, Breslow JL, Tall AR
J Biol Chem. 1996
PubMed ID: 8798380
Plasma lipopolysaccharide-binding protein is found associated with a particle containing apolipoprotein A-I, phospholipid, and factor H-related proteins.
Park CT, Wright SD
J Biol Chem. 1996
PubMed ID: 8663389
Genetic regulation of cholesterol homeostasis: chromosomal organization of candidate genes.
Welch CL, Xia YR, Shechter I, Farese R, Mehrabian M, Mehdizadeh S, Warden CH, Lusis AJ
J Lipid Res. 1996
PubMed ID: 8827514
Assignment of the mouse ataxia-telangiectasia gene (Atm) to mouse chromosome 9.
Xia Y, Welch CL, Warden CH, Lange E, Fukao T, Lusis AJ, Gatti RA
Mamm Genome. 1996
PubMed ID: 8672141
Strain distribution pattern for SSLP markers in the SWXJ recombinant inbred strain set: chromosomes 7 to X.
Shultz KL, Svenson KL, Cheah Y, Paigen B, Beamer WG
Mamm Genome. 1996
PubMed ID: 8672132
Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene.
Booth DR, Tan SY, Booth SE, Tennent GA, Hutchinson WL, Hsuan JJ, Totty NF, Truong O, Soutar AK, Hawkins PN, Bruguera M, Caballería J, Solé M, Campistol JM, Pepys MB
J Clin Invest. 1996
PubMed ID: 8675681
Conformation of human serum apolipoprotein A-I(166-185) in the presence of sodium dodecyl sulfate or dodecylphosphocholine by 1H-NMR and CD. Evidence for specific peptide-SDS interactions.
Wang G, Treleaven WD, Cushley RJ
Biochim Biophys Acta. 1996
PubMed ID: 8664326
High density lipoprotein and heart disease: induced mutant mouse studies.
Breslow JL
Isr J Med Sci. 1996
PubMed ID: 8682656
Apolipoprotein A-I is required for cholesteryl ester accumulation in steroidogenic cells and for normal adrenal steroid production.
Plump AS, Erickson SK, Weng W, Partin JS, Breslow JL, Williams DL
J Clin Invest. 1996
PubMed ID: 8647961
Expression of apolipoprotein A-1 mRNA in normal intrahepatic biliary tree.
Ohta T, Numata M, Yamamoto M, Iseki S, Tsukioka Y, Kayahara M, Nagakawa T, Miyazaki I
Liver. 1996
PubMed ID: 8740847
Chromosomal assignment of the porcine gene for apolipoprotein C3 (APOC3) to chromosome 9 by somatic cell hybrids.
Rettenberger G, Bruch J, Hameister H
Mamm Genome. 1996
PubMed ID: 8661715
Molecular cloning and functional expression of murine JE (monocyte chemoattractant protein 1) and murine macrophage inflammatory protein 1alpha receptors: evidence for two closely linked C-C chemokine receptors on chromosome 9.
Boring L, Gosling J, Monteclaro FS, Lusis AJ, Tsou CL, Charo IF
J Biol Chem. 1996
PubMed ID: 8631787
Identification of scavenger receptor SR-BI as a high density lipoprotein receptor.
Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M
Science. 1996
PubMed ID: 8560269
Site-specific mutagenesis demonstrates that cysteine 4326 of apolipoprotein B is required for covalent linkage with apolipoprotein (a) in vivo.
Callow MJ, Rubin EM
J Biol Chem. 1995
PubMed ID: 7592581
Regulation of rat liver apolipoprotein A-I, apolipoprotein A-II and acyl-coenzyme A oxidase gene expression by fibrates and dietary fatty acids.
Berthou L, Saladin R, Yaqoob P, Branellec D, Calder P, Fruchart JC, Denèfle P, Auwerx J, Staels B
Eur J Biochem. 1995
PubMed ID: 7556148
Reconsideration of the catalytic center and mechanism of mammalian paraoxonase/arylesterase.
Sorenson RC, Primo-Parmo SL, Kuo CL, Adkins S, Lockridge O, La Du BN
Proc Natl Acad Sci U S A. 1995
PubMed ID: 7638166
Intestinal apolipoprotein AI gene transcription is regulated by multiple distinct DNA elements and is synergistically activated by the orphan nuclear receptor, hepatocyte nuclear factor 4.
Ginsburg GS, Ozer J, Karathanasis SK
J Clin Invest. 1995
PubMed ID: 7615825
Effect of apolipoprotein A-I deficiency on lecithin:cholesterol acyltransferase activation in mouse plasma.
Parks JS, Li H, Gebre AK, Smith TL, Maeda N
J Lipid Res. 1995
PubMed ID: 7751823
Nerve regeneration and cholesterol reutilization occur in the absence of apolipoproteins E and A-I in mice.
Goodrum JF, Bouldin TW, Zhang SH, Maeda N, Popko B
J Neurochem. 1995
PubMed ID: 7798939
The human myocardial two-dimensional gel protein database: update 1994.
Corbett JM, Wheeler CH, Baker CS, Yacoub MH, Dunn MJ
Electrophoresis. 1994
PubMed ID: 7895732
Characterization of two new human apolipoprotein A-I variants: apolipoprotein A-I Tsushima (Trp-108-->Arg) and A-I Hita (Ala-95-->Asp).
Araki K, Sasaki J, Matsunaga A, Takada Y, Moriyama K, Hidaka K, Arakawa K
Biochim Biophys Acta. 1994
PubMed ID: 7918609
Structural and functional properties of human and mouse apolipoprotein A-I.
Gong EL, Tan CS, Shoukry MI, Rubin EM, Nichols AV
Biochim Biophys Acta. 1994
PubMed ID: 8049247
Developmental changes in methylation of spermatogenesis-specific genes include reprogramming in the epididymis.
Ariel M, Cedar H, McCarrey J
Nat Genet. 1994
PubMed ID: 8075642
A polymorphism in the human apolipoprotein AI promoter region: a study in hypertriglyceridaemic patients.
Needham EW, Mattu RK, Rees A, Stocks J, Galton DJ
Hum Hered. 1994
PubMed ID: 7910586
Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia.
Ng DS, Leiter LA, Vezina C, Connelly PW, Hegele RA
J Clin Invest. 1994
PubMed ID: 8282791
Nucleotide sequence of mouse spermidine synthase cDNA.
Myöhänen S, Wahlfors J, Alhonen L, Jänne J
DNA Seq. 1994
PubMed ID: 7803821
Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice.
Li H, Reddick RL, Maeda N
Arterioscler Thromb. 1993
PubMed ID: 8241102
Linkage mapping of 40 randomly isolated liver cDNA clones in the mouse.
Warden CH, Mehrabian M, He KY, Yoon MY, Diep A, Xia YR, Wen PZ, Svenson KL, Sparkes RS, Lusis AJ
Genomics. 1993
PubMed ID: 8288233
Chromosomal localization of uroplakin genes of cattle and mice.
Ryan AM, Womack JE, Yu J, Lin JH, Wu XR, Sun TT, Clarke V, D'Eustachio P
Mamm Genome. 1993
PubMed ID: 8281015
Autosomal dominant hypoalphalipoproteinemia due to a completely defective apolipoprotein A-I gene.
Nakata K, Kobayashi K, Yanagi H, Shimakura Y, Tsuchiya S, Arinami T, Hamaguchi H
Biochem Biophys Res Commun. 1993
PubMed ID: 8240372
The preferential site of non-enzymatic glycation of human apolipoprotein A-I in vivo.
Calvo C, Ulloa N, Campos M, Verdugo C, Ayrault-Jarrier M
Clin Chim Acta. 1993
PubMed ID: 8261628
Chromosomal localization of lipolytic enzymes in the mouse: pancreatic lipase, colipase, hormone-sensitive lipase, hepatic lipase, and carboxyl ester lipase.
Warden CH, Davis RC, Yoon MY, Hui DY, Svenson K, Xia YR, Diep A, He KY, Lusis AJ
J Lipid Res. 1993
PubMed ID: 8105016
The IL-2 receptor beta chain gene (Il-2rb) is closely linked to the Pdgfb locus on mouse chromosome 15.
Malek TR, Vincek V, Gatalica B, Bucan M
Immunogenetics. 1993
PubMed ID: 8482578
Encyclopedia of the mouse genome III. October 1993. Mouse chromosome 9.
Kingsley DM
Mamm Genome. 1993
PubMed ID: 8268669
Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a).
Chiesa G, Hobbs HH, Koschinsky ML, Lawn RM, Maika SD, Hammer RE
J Biol Chem. 1992
PubMed ID: 1280258
Characterization of the mouse apolipoprotein Apoa-1/Apoc-3 gene locus: genomic, mRNA, and protein sequences with comparisons to other species.
Januzzi JL, Azrolan N, O'Connell A, Aalto-Setälä K, Breslow JL
Genomics. 1992
PubMed ID: 1478650
Differential regulation of hepatic apolipoprotein A-I and A-II gene expression by thyroid hormone in rat liver.
Strobl W, Chan L, Patsch W
Atherosclerosis. 1992
PubMed ID: 1466661
Site-directed mutagenesis and structure-function analysis of the human apolipoprotein A-I. Relation between lecithin-cholesterol acyltransferase activation and lipid binding.
Minnich A, Collet X, Roghani A, Cladaras C, Hamilton RL, Fielding CJ, Zannis VI
J Biol Chem. 1992
PubMed ID: 1644835
Structure of the murine gene encoding apolipoprotein A-I.
Boyle TP, Marotti KR
Gene. 1992
PubMed ID: 1639271
Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis.
Soutar AK, Hawkins PN, Vigushin DM, Tennent GA, Booth SE, Hutton T, Nguyen O, Totty NF, Feest TG, Hsuan JJ
Proc Natl Acad Sci U S A. 1992
PubMed ID: 1502149
Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I.
Williamson R, Lee D, Hagaman J, Maeda N
Proc Natl Acad Sci U S A. 1992
PubMed ID: 1496008
Dietary fatty acids and dietary cholesterol differ in their effect on the in vivo regulation of apolipoprotein A-I and A-II gene expression in inbred strains of mice.
Srivastava RA, Tang J, Krul ES, Pfleger B, Kitchens RT, Schonfeld G
Biochim Biophys Acta. 1992
PubMed ID: 1596514
Treatment of Haemophilus aphrophilus endocarditis with ciprofloxacin.
Dawson SJ, White LA
J Infect. 1992
PubMed ID: 1602151
Genetic and dietary interactions in the regulation of HMG-CoA reductase gene expression.
Hwa JJ, Zollman S, Warden CH, Taylor BA, Edwards PA, Fogelman AM, Lusis AJ
J Lipid Res. 1992
PubMed ID: 1352323
Mouse apolipoprotein AI. cDNA-derived primary structure, gene organisation and complete nucleotide sequence.
Stoffel W, Müller R, Binczek E, Hofmann K
Biol Chem Hoppe Seyler. 1992
PubMed ID: 1596360
Cellular cholesterol efflux. Role of cell membrane kinetic pools and interaction with apolipoproteins AI, AII, and Cs.
Mahlberg FH, Rothblat GH
J Biol Chem. 1992
PubMed ID: 1537840
Interaction of rat lecithin-cholesterol acyltransferase with rat apolipoprotein A-I and with lecithin-cholesterol vesicles.
Furukawa Y, Urano T, Hida Y, Itoh H, Takahashi C, Kimura S
J Biochem. 1992
PubMed ID: 1587806
The AXB and BXA set of recombinant inbred mouse strains.
Marshall JD, Mu JL, Cheah YC, Nesbitt MN, Frankel WN, Paigen B
Mamm Genome. 1992
PubMed ID: 1477475
Lipoproteins of human peripheral lymph. Apolipoprotein AI-containing lipoprotein with alpha-2 electrophoretic mobility.
Reichl D, Hathaway CB, Sterchi JM, Miller NE
Eur J Clin Invest. 1991
PubMed ID: 1723385
The apolipoprotein A-I binding protein of placenta and the SP-40,40 protein of human blood are different proteins which both bind to apolipoprotein A-I.
Ehnholm C, Bozas SE, Tenkanen H, Kirszbaum L, Metso J, Murphy B, Walker ID
Biochim Biophys Acta. 1991
PubMed ID: 1742316
Familial nephropathic non-neuropathic amyloidosis: clinical features, immunohistochemistry and chemistry.
Zalin AM, Jones S, Fitch NJ, Ramsden DB
Q J Med. 1991
PubMed ID: 1808634
Structure, expression and chromosomal location of the Oct-4 gene.
Yeom YI, Ha HS, Balling R, Schöler HR, Artzt K
Mech Dev. 1991
PubMed ID: 1768618
Identification of apolipoprotein A1 and immunoglobulin as components of a serum complex that mediates activation of human sperm motility.
Akerlöf E, Jörnvall H, Slotte H, Pousette A
Biochemistry. 1991
PubMed ID: 1909888
Heterogeneity and tissue-specific expression of eukaryotic transcription factor S-II-related protein mRNA.
Kanai A, Kuzuhara T, Sekimizu K, Natori S
J Biochem. 1991
PubMed ID: 1917889
Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses.
Rubin EM, Ishida BY, Clift SM, Krauss RM
Proc Natl Acad Sci U S A. 1991
PubMed ID: 1703299
A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacities.
Funke H, von Eckardstein A, Pritchard PH, Karas M, Albers JJ, Assmann G
J Clin Invest. 1991
PubMed ID: 1898657
Activation of erythropoietin receptors by Friend viral gp55 and by erythropoietin and down-modulation by the murine Fv-2r resistance gene.
Hoatlin ME, Kozak SL, Lilly F, Chakraborti A, Kozak CA, Kabat D
Proc Natl Acad Sci U S A. 1990
PubMed ID: 2175917
Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. Identification of apolipoprotein D, apolipoprotein A-IV, apolipoprotein E, and apolipoprotein A-I.
Boyles JK, Notterpek LM, Anderson LJ
J Biol Chem. 1990
PubMed ID: 2120218
A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy.
Nichols WC, Gregg RE, Brewer HB, Benson MD
Genomics. 1990
PubMed ID: 2123470
Transcriptional and posttranscriptional regulation of apolipoprotein E, A-I, and A-II gene expression in normal rat liver and during several pathophysiologic states.
Pandurò A, Lin-Lee YC, Chan L, Shafritz DA
Biochemistry. 1990
PubMed ID: 2123716
Mapping of class alpha glutathione S-transferase 2 (GST-2) genes to the vicinity of the d locus on mouse chromosome 9.
Kasahara M, Matsumura E, Webb G, Board PG, Figueroa F, Klein J
Genomics. 1990
PubMed ID: 1981995
[Serum apolipoprotein AI, B levels in patients with coronary diseases].
He Y
Zhonghua Xin Xue Guan Bing Za Zhi. 1990
PubMed ID: 2128269
Structural analysis of human apolipoprotein A-I variants. Amino acid substitutions are nonrandomly distributed throughout the apolipoprotein A-I primary structure.
von Eckardstein A, Funke H, Walter M, Altland K, Benninghoven A, Assmann G
J Biol Chem. 1990
PubMed ID: 2111322
Isolation and characterization of human apolipoprotein A-I Fukuoka (110 Glu----Lys). A novel apolipoprotein variant.
Takada Y, Sasaki J, Ogata S, Nakanishi T, Ikehara Y, Arakawa K
Biochim Biophys Acta. 1990
PubMed ID: 2107878
Genetic analysis of nonhistone chromosomal protein inheritance in recombinant inbred mouse strains using two-dimensional electrophoresis.
Ramagli LS, Womack JE, Rodriguez LV
Biochem Genet. 1990
PubMed ID: 2383242
Apolipoprotein A1 Baltimore (Arg10----Leu), a new ApoA1 variant.
Ladias JA, Kwiterovich PO, Smith HH, Karathanasis SK, Antonarakis SE
Hum Genet. 1990
PubMed ID: 2108924
Structure and chromosome assignment of the murine p36 (calpactin I heavy chain) gene.
Amiguet P, D'Eustachio P, Kristensen T, Wetsel RA, Saris CJ, Hunter T, Chaplin DD, Tack BF
Biochemistry. 1990
PubMed ID: 2138915
Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I.
von Eckardstein A, Funke H, Henke A, Altland K, Benninghoven A, Assmann G
J Clin Invest. 1989
PubMed ID: 2512329
The structural genes encoding P450scc and P450arom are closely linked on mouse chromosome 9.
Youngblood GL, Nesbitt MN, Payne AH
Endocrinology. 1989
PubMed ID: 2792009
The human ATP synthase beta subunit gene: sequence analysis, chromosome assignment, and differential expression.
Neckelmann N, Warner CK, Chung A, Kudoh J, Minoshima S, Fukuyama R, Maekawa M, Shimizu Y, Shimizu N, Liu JD
Genomics. 1989
PubMed ID: 2687158
Apolipoprotein A-I binds to a family of bovine seminal plasma proteins.
Manjunath P, Marcel YL, Uma J, Seidah NG, Chrétien M, Chapdelaine A
J Biol Chem. 1989
PubMed ID: 2506184
Familial apolipoprotein A-I, C-III, and A-IV deficiency and premature atherosclerosis due to deletion of a gene complex on chromosome 11.
Ordovas JM, Cassidy DK, Civeira F, Bisgaier CL, Schaefer EJ
J Biol Chem. 1989
PubMed ID: 2506176
Influence of development, estrogens, and food intake on apolipoprotein A-I, A-II, and E mRNA in rat liver and intestine.
Staels B, Auwerx J, Chan L, van Tol A, Rosseneu M, Verhoeven G
J Lipid Res. 1989
PubMed ID: 2504861
Production of human recombinant proapolipoprotein A-I in Escherichia coli: purification and biochemical characterization.
Moguilevsky N, Roobol C, Loriau R, Guillaume JP, Jacobs P, Cravador A, Herzog A, Brouwers L, Scarso A, Gilles P
DNA. 1989
PubMed ID: 2673706
Ath-2, a second gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice.
Paigen B, Nesbitt MN, Mitchell D, Albee D, LeBoeuf RC
Genetics. 1989
PubMed ID: 2499515
Genetic mapping of mouse T3d and T3e between Apoa1 and Ncam.
Miller RD, Ozaki JH, Riblet RJ, Gold DP
Immunogenetics. 1989
PubMed ID: 2512252
Tissue-specific expression of apolipoprotein A-I (ApoA-I) is regulated by the 5'-flanking region of the human ApoA-I gene.
Higuchi K, Law SW, Hoeg JM, Schumacher UK, Meglin N, Brewer HB
J Biol Chem. 1988
PubMed ID: 3142880
Variant apolipoprotein AI as a major constituent of a human hereditary amyloid.
Nichols WC, Dwulet FE, Liepnieks J, Benson MD
Biochem Biophys Res Commun. 1988
PubMed ID: 3142462
Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I). A novel function of Apo A-I.
Yui Y, Aoyama T, Morishita H, Takahashi M, Takatsu Y, Kawai C
J Clin Invest. 1988
PubMed ID: 3047170
[Mapping of apolipoprotein A-1 and ceruloplasmin genes on human, rat and mouse chromosomes by hybridization in situ with specific human DNA probes]
Baranov VS, Gorbunova VN, Tsymbalenko NV, Shvartsman AL, Gaĭtskhoki VS
Biull Eksp Biol Med. 1988
PubMed ID: 3132994
Sequence and expression of Tangier apoA-I gene.
Makrides SC, Ruiz-Opazo N, Hayden M, Nussbaum AL, Breslow JL, Zannis VI
Eur J Biochem. 1988
PubMed ID: 3129297
Similarity of cruzin, an inhibitor of Trypanosoma cruzi neuraminidase, to high-density lipoprotein.
Prioli RP, Ordovas JM, Rosenberg I, Schaefer EJ, Pereira ME
Science. 1987
PubMed ID: 3120314
In vivo metabolism of proapolipoprotein A-I in Tangier disease.
Bojanovski D, Gregg RE, Zech LA, Meng MS, Bishop C, Ronan R, Brewer HB
J Clin Invest. 1987
PubMed ID: 3119665
Distribution and localization of lecithin:cholesterol acyltransferase and cholesteryl ester transfer activity in A-I-containing lipoproteins.
Cheung MC, Wolf AC, Lum KD, Tollefson JH, Albers JJ
J Lipid Res. 1986
PubMed ID: 3104518
Linkage, evolution, and expression of the rat apolipoprotein A-I, C-III, and A-IV genes.
Haddad IA, Ordovas JM, Fitzpatrick T, Karathanasis SK
J Biol Chem. 1986
PubMed ID: 3020028
Fourteen genetically variant proteins of mouse brain: discovery of two new variants and chromosomal mapping of four loci.
Goldman D, Pikus HJ
Biochem Genet. 1986
PubMed ID: 3729925
Developmental regulation of a gene that encodes a cysteine-rich intestinal protein and maps near the murine immunoglobulin heavy chain locus.
Birkenmeier EH, Gordon JI
Proc Natl Acad Sci U S A. 1986
PubMed ID: 3085096
Human apolipoprotein A-I. Post-translational modification by fatty acid acylation.
Hoeg JM, Meng MS, Ronan R, Fairwell T, Brewer HB
J Biol Chem. 1986
PubMed ID: 3005308
Use of chromosomally mapped and identified mouse brain proteins for behavioral genetic analysis of alcoholism.
Goldman D, Crabbe J
Prog Neuropsychopharmacol Biol Psychiatry. 1986
PubMed ID: 3749510
Chromosomal location of the gene encoding the neural cell adhesion molecule (N-CAM) in the mouse.
D'Eustachio P, Owens GC, Edelman GM, Cunningham BA
Proc Natl Acad Sci U S A. 1985
PubMed ID: 3865183
Tangier disease. The complete mRNA sequence encoding for preproapo-A-I.
Law SW, Brewer HB
J Biol Chem. 1985
PubMed ID: 2995392
Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII, and AIV genes.
Karathanasis SK
Proc Natl Acad Sci U S A. 1985
PubMed ID: 3931073
Leupeptin as a tool for the detection of the sites of catabolism of rat high-density lipoprotein apolipoproteins A-I and E.
van 't Hooft FM, Dallinga-Thie GM, van Tol A
Biochim Biophys Acta. 1985
PubMed ID: 2579677
Comparative analysis of repeated sequences in rat apolipoproteins A-I, A-IV, and E.
Boguski MS, Elshourbagy N, Taylor JM, Gordon JI
Proc Natl Acad Sci U S A. 1985
PubMed ID: 3919393
Genetics and evolution of the acute phase proteins in mice.
Baumann H, Berger FG
Mol Gen Genet. 1985
PubMed ID: 3866909
Isolation and sequence analysis of the human apolipoprotein CIII gene and the intergenic region between the apo AI and apo CIII genes.
Protter AA, Levy-Wilson B, Miller J, Bencen G, White T, Seilhamer JJ
DNA. 1984
PubMed ID: 6439535
Plasma lipoproteins: apolipoprotein structure and function.
Mahley RW, Innerarity TL, Rall SC, Weisgraber KH
J Lipid Res. 1984
PubMed ID: 6099394
Apolipoprotein A-IGiessen (Pro143----Arg). A mutant that is defective in activating lecithin:cholesterol acyltransferase.
Utermann G, Haas J, Steinmetz A, Paetzold R, Rall SC, Weisgraber KH, Mahley RW
Eur J Biochem. 1984
PubMed ID: 6489332
Abnormal lecithin:cholesterol acyltransferase activation by a human apolipoprotein A-I variant in which a single lysine residue is deleted.
Rall SC, Weisgraber KH, Mahley RW, Ogawa Y, Fielding CJ, Utermann G, Haas J, Steinmetz A, Menzel HJ, Assmann G
J Biol Chem. 1984
PubMed ID: 6432779
Isolation and DNA sequence of full-length cDNA and of the entire gene for human apolipoprotein AI--discovery of a new genetic polymorphism in the apo AI gene.
Seilhamer JJ, Protter AA, Frossard P, Levy-Wilson B
DNA. 1984
PubMed ID: 6207999
Conserved linkage within a 4-cM region of mouse chromosome 9 and human chromosome 11.
Antonucci TK, Von Deimling OH, Rosenblum BB, Skow LC, Meisler MH
Genetics. 1984
PubMed ID: 6735174
Human apolipoproteins AI, AII, CII and CIII. cDNA sequences and mRNA abundance.
Sharpe CR, Sidoli A, Shelley CS, Lucero MA, Shoulders CC, Baralle FE
Nucleic Acids Res. 1984
PubMed ID: 6328445
Cloning and structure analysis of the rat apolipoprotein A-I cDNA.
Poncin JE, Martial JA, Gielen JE
Eur J Biochem. 1984
PubMed ID: 6426956
Nucleotide sequence and the encoded amino acids of human apolipoprotein A-I mRNA.
Law SW, Brewer HB
Proc Natl Acad Sci U S A. 1984
PubMed ID: 6198645
Isolation and characterization of the human apolipoprotein A-I gene.
Karathanasis SK, Zannis VI, Breslow JL
Proc Natl Acad Sci U S A. 1983
PubMed ID: 6413973
Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (pro-apo A-i) with high density lipoproteins.
Schmitz G, Assmann G, Rall SC, Mahley RW
Proc Natl Acad Sci U S A. 1983
PubMed ID: 6412234
Linkage of human apolipoproteins A-I and C-III genes.
Karathanasis SK, McPherson J, Zannis VI, Breslow JL
Nature. 1983
PubMed ID: 6308458
Human plasma proapoA-I: isolation and amino-terminal sequence.
Brewer HB, Fairwell T, Kay L, Meng M, Ronan R, Law S, Light JA
Biochem Biophys Res Commun. 1983
PubMed ID: 6409108
Nucleotide sequence of cloned cDNA of human apolipoprotein A-I.
Cheung P, Chan L
Nucleic Acids Res. 1983
PubMed ID: 6304641
Gene structure of human apolipoprotein A1.
Shoulders CC, Kornblihtt AR, Munro BS, Baralle FE
Nucleic Acids Res. 1983
PubMed ID: 6406984
Intracellular and extracellular processing of human apolipoprotein A-I: secreted apolipoprotein A-I isoprotein 2 is a propeptide.
Zannis VI, Karathanasis SK, Keutmann HT, Goldberger G, Breslow JL
Proc Natl Acad Sci U S A. 1983
PubMed ID: 6405383
Genetic control of lipid transport in mice. II. Genes controlling structure of high density lipoproteins.
Lusis AJ, Taylor BA, Wangenstein RW, LeBoeuf RC
J Biol Chem. 1983
PubMed ID: 6403543
cDNA cloning of human apoA-I: amino acid sequence of preproapoA-I.
Law SW, Gray G, Brewer HB
Biochem Biophys Res Commun. 1983
PubMed ID: 6404278
Identification of a cDNA clone for mouse apoprotein A-1 (apo A-1) and its use in characterization of apo A-1 mRNA expression in liver and small intestine.
Miller JC, Barth RK, Shaw PH, Elliott RW, Hastie ND
Proc Natl Acad Sci U S A. 1983
PubMed ID: 6572912
Apolipoprotein A-IMilano. Detection of normal A-I in affected subjects and evidence for a cysteine for arginine substitution in the variant A-I.
Weisgraber KH, Rall SC, Bersot TP, Mahley RW, Franceschini G, Sirtori CR
J Biol Chem. 1983
PubMed ID: 6401735
An inherited polymorphism in the human apolipoprotein A-I gene locus related to the development of atherosclerosis.
Karathanasis SK, Norum RA, Zannis VI, Breslow JL
Nature. 1983
PubMed ID: 6402711
Isolation and characterization of cDNA clones for human apolipoprotein A-I.
Breslow JL, Ross D, McPherson J, Williams H, Kurnit D, Nussbaum AL, Karathanasis SK, Zannis VI
Proc Natl Acad Sci U S A. 1982
PubMed ID: 6294659
Isolation and characterization of simple and complex lipoproteins containing apolipoprotein F from human plasma.
Koren E, McConathy WJ, Alaupovic P
Biochemistry. 1982
PubMed ID: 6816269
The primary translation product of rat intestinal apolipoprotein A-I mRNA is an unusual preproprotein.
Gordon JI, Smith DP, Andy R, Alpers DH, Schonfeld G, Strauss AW
J Biol Chem. 1982
PubMed ID: 6798036
Characterization of the proteins of isolated human platelet alpha-granules. Evidence for a separate alpha-granule-pool of the glycoproteins IIb and IIIa.
Gogstad GO, Hagen I, Korsmo R, Solum NO
Biochim Biophys Acta. 1981
PubMed ID: 6457647
Polymorphism of kidney pyruvate kinase in the mouse is determined by a gene, Pk-3, on chromosome 9.
Peters J, Nash HR, Eicher EM, Bulfield G
Biochem Genet. 1981
PubMed ID: 7295297
Linkage of Pgm-3 in the house mouse and homologies of three phosphoglucomutase loci in mouse and man.
Nadeau JH, Kömpf J, Siebert G, Taylor BA
Biochem Genet. 1981
PubMed ID: 6457599
Ly-15: a new murine lymphocyte alloantigenic locus.
Potter TA, Hogarth PM, McKenzie IF
Transplantation. 1981
PubMed ID: 6785912
Genetic control of cross-reactive cytotoxic T-lymphocyte responses to a BALB/c tumor.
Russell JH, Dobos CB, Graff RJ, Taylor BA
Immunogenetics. 1981
PubMed ID: 6800944
An autosomal dominant gene regulates the extent of 9-O-acetylation of murine erythrocyte sialic acids. A probable explanation for the variation in capacity to activate the human alternate complement pathway.
Varki A, Kornfeld S
J Exp Med. 1980
PubMed ID: 7411019
Genetic analysis of protein variations in Mus musculus using two-dimensional electrophoresis.
Racine RR, Langley CH
Biochem Genet. 1980
PubMed ID: 7387621
A serum protein polymorphism determinant on chromosome 9 of Mus musculus.
Eicher EM, Taylor BA, Leighton SC, Womack JE
Mol Gen Genet. 1980
PubMed ID: 6929943
Gene for a serum protein on chromosome 9 in the mouse.
Håkansson EM, Juneja RK, Lundin LG
Genet Res. 1979
PubMed ID: 478292
Use of two-dimensional electrophoresis to identify and map new mouse genes.
Elliott RW
Genetics. 1979
PubMed ID: 447069
Apoprotein (E--A-II) complex of human plasma lipoproteins. I. Characterization of this mixed disulfide and its identification in a high density lipoprotein subfraction.
Weisgraber KH, Mahley RW
J Biol Chem. 1978
PubMed ID: 210174
The amino acid sequence of human APOA-I, an apolipoprotein isolated from high density lipoproteins.
Brewer HB, Fairwell T, LaRue A, Ronan R, Houser A, Bronzert TJ
Biochem Biophys Res Commun. 1978
PubMed ID: 204308
Role of apolipoprotein A-I in the structure of human serum high density lipoproteins. Reconstitution studies.
Ritter MC, Scanus AM
J Biol Chem. 1977
PubMed ID: 190223
The new era in restorative dental materials.
Phillips RW
Oper Dent. 1976
PubMed ID: 1076467
The primary structure of human plasma high density apolipoprotein glutamine I (ApoA-I). II. The amino acid sequence and alignment of cyanogen bromide fragments IV, III, and I.
Baker HN, Gotto AM, Jackson RL
J Biol Chem. 1975
PubMed ID: 164450
Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man.
Havel RJ, Kane JP, Kashyap ML
J Clin Invest. 1973
PubMed ID: 4345202
A protein cofactor of lecithin:cholesterol acyltransferase.
Fielding CJ, Shore VG, Fielding PE
Biochem Biophys Res Commun. 1972
PubMed ID: 4335615
Fractionation of human serum high density lipoprotein in urea solutions. Evidence for polypeptide heterogeneity.
Scanu A, Toth J, Edelstein C, Koga S, Stiller E
Biochemistry. 1969
PubMed ID: 4980192

Model Organism Phenotype Links from MGI Top Help

Model Organism Phenotype Links

External Links Top Help

	Human	Mouse	Rat
Entrez Gene	335	11806	25081
EnsEMBL Gene(s)	ENSG00000118137	ENSMUSG00000032083	N/A
Unigene	Hs.93194	Mm.26743	Rn.10308
Homologene	APOA1	Apoa1	Apoa1
OMIM	107680	N/A	N/A
GeneCards	APOA1	N/A	N/A
Beta Cell Genomics	DT.100845339 DT.100845340 DT.100845342 DT.100845344 DT.451322	DT.101741108 DT.40176266 DT.94156432 DT.99871655	N/A
Reactome	P02647	N/A	N/A
Plasma Peptide Atlas	ENSP00000236850	N/A	N/A
WikiGenes	335	11806	25081

External resources from NIDDK Consortium Interconnectivity Network Top Help

Relevant resources:

View this page in archive site

Interactor	Interactor	Sources	Classification	Pubmed IDs
APOA1	ERVK-10	IntAct	empirical	15174051
APOA1	ABCA7	Reactome	predicted
APOA1	CETP	HPRD	empirical	9305883
APOA1	SMPDL3A	IntAct	empirical	15174051
APOA1	LECT1	IntAct	empirical	15174051
APOA1	CLU	IntAct	empirical	15174051
APOA1	APOA1BP	HPRD, BioGRID	empirical	11991719
APOA1	FAM83C	IntAct	empirical	15174051
APOA1	CP	IntAct	empirical	15174051
APOA1	CTSL1	IntAct	empirical	15174051
APOA1	ABCA13	BioGRID	empirical	11162594
APOA1	DNTT	IntAct	empirical	15174051
APOA1	ABCA1	HPRD, BioGRID	empirical	12084722
APOA1	AKT2	IntAct	empirical	21988832
APOA1	ALB	IntAct	empirical	15174051
APOA1	ACSL1	IntAct	empirical	20391537
APOA1	FBLN1	IntAct	empirical	21988832
APOA1	FGA	IntAct	empirical	15174051
APOA1	NLRP1	IntAct	empirical	15174051
APOA1	SETX	IntAct	empirical	15174051
APOA1	RRP1B	IntAct	empirical	15174051
APOA1	FN1	IntAct	empirical	15174051
APOA1	ABCA6	IntAct	empirical	15174051
APOA1	FAM169A	IntAct	empirical	15174051
APOA1	GPLD1	HPRD, BioGRID	empirical	11254757
APOA1	IGKV2-40	IntAct	empirical	15174051
APOA1	SERTAD3	IntAct	empirical	15174051
APOA1	CFHR1	HPRD	empirical	8663389
APOA1	ZNRD1	IntAct	empirical	21988832
APOA1	APOF	HPRD, BioGRID	empirical	6816269
APOA1	HPR	HPRD	empirical	10085035
APOA1	APOA1	HPRD, BioGRID	empirical	9003180 9200714 9356442
APOA1	APOA2	Reactome	predicted	14732096 12518019 12692552 4345202
APOA1	APOA4	Reactome	predicted	14732096 12518019 12692552 4345202
APOA1	APOB	HPRD	empirical	7592581
APOA1	CLEC4G	IntAct, BioGRID	empirical	18624398
APOA1	APOC1	IntAct, BioGRID	empirical	15174051 11991719
APOA1	APOC2	Reactome	predicted	4345202
APOA1	APOC3	IntAct, Reactome	empirical	15174051 4345202
APOA1	APOE	Reactome	predicted	4345202
APOA1	IGHA1	IntAct	empirical	15174051
APOA1	IGHG1	IntAct	empirical	15174051
APOA1	IGHM	IntAct	empirical	15174051
APOA1	APP	IntAct	empirical	11297421
APOA1	IGKC	IntAct	empirical	15174051
APOA1	JAK3	IntAct	empirical	21988832
APOA1	KCNMA1	IntAct	empirical	19423573
APOA1	KRT1	IntAct	empirical	15174051
APOA1	KRT9	IntAct	empirical	15174051
APOA1	KRT16	IntAct	empirical	15174051
APOA1	LBP	HPRD, MIPS, BioGRID	empirical	8663389
APOA1	LCAT	HPRD, BioGRID	empirical	1587806 1644835
APOA1	ATP5B	HPRD	empirical	2687158
APOA1	PCMT1	HPRD, IntAct	empirical	16169070
APOA1	PDE1A	HPRD, BioGRID	empirical	11991719
APOA1	UCHL5	BioGRID	empirical	21800051
APOA1	PDE4B	IntAct	empirical	15174051
APOA1	PLTP	HPRD, BioGRID	empirical	11854286 9469594
APOA1	PON1	HPRD	empirical	16128586
APOA1	MOCOS	IntAct	empirical	15174051
APOA1	MAP7D1	HPRD, IntAct, BioGRID	empirical	16169070
APOA1	MAPK6	BioGRID	empirical	21900206
APOA1	QDPR	IntAct	empirical	15174051
APOA1	SAA2	BioGRID	empirical	11991719
APOA1	ROBO3	IntAct	empirical	15174051
APOA1	KIAA0754	IntAct	empirical	15174051
APOA1	TNS3	IntAct	empirical	15174051
APOA1	SPP1	IntAct	empirical	21988832
APOA1	TF	IntAct	empirical	15174051
APOA1	C1QA	IntAct	empirical	15174051
APOA1	C1QC	IntAct	empirical	15174051
APOA1	TTR	HPRD, IntAct	empirical	10627502 15174051
APOA1	MIS12	IntAct, BioGRID	empirical	20360068
APOA1	SPEF2	IntAct	empirical	15174051
APOA1	TXNDC2	IntAct	empirical	15174051
APOA1	PTPN5	IntAct	empirical	15174051
APOA1	APOL1	HPRD, BioGRID	empirical	9325276
APOA1	TNFRSF10C	HPRD, MINT, IntAct, BioGRID	empirical	16169070
APOA1	SCARB1	HPRD, BioGRID	empirical	1076467 10764676
APOA1	SAFB2	IntAct	empirical	15174051
APOA1	TOMM20	HPRD, MINT, IntAct, BioGRID	empirical	16169070